Carcinoma that arises from the PANCREATIC DUCTS. It accounts for the majority of cancers derived from the PANCREAS.
Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA).
Ducts that collect PANCREATIC JUICE from the PANCREAS and supply it to the DUODENUM.
A malignant neoplasm made up of epithelial cells tending to infiltrate the surrounding tissues and give rise to metastases. It is a histological type of neoplasm but is often wrongly used as a synonym for "cancer." (From Dorland, 27th ed)
An invasive (infiltrating) CARCINOMA of the mammary ductal system (MAMMARY GLANDS) in the human BREAST.
A lesion with cytological characteristics associated with invasive carcinoma but the tumor cells are confined to the epithelium of origin, without invasion of the basement membrane.
A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed)
A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested.
A malignant epithelial tumor with a glandular organization.
Histochemical localization of immunoreactive substances using labeled antibodies as reagents.
A noninvasive (noninfiltrating) carcinoma of the breast characterized by a proliferation of malignant epithelial cells confined to the mammary ducts or lobules, without light-microscopy evidence of invasion through the basement membrane into the surrounding stroma.
Malignant neoplasms involving the ductal systems of any of a number of organs, such as the MAMMARY GLANDS, the PANCREAS, the PROSTATE, or the LACRIMAL GLAND.
A nodular organ in the ABDOMEN that contains a mixture of ENDOCRINE GLANDS and EXOCRINE GLANDS. The small endocrine portion consists of the ISLETS OF LANGERHANS secreting a number of hormones into the blood stream. The large exocrine portion (EXOCRINE PANCREAS) is a compound acinar gland that secretes several digestive enzymes into the pancreatic ductal system that empties into the DUODENUM.
Molecular products metabolized and secreted by neoplastic tissue and characterized biochemically in cells or body fluids. They are indicators of tumor stage and grade as well as useful for monitoring responses to treatment and predicting recurrence. Many chemical groups are represented including hormones, antigens, amino and nucleic acids, enzymes, polyamines, and specific cell membrane proteins and lipids.
A malignant neoplasm characterized by the formation of numerous, irregular, finger-like projections of fibrous stroma that is covered with a surface layer of neoplastic epithelial cells. (Stedman, 25th ed)
A cell line derived from cultured tumor cells.
INFLAMMATION of the PANCREAS that is characterized by recurring or persistent ABDOMINAL PAIN with or without STEATORRHEA or DIABETES MELLITUS. It is characterized by the irregular destruction of the pancreatic parenchyma which may be focal, segmental, or diffuse.
Ability of neoplasms to infiltrate and actively destroy surrounding tissue.
An adenocarcinoma producing mucin in significant amounts. (From Dorland, 27th ed)
Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action in neoplastic tissue.
Surgical removal of the pancreas. (Dorland, 28th ed)
A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations.
A malignant tumor arising from secreting cells of a racemose gland, particularly the salivary glands. Racemose (Latin racemosus, full of clusters) refers, as does acinar (Latin acinus, grape), to small saclike dilatations in various glands. Acinar cell carcinomas are usually well differentiated and account for about 13% of the cancers arising in the parotid gland. Lymph node metastasis occurs in about 16% of cases. Local recurrences and distant metastases many years after treatment are common. This tumor appears in all age groups and is most common in women. (Stedman, 25th ed; Holland et al., Cancer Medicine, 3d ed, p1240; from DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p575)
Tumors or cancer of the human BREAST.
INFLAMMATION of the PANCREAS. Pancreatitis is classified as acute unless there are computed tomographic or endoscopic retrograde cholangiopancreatographic findings of CHRONIC PANCREATITIS (International Symposium on Acute Pancreatitis, Atlanta, 1992). The two most common forms of acute pancreatitis are ALCOHOLIC PANCREATITIS and gallstone pancreatitis.
Tumors or cancer of the LIVER.
The excision of the head of the pancreas and the encircling loop of the duodenum to which it is connected.
Methods which attempt to express in replicable terms the extent of the neoplasm in the patient.
The fluid containing digestive enzymes secreted by the pancreas in response to food in the duodenum.
The simultaneous analysis of multiple samples of TISSUES or CELLS from BIOPSY or in vitro culture that have been arranged in an array format on slides or microchips.
A malignant skin neoplasm that seldom metastasizes but has potentialities for local invasion and destruction. Clinically it is divided into types: nodular, cicatricial, morphaic, and erythematoid (pagetoid). They develop on hair-bearing skin, most commonly on sun-exposed areas. Approximately 85% are found on the head and neck area and the remaining 15% on the trunk and limbs. (From DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1471)
Family of retrovirus-associated DNA sequences (ras) originally isolated from Harvey (H-ras, Ha-ras, rasH) and Kirsten (K-ras, Ki-ras, rasK) murine sarcoma viruses. Ras genes are widely conserved among animal species and sequences corresponding to both H-ras and K-ras genes have been detected in human, avian, murine, and non-vertebrate genomes. The closely related N-ras gene has been detected in human neuroblastoma and sarcoma cell lines. All genes of the family have a similar exon-intron structure and each encodes a p21 protein.
Pathological processes that tend eventually to become malignant. (From Dorland, 27th ed)
A variation of the PCR technique in which cDNA is made from RNA via reverse transcription. The resultant cDNA is then amplified using standard PCR protocols.
Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely.
An adenocarcinoma containing finger-like processes of vascular connective tissue covered by neoplastic epithelium, projecting into cysts or the cavity of glands or follicles. It occurs most frequently in the ovary and thyroid gland. (Stedman, 25th ed)
Mutant mice homozygous for the recessive gene "nude" which fail to develop a thymus. They are useful in tumor studies and studies on immune responses.
All of the processes involved in increasing CELL NUMBER including CELL DIVISION.
Transfer of a neoplasm from its primary site to lymph nodes or to distant parts of the body by way of the lymphatic system.
Cells lining the saclike dilatations known as acini of various glands or the lungs.
Cellular proteins encoded by the H-ras, K-ras and N-ras genes. The proteins have GTPase activity and are involved in signal transduction as monomeric GTP-binding proteins. Elevated levels of p21 c-ras have been associated with neoplasia. This enzyme was formerly listed as EC 3.6.1.47.
Proteins whose abnormal expression (gain or loss) are associated with the development, growth, or progression of NEOPLASMS. Some neoplasm proteins are tumor antigens (ANTIGENS, NEOPLASM), i.e. they induce an immune reaction to their tumor. Many neoplasm proteins have been characterized and are used as tumor markers (BIOMARKERS, TUMOR) when they are detectable in cells and body fluids as monitors for the presence or growth of tumors. Abnormal expression of ONCOGENE PROTEINS is involved in neoplastic transformation, whereas the loss of expression of TUMOR SUPPRESSOR PROTEINS is involved with the loss of growth control and progression of the neoplasm.
A signal transducing adaptor protein and tumor suppressor protein. It forms a complex with activated RECEPTOR-REGULATED SMAD PROTEINS. The complex then translocates to the CELL NUCLEUS and regulates GENETIC TRANSCRIPTION of target GENES.
The transfer of a neoplasm from one organ or part of the body to another remote from the primary site.
The worsening of a disease over time. This concept is most often used for chronic and incurable diseases where the stage of the disease is an important determinant of therapy and prognosis.
A malignant neoplasm derived from TRANSITIONAL EPITHELIAL CELLS, occurring chiefly in the URINARY BLADDER; URETERS; or RENAL PELVIS.
RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm.
Cell changes manifested by escape from control mechanisms, increased growth potential, alterations in the cell surface, karyotypic abnormalities, morphological and biochemical deviations from the norm, and other attributes conferring the ability to invade, metastasize, and kill.
Malignant neoplasm arising from the epithelium of the BRONCHI. It represents a large group of epithelial lung malignancies which can be divided into two clinical groups: SMALL CELL LUNG CANCER and NON-SMALL-CELL LUNG CARCINOMA.
Two or more abnormal growths of tissue occurring simultaneously and presumed to be of separate origin. The neoplasms may be histologically the same or different, and may be found in the same or different sites.
A carcinoma composed mainly of epithelial elements with little or no stroma. Medullary carcinomas of the breast constitute 5%-7% of all mammary carcinomas; medullary carcinomas of the thyroid comprise 3%-10% of all thyroid malignancies. (From Dorland, 27th ed; DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1141; Segen, Dictionary of Modern Medicine, 1992)
A nonparametric method of compiling LIFE TABLES or survival tables. It combines calculated probabilities of survival and estimates to allow for observations occurring beyond a measurement threshold, which are assumed to occur randomly. Time intervals are defined as ending each time an event occurs and are therefore unequal. (From Last, A Dictionary of Epidemiology, 1995)
Carcinoma characterized by bands or cylinders of hyalinized or mucinous stroma separating or surrounded by nests or cords of small epithelial cells. When the cylinders occur within masses of epithelial cells, they give the tissue a perforated, sievelike, or cribriform appearance. Such tumors occur in the mammary glands, the mucous glands of the upper and lower respiratory tract, and the salivary glands. They are malignant but slow-growing, and tend to spread locally via the nerves. (Dorland, 27th ed)
A dilation of the duodenal papilla that is the opening of the juncture of the COMMON BILE DUCT and the MAIN PANCREATIC DUCT, also known as the hepatopancreatic ampulla.
An anaplastic, highly malignant, and usually bronchogenic carcinoma composed of small ovoid cells with scanty neoplasm. It is characterized by a dominant, deeply basophilic nucleus, and absent or indistinct nucleoli. (From Stedman, 25th ed; Holland et al., Cancer Medicine, 3d ed, p1286-7)
The determination of the pattern of genes expressed at the level of GENETIC TRANSCRIPTION, under specific circumstances or in a specific cell.
A condition in which there is a change of one adult cell type to another similar adult cell type.
A class of statistical procedures for estimating the survival function (function of time, starting with a population 100% well at a given time and providing the percentage of the population still well at later times). The survival analysis is then used for making inferences about the effects of treatments, prognostic factors, exposures, and other covariates on the function.
The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site.
A infiltrating (invasive) breast cancer, relatively uncommon, accounting for only 5%-10% of breast tumors in most series. It is often an area of ill-defined thickening in the breast, in contrast to the dominant lump characteristic of ductal carcinoma. It is typically composed of small cells in a linear arrangement with a tendency to grow around ducts and lobules. There is likelihood of axillary nodal involvement with metastasis to meningeal and serosal surfaces. (DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1205)
Experimental transplantation of neoplasms in laboratory animals for research purposes.
The proportion of survivors in a group, e.g., of patients, studied and followed over a period, or the proportion of persons in a specified group alive at the beginning of a time interval who survive to the end of the interval. It is often studied using life table methods.
A group of carcinomas which share a characteristic morphology, often being composed of clusters and trabecular sheets of round "blue cells", granular chromatin, and an attenuated rim of poorly demarcated cytoplasm. Neuroendocrine tumors include carcinoids, small ("oat") cell carcinomas, medullary carcinoma of the thyroid, Merkel cell tumor, cutaneous neuroendocrine carcinoma, pancreatic islet cell tumors, and pheochromocytoma. Neurosecretory granules are found within the tumor cells. (Segen, Dictionary of Modern Medicine, 1992)
Immunologic techniques based on the use of: (1) enzyme-antibody conjugates; (2) enzyme-antigen conjugates; (3) antienzyme antibody followed by its homologous enzyme; or (4) enzyme-antienzyme complexes. These are used histologically for visualizing or labeling tissue specimens.
Deoxycytidine is a nucleoside that is a building block of DNA and is involved in DNA replication and repair.
Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons.
Sialylated Lewis blood group carbohydrate antigen found in many adenocarcinomas of the digestive tract, especially pancreatic tumors.
Cells that line the inner and outer surfaces of the body by forming cellular layers (EPITHELIUM) or masses. Epithelial cells lining the SKIN; the MOUTH; the NOSE; and the ANAL CANAL derive from ectoderm; those lining the RESPIRATORY SYSTEM and the DIGESTIVE SYSTEM derive from endoderm; others (CARDIOVASCULAR SYSTEM and LYMPHATIC SYSTEM) derive from mesoderm. Epithelial cells can be classified mainly by cell shape and function into squamous, glandular and transitional epithelial cells.
Nuclear phosphoprotein encoded by the p53 gene (GENES, P53) whose normal function is to control CELL PROLIFERATION and APOPTOSIS. A mutant or absent p53 protein has been found in LEUKEMIA; OSTEOSARCOMA; LUNG CANCER; and COLORECTAL CANCER.
Tumors or cancer of the NASOPHARYNX.
DNA present in neoplastic tissue.
Cyclic S-oxides are a class of organic compounds containing a sulfur-oxygen ring, which have potential medicinal applications such as anti-inflammatory and analgesic effects.
The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway.
Substances that inhibit or prevent the proliferation of NEOPLASMS.
Tumors or cancer of the THYROID GLAND.
In humans, one of the paired regions in the anterior portion of the THORAX. The breasts consist of the MAMMARY GLANDS, the SKIN, the MUSCLES, the ADIPOSE TISSUE, and the CONNECTIVE TISSUES.
Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series.
Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations.
Small, monomeric GTP-binding proteins encoded by ras genes (GENES, RAS). The protooncogene-derived protein, PROTO-ONCOGENE PROTEIN P21(RAS), plays a role in normal cellular growth, differentiation and development. The oncogene-derived protein (ONCOGENE PROTEIN P21(RAS)) can play a role in aberrant cellular regulation during neoplastic cell transformation (CELL TRANSFORMATION, NEOPLASTIC). This enzyme was formerly listed as EC 3.6.1.47.
One of the mechanisms by which CELL DEATH occurs (compare with NECROSIS and AUTOPHAGOCYTOSIS). Apoptosis is the mechanism responsible for the physiological deletion of cells and appears to be intrinsically programmed. It is characterized by distinctive morphologic changes in the nucleus and cytoplasm, chromatin cleavage at regularly spaced sites, and the endonucleolytic cleavage of genomic DNA; (DNA FRAGMENTATION); at internucleosomal sites. This mode of cell death serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth.
A mixed adenocarcinoma and squamous cell or epidermoid carcinoma.
Carbohydrate antigen elevated in patients with tumors of the breast, ovary, lung, and prostate as well as other disorders. The mucin is expressed normally by most glandular epithelia but shows particularly increased expression in the breast at lactation and in malignancy. It is thus an established serum marker for breast cancer.
Tumors or cancer of the LUNG.
A class of fibrous proteins or scleroproteins that represents the principal constituent of EPIDERMIS; HAIR; NAILS; horny tissues, and the organic matrix of tooth ENAMEL. Two major conformational groups have been characterized, alpha-keratin, whose peptide backbone forms a coiled-coil alpha helical structure consisting of TYPE I KERATIN and a TYPE II KERATIN, and beta-keratin, whose backbone forms a zigzag or pleated sheet structure. alpha-Keratins have been classified into at least 20 subtypes. In addition multiple isoforms of subtypes have been found which may be due to GENE DUPLICATION.
Calcium-dependent cell adhesion proteins. They are important in the formation of ADHERENS JUNCTIONS between cells. Cadherins are classified by their distinct immunological and tissue specificities, either by letters (E- for epithelial, N- for neural, and P- for placental cadherins) or by numbers (cadherin-12 or N-cadherin 2 for brain-cadherin). Cadherins promote cell adhesion via a homophilic mechanism as in the construction of tissues and of the whole animal body.
A tumor of both low- and high-grade malignancy. The low-grade grow slowly, appear in any age group, and are readily cured by excision. The high-grade behave aggressively, widely infiltrate the salivary gland and produce lymph node and distant metastases. Mucoepidermoid carcinomas account for about 21% of the malignant tumors of the parotid gland and 10% of the sublingual gland. They are the most common malignant tumor of the parotid. (From DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p575; Holland et al., Cancer Medicine, 3d ed, p1240)
Genes that inhibit expression of the tumorigenic phenotype. They are normally involved in holding cellular growth in check. When tumor suppressor genes are inactivated or lost, a barrier to normal proliferation is removed and unregulated growth is possible.
RNA present in neoplastic tissue.
The total amount (cell number, weight, size or volume) of tumor cells or tissue in the body.
Star-shaped, myofibroblast-like cells located in the periacinar, perivascular, and periductal regions of the EXOCRINE PANCREAS. They play a key role in the pathobiology of FIBROSIS; PANCREATITIS; and PANCREATIC CANCER.
Tumor or cancer of the COMMON BILE DUCT including the AMPULLA OF VATER and the SPHINCTER OF ODDI.
Methods which attempt to express in replicable terms the level of CELL DIFFERENTIATION in neoplasms as increasing ANAPLASIA correlates with the aggressiveness of the neoplasm.
A class of compounds that contain a -NH2 and a -NO radical. Many members of this group have carcinogenic and mutagenic properties.
Proteins, glycoprotein, or lipoprotein moieties on surfaces of tumor cells that are usually identified by monoclonal antibodies. Many of these are of either embryonic or viral origin.
A benign neoplasm of the ovary.
Hybridization of a nucleic acid sample to a very large set of OLIGONUCLEOTIDE PROBES, which have been attached individually in columns and rows to a solid support, to determine a BASE SEQUENCE, or to detect variations in a gene sequence, GENE EXPRESSION, or for GENE MAPPING.
A malignant cystic or semisolid tumor most often occurring in the ovary. Rarely, one is solid. This tumor may develop from a mucinous cystadenoma, or it may be malignant at the onset. The cysts are lined with tall columnar epithelial cells; in others, the epithelium consists of many layers of cells that have lost normal structure entirely. In the more undifferentiated tumors, one may see sheets and nests of tumor cells that have very little resemblance to the parent structure. (Hughes, Obstetric-Gynecologic Terminology, 1972, p184)
Basic glycoprotein members of the SERPIN SUPERFAMILY that function as COLLAGEN-specific MOLECULAR CHAPERONES in the ENDOPLASMIC RETICULUM.
One or more layers of EPITHELIAL CELLS, supported by the basal lamina, which covers the inner or outer surfaces of the body.
An adenocarcinoma characterized by the presence of cells resembling the glandular cells of the ENDOMETRIUM. It is a common histological type of ovarian CARCINOMA and ENDOMETRIAL CARCINOMA. There is a high frequency of co-occurrence of this form of adenocarcinoma in both tissues.
Soft tissue tumors or cancer arising from the mucosal surfaces of the LIP; oral cavity; PHARYNX; LARYNX; and cervical esophagus. Other sites included are the NOSE and PARANASAL SINUSES; SALIVARY GLANDS; THYROID GLAND and PARATHYROID GLANDS; and MELANOMA and non-melanoma skin cancers of the head and neck. (from Holland et al., Cancer Medicine, 4th ed, p1651)
In vivo methods of screening investigative anticancer drugs, biologic response modifiers or radiotherapies. Human tumor tissue or cells are transplanted into mice or rats followed by tumor treatment regimens. A variety of outcomes are monitored to assess antitumor effectiveness.
The conic organs which usually give outlet to milk from the mammary glands.
Identification of proteins or peptides that have been electrophoretically separated by blot transferring from the electrophoresis gel to strips of nitrocellulose paper, followed by labeling with antibody probes.
A type I keratin found associated with KERATIN-7 in ductal epithelia and gastrointestinal epithelia.
Pathological processes of the PANCREAS.
The phenotypic manifestation of a gene or genes by the processes of GENETIC TRANSCRIPTION and GENETIC TRANSLATION.
A highly malignant, primitive form of carcinoma, probably of germinal cell or teratomatous derivation, usually arising in a gonad and rarely in other sites. It is rare in the female ovary, but in the male it accounts for 20% of all testicular tumors. (From Dorland, 27th ed & Holland et al., Cancer Medicine, 3d ed, p1595)
Tumors or cancer of the ESOPHAGUS.
Elements of limited time intervals, contributing to particular results or situations.
Tumors or cancer of the MOUTH.
A product of the p16 tumor suppressor gene (GENES, P16). It is also called INK4 or INK4A because it is the prototype member of the INK4 CYCLIN-DEPENDENT KINASE INHIBITORS. This protein is produced from the alpha mRNA transcript of the p16 gene. The other gene product, produced from the alternatively spliced beta transcript, is TUMOR SUPPRESSOR PROTEIN P14ARF. Both p16 gene products have tumor suppressor functions.
A carcinoma arising from MERKEL CELLS located in the basal layer of the epidermis and occurring most commonly as a primary neuroendocrine carcinoma of the skin. Merkel cells are tactile cells of neuroectodermal origin and histologically show neurosecretory granules. The skin of the head and neck are a common site of Merkel cell carcinoma, occurring generally in elderly patients. (Holland et al., Cancer Medicine, 3d ed, p1245)
Fiberoptic endoscopy designed for duodenal observation and cannulation of VATER'S AMPULLA, in order to visualize the pancreatic and biliary duct system by retrograde injection of contrast media. Endoscopic (Vater) papillotomy (SPHINCTEROTOMY, ENDOSCOPIC) may be performed during this procedure.
Transplantation between animals of different species.
The milieu surrounding neoplasms consisting of cells, vessels, soluble factors, and molecules, that can influence and be influenced by, the neoplasm's growth.
The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION.
Processes required for CELL ENLARGEMENT and CELL PROLIFERATION.
Small double-stranded, non-protein coding RNAs (21-31 nucleotides) involved in GENE SILENCING functions, especially RNA INTERFERENCE (RNAi). Endogenously, siRNAs are generated from dsRNAs (RNA, DOUBLE-STRANDED) by the same ribonuclease, Dicer, that generates miRNAs (MICRORNAS). The perfect match of the siRNAs' antisense strand to their target RNAs mediates RNAi by siRNA-guided RNA cleavage. siRNAs fall into different classes including trans-acting siRNA (tasiRNA), repeat-associated RNA (rasiRNA), small-scan RNA (scnRNA), and Piwi protein-interacting RNA (piRNA) and have different specific gene silencing functions.
Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS.
Laboratory mice that have been produced from a genetically manipulated EGG or EMBRYO, MAMMALIAN.
An increase in the number of cells in a tissue or organ without tumor formation. It differs from HYPERTROPHY, which is an increase in bulk without an increase in the number of cells.
A positive regulatory effect on physiological processes at the molecular, cellular, or systemic level. At the molecular level, the major regulatory sites include membrane receptors, genes (GENE EXPRESSION REGULATION), mRNAs (RNA, MESSENGER), and proteins.
High molecular weight mucoproteins that protect the surface of EPITHELIAL CELLS by providing a barrier to particulate matter and microorganisms. Membrane-anchored mucins may have additional roles concerned with protein interactions at the cell surface.
A gel-forming mucin found predominantly in SMALL INTESTINE and variety of mucous membrane-containing organs. It provides a protective, lubricating barrier against particles and infectious agents.
A negative regulatory effect on physiological processes at the molecular, cellular, or systemic level. At the molecular level, the major regulatory sites include membrane receptors, genes (GENE EXPRESSION REGULATION), mRNAs (RNA, MESSENGER), and proteins.
A homolog of ALPHA-SYNUCLEIN that plays a role in neurofilament network integrity. It is overexpressed in a variety of human NEOPLASMS and may be involved in modulating AXON architecture during EMBRYONIC DEVELOPMENT and in the adult. Gamma-Synuclein may also activate SIGNAL TRANSDUCTION PATHWAYS associated with ETS-DOMAIN PROTEIN ELK-1.
Tumors or cancer of the COLON.
A malignant neoplasm of the ADRENAL CORTEX. Adrenocortical carcinomas are unencapsulated anaplastic (ANAPLASIA) masses sometimes exceeding 20 cm or 200 g. They are more likely to be functional than nonfunctional, and produce ADRENAL CORTEX HORMONES that may result in hypercortisolism (CUSHING SYNDROME); HYPERALDOSTERONISM; and/or VIRILISM.
Death resulting from the presence of a disease in an individual, as shown by a single case report or a limited number of patients. This should be differentiated from DEATH, the physiological cessation of life and from MORTALITY, an epidemiological or statistical concept.
Products of proto-oncogenes. Normally they do not have oncogenic or transforming properties, but are involved in the regulation or differentiation of cell growth. They often have protein kinase activity.
Connective tissue cells of an organ found in the loose connective tissue. These are most often associated with the uterine mucosa and the ovary as well as the hematopoietic system and elsewhere.
A variant of well-differentiated epidermoid carcinoma that is most common in the oral cavity, but also occurs in the larynx, nasal cavity, esophagus, penis, anorectal region, vulva, vagina, uterine cervix, and skin, especially on the sole of the foot. Most intraoral cases occur in elderly male abusers of smokeless tobacco. The treatment is surgical resection. Radiotherapy is not indicated, as up to 30% treated with radiation become highly aggressive within six months. (Segen, Dictionary of Modern Medicine, 1992)
Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease.
Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs.
A poorly differentiated adenocarcinoma in which the nucleus is pressed to one side by a cytoplasmic droplet of mucus. It usually arises in the gastrointestinal system.
Diffusible gene products that act on homologous or heterologous molecules of viral or cellular DNA to regulate the expression of proteins.
Tumors or cancer of the URINARY BLADDER.
Tumors or cancer of the STOMACH.
Naturally occurring or experimentally induced animal diseases with pathological processes sufficiently similar to those of human diseases. They are used as study models for human diseases.
Tomography using x-ray transmission and a computer algorithm to reconstruct the image.
Small double-stranded, non-protein coding RNAs, 21-25 nucleotides in length generated from single-stranded microRNA gene transcripts by the same RIBONUCLEASE III, Dicer, that produces small interfering RNAs (RNA, SMALL INTERFERING). They become part of the RNA-INDUCED SILENCING COMPLEX and repress the translation (TRANSLATION, GENETIC) of target RNA by binding to homologous 3'UTR region as an imperfect match. The small temporal RNAs (stRNAs), let-7 and lin-4, from C. elegans, are the first 2 miRNAs discovered, and are from a class of miRNAs involved in developmental timing.
Tumors or cancer of the SKIN.
The movement of cells from one location to another. Distinguish from CYTOKINESIS which is the process of dividing the CYTOPLASM of a cell.
Period after successful treatment in which there is no appearance of the symptoms or effects of the disease.
An abnormal concretion occurring mostly in the urinary and biliary tracts, usually composed of mineral salts. Also called stones.
Cyst-like space not lined by EPITHELIUM and contained within the PANCREAS. Pancreatic pseudocysts account for most of the cystic collections in the pancreas and are often associated with chronic PANCREATITIS.
A cell surface receptor involved in regulation of cell growth and differentiation. It is specific for EPIDERMAL GROWTH FACTOR and EGF-related peptides including TRANSFORMING GROWTH FACTOR ALPHA; AMPHIREGULIN; and HEPARIN-BINDING EGF-LIKE GROWTH FACTOR. The binding of ligand to the receptor causes activation of its intrinsic tyrosine kinase activity and rapid internalization of the receptor-ligand complex into the cell.
MAMMARY GLANDS in the non-human MAMMALS.
A cell surface protein-tyrosine kinase receptor that is overexpressed in a variety of ADENOCARCINOMAS. It has extensive homology to and heterodimerizes with the EGF RECEPTOR, the ERBB-3 RECEPTOR, and the ERBB-4 RECEPTOR. Activation of the erbB-2 receptor occurs through heterodimer formation with a ligand-bound erbB receptor family member.
Interruption or suppression of the expression of a gene at transcriptional or translational levels.
The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence.
A family of serine proteinase inhibitors which are similar in amino acid sequence and mechanism of inhibition, but differ in their specificity toward proteolytic enzymes. This family includes alpha 1-antitrypsin, angiotensinogen, ovalbumin, antiplasmin, alpha 1-antichymotrypsin, thyroxine-binding protein, complement 1 inactivators, antithrombin III, heparin cofactor II, plasminogen inactivators, gene Y protein, placental plasminogen activator inhibitor, and barley Z protein. Some members of the serpin family may be substrates rather than inhibitors of SERINE ENDOPEPTIDASES, and some serpins occur in plants where their function is not known.
A cystic tumor of the ovary, containing thin, clear, yellow serous fluid and varying amounts of solid tissue, with a malignant potential several times greater than that of mucinous cystadenoma (CYSTADENOMA, MUCINOUS). It can be unilocular, parvilocular, or multilocular. It is often bilateral and papillary. The cysts may vary greatly in size. (Dorland, 27th ed; from Hughes, Obstetric-Gynecologic Terminology, 1972)
A CELL CYCLE and tumor growth marker which can be readily detected using IMMUNOCYTOCHEMISTRY methods. Ki-67 is a nuclear antigen present only in the nuclei of cycling cells.
A tumor of undifferentiated (anaplastic) cells of large size. It is usually bronchogenic. (From Dorland, 27th ed)
Antibodies produced by a single clone of cells.
Mice homozygous for the mutant autosomal recessive gene "scid" which is located on the centromeric end of chromosome 16. These mice lack mature, functional lymphocytes and are thus highly susceptible to lethal opportunistic infections if not chronically treated with antibiotics. The lack of B- and T-cell immunity resembles severe combined immunodeficiency (SCID) syndrome in human infants. SCID mice are useful as animal models since they are receptive to implantation of a human immune system producing SCID-human (SCID-hu) hematochimeric mice.
The uptake of naked or purified DNA by CELLS, usually meaning the process as it occurs in eukaryotic cells. It is analogous to bacterial transformation (TRANSFORMATION, BACTERIAL) and both are routinely employed in GENE TRANSFER TECHNIQUES.
A set of techniques used when variation in several variables has to be studied simultaneously. In statistics, multivariate analysis is interpreted as any analytic method that allows simultaneous study of two or more dependent variables.
Cytoplasmic proteins that bind estrogens and migrate to the nucleus where they regulate DNA transcription. Evaluation of the state of estrogen receptors in breast cancer patients has become clinically important.
Any of the ducts which transport saliva. Salivary ducts include the parotid duct, the major and minor sublingual ducts, and the submandibular duct.
A pathologic process consisting of the proliferation of blood vessels in abnormal tissues or in abnormal positions.
A glycoprotein that is secreted into the luminal surface of the epithelia in the gastrointestinal tract. It is found in the feces and pancreaticobiliary secretions and is used to monitor the response to colon cancer treatment.
Resistance or diminished response of a neoplasm to an antineoplastic agent in humans, animals, or cell or tissue cultures.
Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed)
A multi-functional catenin that participates in CELL ADHESION and nuclear signaling. Beta catenin binds CADHERINS and helps link their cytoplasmic tails to the ACTIN in the CYTOSKELETON via ALPHA CATENIN. It also serves as a transcriptional co-activator and downstream component of WNT PROTEIN-mediated SIGNAL TRANSDUCTION PATHWAYS.
The period before a surgical operation.
Procedures of applying ENDOSCOPES for disease diagnosis and treatment. Endoscopy involves passing an optical instrument through a small incision in the skin i.e., percutaneous; or through a natural orifice and along natural body pathways such as the digestive tract; and/or through an incision in the wall of a tubular structure or organ, i.e. transluminal, to examine or perform surgery on the interior parts of the body.
Endogenous substances, usually proteins, which are effective in the initiation, stimulation, or termination of the genetic transcription process.
They are oval or bean shaped bodies (1 - 30 mm in diameter) located along the lymphatic system.
Cancers or tumors of the LARYNX or any of its parts: the GLOTTIS; EPIGLOTTIS; LARYNGEAL CARTILAGES; LARYNGEAL MUSCLES; and VOCAL CORDS.
Tumors or cancer of the UTERINE CERVIX.
The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability.
Methods used for detecting the amplified DNA products from the polymerase chain reaction as they accumulate instead of at the end of the reaction.
A fetal blood vessel connecting the pulmonary artery with the descending aorta.
A peptide hormone of about 27 amino acids from the duodenal mucosa that activates pancreatic secretion and lowers the blood sugar level. (USAN and the USP Dictionary of Drug Names, 1994, p597)
Studies which start with the identification of persons with a disease of interest and a control (comparison, referent) group without the disease. The relationship of an attribute to the disease is examined by comparing diseased and non-diseased persons with regard to the frequency or levels of the attribute in each group.
Experimentally induced new abnormal growth of TISSUES in animals to provide models for studying human neoplasms.
A technique that localizes specific nucleic acid sequences within intact chromosomes, eukaryotic cells, or bacterial cells through the use of specific nucleic acid-labeled probes.
A genus of the family Muridae having three species. The present domesticated strains were developed from individuals brought from Syria. They are widely used in biomedical research.
The smallest member of the MATRIX METALLOPROTEINASES. It plays a role in tumor progression.
Proteins that are normally involved in holding cellular growth in check. Deficiencies or abnormalities in these proteins may lead to unregulated cell growth and tumor development.
DNA sequences which are recognized (directly or indirectly) and bound by a DNA-dependent RNA polymerase during the initiation of transcription. Highly conserved sequences within the promoter include the Pribnow box in bacteria and the TATA BOX in eukaryotes.
Statistical models used in survival analysis that assert that the effect of the study factors on the hazard rate in the study population is multiplicative and does not change over time.
An adenocarcinoma of the thyroid gland, in which the cells are arranged in the form of follicles. (From Dorland, 27th ed)
Phenotypic changes of EPITHELIAL CELLS to MESENCHYME type, which increase cell mobility critical in many developmental processes such as NEURAL TUBE development. NEOPLASM METASTASIS and DISEASE PROGRESSION may also induce this transition.
Antimetabolites that are useful in cancer chemotherapy.
Experimentally induced mammary neoplasms in animals to provide a model for studying human BREAST NEOPLASMS.
Established cell cultures that have the potential to propagate indefinitely.
Proteins encoded by homeobox genes (GENES, HOMEOBOX) that exhibit structural similarity to certain prokaryotic and eukaryotic DNA-binding proteins. Homeodomain proteins are involved in the control of gene expression during morphogenesis and development (GENE EXPRESSION REGULATION, DEVELOPMENTAL).
The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment.
Biochemical identification of mutational changes in a nucleotide sequence.
In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test.
Tumors or cancer of the gallbladder.
The artificial induction of GENE SILENCING by the use of RNA INTERFERENCE to reduce the expression of a specific gene. It includes the use of DOUBLE-STRANDED RNA, such as SMALL INTERFERING RNA and RNA containing HAIRPIN LOOP SEQUENCE, and ANTI-SENSE OLIGONUCLEOTIDES.
Pathological processes of the BREAST.
A family of intercellular signaling proteins that play and important role in regulating the development of many TISSUES and organs. Their name derives from the observation of a hedgehog-like appearance in DROSOPHILA embryos with genetic mutations that block their action.
The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used.
The malignant stem cells of TERATOCARCINOMAS, which resemble pluripotent stem cells of the BLASTOCYST INNER CELL MASS. The EC cells can be grown in vitro, and experimentally induced to differentiate. They are used as a model system for studying early embryonic cell differentiation.
Proteins found in the nucleus of a cell. Do not confuse with NUCLEOPROTEINS which are proteins conjugated with nucleic acids, that are not necessarily present in the nucleus.
Proteins which bind to DNA. The family includes proteins which bind to both double- and single-stranded DNA and also includes specific DNA binding proteins in serum which can be used as markers for malignant diseases.

Dpc-4 protein is expressed in virtually all human intraductal papillary mucinous neoplasms of the pancreas: comparison with conventional ductal adenocarcinomas. (1/1051)

DPC4 (MADH4, SMAD4) encodes a nuclear transcription factor shown to be genetically inactivated in over one-half of conventional infiltrating ductal adenocarcinomas of the pancreas. Intraductal papillary mucinous neoplasms (IPMNs) of the pancreas have been suggested to be distinct neoplasms with a significantly less aggressive course than conventional ductal adenocarcinomas of the pancreas, but molecular comparisons of these tumor types have previously been impaired by technical difficulties. Recently, immunohistochemical labeling for the DPC4 gene product has been shown to be an extremely sensitive and specific marker for DPC4 gene alterations in pancreatic adenocarcinomas. Therefore, we analyzed the immunohistochemical expression of Dpc4 protein in 79 IPMNs using a previously characterized monoclonal antibody. Twenty-nine of the IPMNs also had an associated infiltrating adenocarcinoma available for analysis. The labeling patterns observed were compared to those we have previously reported for conventional ductal carcinomas. All 79 of the intraductal components of the IPMNs strongly expressed Dpc4 protein. In 77 of the 79 cases (97%), the labeling was diffusely positive, and in 2 of the 79 (3%) the labeling was focally positive. Dpc4 expression was seen in 28 (97%) of the associated 29 invasive cancers. The one infiltrating carcinoma that showed loss of Dpc4 expression was associated with an intraductal component which showed focal loss of Dpc4 expression. The strong and almost universal expression of Dpc4 in IPMNs contrasts sharply with the loss of Dpc4 expression seen in approximately 30% of in situ adenocarcinomas of the pancreas (so-called pancreatic intraepithelial neoplasms, grade 3; P: < 0.001) and in 55% of pancreatic duct carcinomas (P: < 0.0001). Differences in Dpc4 expression between IPMNs and ductal carcinomas suggest a fundamental genetic difference in tumorigenesis, which may relate to the significantly better clinical outcomes observed for IPMNs.  (+info)

Phase III evaluation of octreotide versus chemotherapy with 5-fluorouracil or 5-fluorouracil plus leucovorin in advanced exocrine pancreatic cancer: a North Central Cancer Treatment Group study. (2/1051)

There continues to be a need for new systemic approaches for the treatment of advanced pancreatic cancer. The purpose of this study was to compare the antitumor activity of the somatostatin analogue octreotide to 5-fluorouracil chemotherapy in a Phase III setting. Eighty-four patients with an Eastern Cooperative Oncology Group performance status of 0 or 1 and limited tumor volume were randomized to receive octreotide 200 microg three times daily or 5-fluorouracil with or without leucovorin. After the first 12 patients had been randomized to octreotide, we increased the dose in the remaining patients to 500 microg three times daily. This change was based on early reports in other studies, suggesting that our original dose may not have been effective and that higher doses of octreotide were well tolerated. A planned interim analysis performed after 84 patients were enrolled demonstrated inferior time to progression and survival for the patients randomized to octreotide. Further accrual to the octreotide arm of this protocol was therefore terminated. Octreotide in doses of 200-500 microg three times daily does not delay progression or extend survival in patients with advanced pancreatic cancer compared with treatment with 5-fluorouracil with or without leucovorin.  (+info)

Expression of stromal cell-derived factor 1 and CXCR4 ligand receptor system in pancreatic cancer: a possible role for tumor progression. (3/1051)

To examine the expression of the stromal cell-derived factor 1 (SDF-1)/CXCR4 receptor ligand system in pancreatic cancer cells and endothelial cells, we performed immunohistochemical analysis for 52 pancreatic cancer tissue samples with anti-CXCR4 antibody and reverse transcription-PCR analysis for CXCR4 and SDF-1 in five pancreatic cancer cell lines (AsPC-1, BxPC-3, CFPAC-1, HPAC, and PANC-1), an endothelial cell line (HUVEC), and eight pancreatic cancer tissues. We then performed cell migration assay on AsPC-1 cells, HUVECs, and CFPAC-1 cells in the presence of SDF-1 or MRC-9 fibroblast cells. Immunoreactive CXCR4 was found mainly in pancreatic cancer cells and endothelial cells of relatively large vessels around a tumorous lesion. The immunopositive ratio in the pancreatic cancer was 71.2%. There was no statistically significant correlation with clinicopathological features. SDF-1 mRNA expressions were detected in all pancreatic cancer tissues but not in pancreatic cancer cell lines and HUVECs; meanwhile, CXCR4 mRNA was detected in all pancreatic cancer tissues, cancer cell lines, and HUVECs. The results indicate that the paracrine mechanism is involved in the SDF-1/CXCR4 receptor ligand system in pancreatic cancer. In vitro studies demonstrated that SDF-1 significantly increased the migration ability of AsPC-1 and HUVECs, and these effects were inhibited by CXCR4 antagonist T22, and that the coculture system with MRC-9 also increased the migration ability of CFPAC-1 cells, and this effect was significantly inhibited by T22. Our results suggested that the SDF-1/CXCR4 receptor ligand system may have a possible role in the pancreatic cancer progression through tumor cell migration and angiogenesis.  (+info)

Multiple primaries in pancreatic cancer patients: indicator of a genetic predisposition? (4/1051)

BACKGROUND: The genetic basis of several familial cancers including breast and colon cancers has been identified recently. The occurrence of multiple cancers in one individual is also suggestive of a genetic predisposition. To evaluate inherited predisposition in pancreatic cancer we compared the clinical data of pancreatic cancer patients with and without multiple primaries as well as the frequency of malignancies among their relatives. METHODS: Detailed data on 69 pancreatic cancer patients included survival time and TNM-classification. Index case data were separated into two groups. The first group (group 1) developed only pancreatic cancer during their lifetime, whereas the second group (group 2) developed additional primary tumours. A systematic family history was taken from 59 of these pancreatic cancer patients using a standardized questionnaire. The pancreatic cancers and the multiple primaries of the 59 patients were histologically proven. RESULTS: Of the 69 pancreatic cancer patients, 13 (18.8%) had multiple primaries. Neither the clinical data nor the survival data of the index cases revealed differences between the two groups (all nominal P-values >0.05). In the family history study blood relatives developed a malignancy in 51% (24 of 47) of the families in group 1 compared to 75% (9 of 12) in group 2. The risk of relatives in group 2 of developing a malignant tumour was significantly higher (P = 0.034) than in group 1 after adjustments for family size and age of disease onset of the index case. The cancer spectrum of the 59 families mainly included tumours of the digestive tract and the reproductive organs. CONCLUSIONS: A multiple primary cancer history is a common condition among pancreatic cancer patients. Relatives of these patients seem to have an increased risk for the development of distinct malignant solid tumours, which might be caused by an inherited predisposition. Clinical and genetic investigation of pancreatic cancer patients with multiple primaries and their families might lead to the identification of predisposing gene defects providing a new goal for the understanding of a shared genetic basis of different solid tumours.  (+info)

PGP9.5 as a prognostic factor in pancreatic cancer. (5/1051)

The expression of PGP9.5 was evaluated using immunohistochemistry in 69 resected ductal carcinomas of the pancreas and in normal pancreatic tissue. Overexpression did not seem to differ with histological type or pathological stage. A significant negative correlation was found between overexpression of PGP9.5 and postoperative survival. Multivariate analysis also suggested PGP9.5 along with tumor stage and extrapancreatic plexus invasion as strong predictors of the outcome. This study suggests that PGP9.5 expression may be used as a marker for predicting the outcome of resection-treated pancreatic cancer patients.  (+info)

Pancreatic tumours: molecular pathways implicated in ductal cancer are involved in ampullary but not in exocrine nonductal or endocrine tumorigenesis. (6/1051)

Alterations of K- ras, p53, p16 and DPC4/Smad4 characterize pancreatic ductal cancer (PDC). Reports of inactivation of these latter two genes in pancreatic endocrine tumours (PET) suggest that common molecular pathways are involved in the tumorigenesis of pancreatic exocrine and endocrine epithelia. We characterized 112 primary pancreatic tumours for alterations in p16 and DPC4 and immunohistochemical expression of DPC4. The cases included 34 PDC, 10 intraductal papillary-mucinous tumours (IPMT), 6 acinar carcinomas (PAC), 5 solid-pseudopapillary tumours (SPT), 16 ampulla of Vater cancers (AVC) and 41 PET. All tumours were also presently or previously analysed for K- ras and p53 mutations and allelic loss at 9p, 17p and 18q. Alterations in K- ras, p53, p16 and DPC4 were found in 82%, 53%, 38% and 9% of PDC, respectively and in 47%, 60%, 25% and 6% of AVC. Alterations in these genes were virtually absent in PET, PAC or SPT, while in IPMT only K- ras mutations were present (30%). Positive immunostaining confirmed the absence of DPC4 alterations in all IPMT, SPT, PAC and PET, while 47% of PDC and 38% of AVC were immunonegative. These data suggest that pancreatic exocrine and endocrine tumourigenesis involves different genetic targets and that among exocrine pancreatic neoplasms, only ductal and ampullary cancers share common molecular events.  (+info)

Expression of p8 in human pancreatic cancer. (7/1051)

The p8 gene is a recently identified gene with mitogenic activity. p8 expression is induced in acute pancreatitis, pancreatic development, and regeneration. However, the expression of p8 in pancreatic cancer is not reported. We investigated p8 expression in 72 human pancreatic tissues, including 38 pancreatic cancers (PCs), by immunohistochemistry. p8 was overexpressed (positive cells >25% in 1,000 cells) in 71% (27 of 38) of PCs, but in only 17% (3 of 18) of chronic pancreatitis cases. There was no overexpression in mucinous cystadenoma or in normal pancreas. The p8 overexpression rate in PC was significantly higher than that in other conditions (P < 0.05). Reverse transcription-PCR analysis confirmed p8 mRNA overexpression (tumor/nontumor ratio >2) in 75% (3 of 4) of PCs. p8 was overexpressed also in human pancreatic cancer cell lines (MIA PaCa-2 and PANC-1). These results suggest that p8 is involved in the development of pancreatic cancer, reflecting its mitogenic activity.  (+info)

Genetic and clinical features of human pancreatic ductal adenocarcinomas with widespread microsatellite instability. (8/1051)

The incidences of microsatellite instability (MSI) and underlying DNA mismatch repair (MMR) defects in pancreatic carcinogenesis have not been well established. We analyzed 100 sporadic and 3 hereditary pancreatic ductal adenocarcinomas for MSI, and high-frequency MSI (MSI-H) and low-frequency MSI (MSI-L) tumors were further analyzed for frameshift mutations of possible target genes and for promoter methylation and mutation of DNA MMR genes, including hMLH1, hMSH2, hMSH3, and hMSH6 genes. Among the 100 sporadic tumors, 13 (13%) were MSI-H, 13 (13%) were MSI-L, and 74 (74%) were microsatellite stable (MSS) tumors. All of the three hereditary tumors from hereditary nonpolyposis colorectal cancer (HNPCC) patients were MSI-H. MSI-H tumors were significantly associated with poor differentiation and the presence of wild-type K-RAS and p53 genes. Patients with MSI-H tumors had a significantly longer overall survival time than did those with MSI-L or MSS tumors (P = 0.0057). Frameshift mutations of hMSH3, hMLH3, BRCA-2, TGF-beta type II receptor, and BAX genes were detected in MSI-H tumors. Hypermethylation of the hMLH1 promoter was observed in 6 (46%) of the 13 sporadic MSI-H tumors but not in any of the 3 hereditary MSI-H tumors or 13 MSI-L tumors. All of the 3 HNPCC cases had germ-line hMLH1 mutation accompanied by loss of heterogeneity or other mutation in the tumor. Our results suggest that pancreatic carcinomas with MSI-H represent a distinctive oncogenic pathway because they exhibit peculiar clinical, pathological, and molecular characteristics. Our results also suggest the principal involvement of epigenetic or genetic inactivation of the hMLH1 gene in the pathogenesis of pancreatic carcinoma with MSI-H.  (+info)

Carcinoma, Pancreatic Ductal is a type of cancer that originates in the cells lining the pancreatic ducts, which are the tubes that carry digestive enzymes and bicarbonate from the pancreas to the small intestine. This type of cancer is also known as pancreatic ductal adenocarcinoma (PDAC) or pancreatic cancer. It is the most common type of pancreatic cancer and is usually diagnosed at an advanced stage, making it difficult to treat. The symptoms of pancreatic ductal carcinoma may include abdominal pain, weight loss, jaundice, and nausea. Treatment options for this type of cancer may include surgery, chemotherapy, radiation therapy, and targeted therapy.

Pancreatic neoplasms refer to abnormal growths or tumors that develop in the pancreas, a gland located in the abdomen behind the stomach. These neoplasms can be either benign (non-cancerous) or malignant (cancerous). Pancreatic neoplasms can occur in various parts of the pancreas, including the exocrine gland (which produces digestive enzymes), the endocrine gland (which produces hormones), and the ducts (which carry digestive juices from the pancreas to the small intestine). Symptoms of pancreatic neoplasms can vary depending on the location and size of the tumor, but may include abdominal pain, weight loss, jaundice (yellowing of the skin and eyes), nausea, vomiting, and unexplained fatigue. Diagnosis of pancreatic neoplasms typically involves imaging tests such as CT scans, MRI scans, or ultrasound, as well as blood tests and biopsies. Treatment options may include surgery, chemotherapy, radiation therapy, or a combination of these approaches, depending on the type and stage of the neoplasm.

Carcinoma is a type of cancer that originates in the epithelial cells, which are the cells that line the surfaces of organs and tissues in the body. Carcinomas can develop in any part of the body, but they are most common in the skin, lungs, breast, prostate, and colon. Carcinomas are classified based on the location and type of epithelial cells from which they originate. For example, a carcinoma that develops in the skin is called a skin carcinoma, while a carcinoma that develops in the lungs is called a lung carcinoma. Carcinomas can be further classified as either non-melanoma skin cancers (such as basal cell carcinoma and squamous cell carcinoma) or melanoma, which is a more aggressive type of skin cancer that can spread to other parts of the body. Treatment for carcinomas depends on the type and stage of the cancer, as well as the overall health of the patient. Treatment options may include surgery, radiation therapy, chemotherapy, targeted therapy, or immunotherapy.

Carcinoma, ductal, breast is a type of cancer that starts in the milk ducts of the breast. It is the most common type of breast cancer, accounting for about 80% of all breast cancer cases. Ductal carcinoma in situ (DCIS) is a non-invasive form of this cancer, where cancer cells are found in the lining of the milk ducts but have not spread to nearby tissues or lymph nodes. Invasive ductal carcinoma (IDC) is a more advanced form of the cancer, where cancer cells have invaded the surrounding breast tissue. The diagnosis of ductal carcinoma is usually made through a combination of a physical examination, imaging tests such as mammography or ultrasound, and a biopsy to confirm the presence of cancer cells. Treatment options for ductal carcinoma may include surgery, radiation therapy, chemotherapy, hormone therapy, or a combination of these approaches, depending on the stage and severity of the cancer.

Carcinoma in situ, also known as CIS or intraepithelial neoplasia, is a type of cancer that has not yet invaded the surrounding tissue. It is a precancerous condition where abnormal cells are present only in the lining of a tissue or organ, but have not yet spread beyond the basement membrane. CIS is often found in the early stages of cancer and can be detected through routine screening tests such as Pap smears for cervical cancer or colonoscopies for colorectal cancer. Treatment for CIS typically involves removing the affected tissue or organ, and may include surgery, radiation therapy, or chemotherapy. CIS is considered a serious condition because it has the potential to develop into invasive cancer if left untreated. However, with early detection and treatment, the risk of progression to invasive cancer can be significantly reduced.

Carcinoma, Squamous Cell is a type of cancer that originates in the squamous cells, which are thin, flat cells that line the surface of the body. Squamous cells are found in the skin, mouth, throat, lungs, and other organs. Carcinoma, Squamous Cell can develop in any part of the body where squamous cells are present, but it is most commonly found in the head and neck, lungs, and skin. The exact cause of Squamous Cell Carcinoma is not always clear, but it is often associated with exposure to certain substances, such as tobacco smoke, alcohol, and certain chemicals. It can also develop as a result of chronic inflammation or infection, such as HPV (human papillomavirus) infection in the cervix. Symptoms of Squamous Cell Carcinoma can vary depending on the location of the tumor, but may include a persistent sore or lesion that does not heal, a change in the appearance of the skin or mucous membranes, difficulty swallowing or breathing, and unexplained weight loss. Treatment for Squamous Cell Carcinoma typically involves surgery to remove the tumor, followed by radiation therapy or chemotherapy to kill any remaining cancer cells. In some cases, targeted therapy or immunotherapy may also be used. The prognosis for Squamous Cell Carcinoma depends on the stage of the cancer at the time of diagnosis and the overall health of the patient.

Carcinoma, Hepatocellular is a type of cancer that originates in the liver cells, specifically in the cells that line the small blood vessels within the liver. It is the most common type of liver cancer and is often associated with chronic liver disease, such as cirrhosis or hepatitis B or C infection. The cancer cells in hepatocellular carcinoma can grow and spread to other parts of the body, including the lungs, bones, and lymph nodes. Symptoms of hepatocellular carcinoma may include abdominal pain, weight loss, jaundice (yellowing of the skin and eyes), and fatigue. Treatment options for hepatocellular carcinoma may include surgery, chemotherapy, radiation therapy, targeted therapy, and liver transplantation. The choice of treatment depends on the stage and location of the cancer, as well as the overall health of the patient.

Adenocarcinoma is a type of cancer that starts in the glandular cells of an organ or tissue. It is one of the most common types of cancer and can occur in many different parts of the body, including the lungs, breast, colon, rectum, pancreas, stomach, and thyroid gland. Adenocarcinomas typically grow slowly and may not cause symptoms in the early stages. However, as the cancer grows, it can invade nearby tissues and spread to other parts of the body through the bloodstream or lymphatic system. This can lead to more serious symptoms and a higher risk of complications. Treatment for adenocarcinoma depends on the location and stage of the cancer, as well as the overall health of the patient. Options may include surgery, radiation therapy, chemotherapy, targeted therapy, or a combination of these approaches. The goal of treatment is to remove or destroy the cancer cells and prevent them from spreading further.

Carcinoma, Intraductal, Noninfiltrating (CIN) is a type of cancer that originates in the lining of the milk ducts in the breast. It is also known as ductal carcinoma in situ (DCIS). CIN is considered a pre-cancerous condition because it has the potential to develop into invasive breast cancer if left untreated. However, it is important to note that not all cases of CIN will progress to invasive cancer. CIN is typically detected through a mammogram, which is an X-ray of the breast. If CIN is detected, a biopsy may be performed to confirm the diagnosis and determine the extent of the disease. Treatment for CIN may include surgery, radiation therapy, or hormone therapy, depending on the specific circumstances of the case. It is important for women to be aware of the signs and symptoms of breast cancer and to have regular mammograms as part of their routine healthcare. Early detection and treatment of breast cancer can improve outcomes and increase the chances of a successful recovery.

Carcinoma, ductal is a type of breast cancer that starts in the milk ducts of the breast. It is the most common type of breast cancer, accounting for about 80% of all breast cancer cases. Ductal carcinoma usually develops slowly over time and may not cause any symptoms in the early stages. However, as the cancer grows, it can cause a lump in the breast, skin changes, nipple discharge, or other symptoms. Treatment for ductal carcinoma usually involves surgery to remove the cancerous tissue, followed by radiation therapy or chemotherapy to kill any remaining cancer cells. In some cases, hormone therapy may also be recommended to slow the growth of the cancer. The prognosis for ductal carcinoma depends on several factors, including the size and stage of the cancer, as well as the age and overall health of the patient.

Carcinoma, papillary refers to a type of cancer that originates in the cells lining a gland or duct, such as the thyroid gland or the breast. Papillary carcinomas are characterized by the presence of small, finger-like projections called papillae, which are a common feature of these types of tumors. These tumors are typically slow-growing and may not cause symptoms until they are quite large. Treatment for papillary carcinoma usually involves surgery to remove the affected gland or duct, followed by radiation therapy or chemotherapy to kill any remaining cancer cells. In some cases, hormone therapy may also be used to treat papillary carcinoma.

A cell line, tumor is a type of cell culture that is derived from a cancerous tumor. These cell lines are grown in a laboratory setting and are used for research purposes, such as studying the biology of cancer and testing potential new treatments. They are typically immortalized, meaning that they can continue to divide and grow indefinitely, and they often exhibit the characteristics of the original tumor from which they were derived, such as specific genetic mutations or protein expression patterns. Cell lines, tumor are an important tool in cancer research and have been used to develop many of the treatments that are currently available for cancer patients.

Chronic pancreatitis is a long-term inflammatory condition of the pancreas that causes damage to the gland over time. It is characterized by persistent inflammation and scarring of the pancreas, which can lead to the destruction of pancreatic tissue and the development of complications such as diabetes, malnutrition, and pain. Chronic pancreatitis can be caused by a variety of factors, including chronic alcohol abuse, smoking, genetic mutations, and certain infections or autoimmune diseases. The symptoms of chronic pancreatitis can vary widely and may include abdominal pain, weight loss, nausea and vomiting, and changes in bowel movements. Diagnosis of chronic pancreatitis typically involves a combination of medical history, physical examination, blood tests, imaging studies such as ultrasound or CT scans, and sometimes endoscopic retrograde cholangiopancreatography (ERCP) or biopsy. Treatment of chronic pancreatitis depends on the underlying cause and the severity of the disease. It may include lifestyle changes such as quitting smoking and limiting alcohol consumption, medications to manage pain and other symptoms, and in severe cases, surgery to remove damaged tissue or create a bypass to allow digestive enzymes to flow around the damaged pancreas.

In the medical field, "neoplasm invasiveness" refers to the ability of a cancerous tumor to invade and spread beyond its original site of origin. This can occur through the bloodstream or lymphatic system, or by direct extension into surrounding tissues. The degree of invasiveness of a neoplasm can be an important factor in determining the prognosis and treatment options for a patient. More invasive tumors are generally considered to be more aggressive and may be more difficult to treat. However, the specific characteristics of the tumor, such as its type, stage, and location, as well as the overall health of the patient, can also play a role in determining the prognosis. Invasive neoplasms may also be referred to as malignant tumors, as they have the potential to spread and cause harm to surrounding tissues and organs. Non-invasive neoplasms, on the other hand, are generally considered to be benign and are less likely to spread.

Adenocarcinoma, mucinous is a type of cancer that starts in the glandular cells of the body's tissues and produces a large amount of mucus. It is a subtype of adenocarcinoma, which is a type of cancer that begins in the glandular cells that produce mucus, sweat, or other fluids. Mucinous adenocarcinomas are often found in the digestive system, such as the colon, stomach, and pancreas, but they can also occur in other parts of the body, such as the lungs, ovaries, and breast. They are typically slow-growing and may not cause symptoms until they are advanced. Treatment for mucinous adenocarcinoma may include surgery, chemotherapy, and radiation therapy, depending on the location and stage of the cancer.

Carcinoma, acinar cell is a type of cancer that originates in the acinar cells of the pancreas. These cells are responsible for producing digestive enzymes and hormones such as insulin and glucagon. Acinar cell carcinoma is a relatively rare type of pancreatic cancer, accounting for less than 1% of all pancreatic cancers. It is more common in women than men and typically occurs in people over the age of 60. The symptoms of acinar cell carcinoma may include abdominal pain, weight loss, jaundice, and nausea. Diagnosis is typically made through imaging studies such as CT scans or MRIs, and a biopsy may be performed to confirm the diagnosis. Treatment options for acinar cell carcinoma may include surgery, chemotherapy, radiation therapy, or a combination of these approaches. The prognosis for acinar cell carcinoma depends on the stage of the cancer at the time of diagnosis, with earlier stages generally having a better prognosis than later stages.

Breast neoplasms refer to abnormal growths or tumors in the breast tissue. These growths can be benign (non-cancerous) or malignant (cancerous). Benign breast neoplasms are usually not life-threatening, but they can cause discomfort or cosmetic concerns. Malignant breast neoplasms, on the other hand, can spread to other parts of the body and are considered a serious health threat. Some common types of breast neoplasms include fibroadenomas, ductal carcinoma in situ (DCIS), invasive ductal carcinoma, and invasive lobular carcinoma.

Pancreatitis is a medical condition characterized by inflammation of the pancreas, a gland located in the abdomen behind the stomach. The pancreas plays a crucial role in the digestive system by producing enzymes that help break down food and hormones that regulate blood sugar levels. There are two main types of pancreatitis: acute and chronic. Acute pancreatitis is a sudden and severe inflammation of the pancreas that usually lasts for a few days to a few weeks. It can be caused by a variety of factors, including excessive alcohol consumption, gallstones, infections, and certain medications. Symptoms of acute pancreatitis may include severe abdominal pain, nausea, vomiting, fever, and elevated levels of certain enzymes in the blood. Chronic pancreatitis is a long-term inflammation of the pancreas that can develop over time due to repeated episodes of acute pancreatitis, long-term alcohol abuse, or other factors. It can cause permanent damage to the pancreas, leading to problems with digestion and blood sugar control. Symptoms of chronic pancreatitis may include abdominal pain, weight loss, malnutrition, and diabetes. Treatment for pancreatitis depends on the severity and underlying cause of the condition. In some cases, hospitalization may be necessary to manage pain, prevent complications, and provide supportive care. In other cases, lifestyle changes such as quitting smoking and reducing alcohol consumption may be recommended to prevent future episodes. Medications and surgery may also be used to treat specific causes of pancreatitis, such as gallstones or infections.

Liver neoplasms refer to abnormal growths or tumors that develop in the liver. These growths can be either benign (non-cancerous) or malignant (cancerous). Benign liver neoplasms include hemangiomas, focal nodular hyperplasia, and adenomas. These growths are usually slow-growing and do not spread to other parts of the body. Malignant liver neoplasms, on the other hand, are more serious and include primary liver cancer (such as hepatocellular carcinoma) and secondary liver cancer (such as metastatic cancer from other parts of the body). These tumors can grow quickly and spread to other parts of the body, leading to serious health complications. Diagnosis of liver neoplasms typically involves imaging tests such as ultrasound, CT scan, or MRI, as well as blood tests and biopsy. Treatment options depend on the type and stage of the neoplasm, and may include surgery, chemotherapy, radiation therapy, or targeted therapy.

Carcinoma, Basal Cell is a type of skin cancer that originates from the basal cells, which are the cells that line the bottom layer of the epidermis, the outermost layer of the skin. It is the most common type of skin cancer and is usually slow-growing and non-aggressive. However, if left untreated, it can spread to other parts of the body and become more serious. The main risk factors for basal cell carcinoma include exposure to UV radiation from the sun or tanning beds, fair skin, and a history of skin cancer. Treatment options for basal cell carcinoma include surgery, radiation therapy, and topical medications.

In the medical field, precancerous conditions refer to abnormal cells or tissues in the body that have the potential to develop into cancer if left untreated. These conditions are not yet cancerous, but they have the potential to become cancerous if they are not detected and treated early. Examples of precancerous conditions include: 1. Dysplasia: A condition in which cells in a tissue or organ do not grow or develop normally, leading to the formation of abnormal cells. 2. Papillomas: Non-cancerous growths on the skin or in the respiratory tract that can become cancerous if left untreated. 3. Leukoplakia: A white patch or plaque on the lining of the mouth or throat that can be caused by smoking, alcohol, or other irritants and can develop into cancer. 4. Barrett's Esophagus: A condition in which the lining of the esophagus is replaced by cells that are similar to those found in the lining of the stomach. This condition can increase the risk of developing esophageal cancer. 5. Atypical Hyperplasia: A condition in which cells in the cervix grow abnormally and may develop into cervical cancer if left untreated. It is important to note that not all precancerous conditions will develop into cancer, and some may spontaneously regress. However, early detection and treatment of precancerous conditions can significantly reduce the risk of developing cancer.

Adenocarcinoma, papillary is a type of cancer that begins in the cells that line certain organs or glands in the body. It is a type of adenocarcinoma, which is a type of cancer that begins in glandular cells. Papillary adenocarcinoma is characterized by the growth of small, finger-like projections called papillae, which can be seen under a microscope. This type of cancer is most commonly found in the thyroid gland, but it can also occur in other organs such as the lungs, breast, and pancreas. Treatment for papillary adenocarcinoma typically involves surgery to remove the affected tissue, followed by radiation therapy or chemotherapy to kill any remaining cancer cells.

Cell proliferation refers to the process of cell division and growth, which is essential for the maintenance and repair of tissues in the body. In the medical field, cell proliferation is often studied in the context of cancer, where uncontrolled cell proliferation can lead to the formation of tumors and the spread of cancer cells to other parts of the body. In normal cells, cell proliferation is tightly regulated by a complex network of signaling pathways and feedback mechanisms that ensure that cells divide only when necessary and that they stop dividing when they have reached their full capacity. However, in cancer cells, these regulatory mechanisms can become disrupted, leading to uncontrolled cell proliferation and the formation of tumors. In addition to cancer, cell proliferation is also important in other medical conditions, such as wound healing, tissue regeneration, and the development of embryos. Understanding the mechanisms that regulate cell proliferation is therefore critical for developing new treatments for cancer and other diseases.

Lymphatic metastasis is a type of cancer spread that occurs when cancer cells from a primary tumor travel through the lymphatic system and spread to other parts of the body. The lymphatic system is a network of vessels and organs that helps to fight infection and remove waste products from the body. When cancer cells enter the lymphatic system, they can travel through the lymph nodes, which are small, bean-shaped structures that filter out harmful substances from the lymph fluid. If the cancer cells reach the lymph nodes, they can multiply and form new tumors, which can then spread to other parts of the body through the lymphatic system. Lymphatic metastasis is a common way for cancer to spread, and it can occur in many different types of cancer, including breast cancer, lung cancer, and colon cancer.

Acinar cells are a type of epithelial cells found in various organs and glands throughout the body, including the pancreas, salivary glands, and liver. These cells are characterized by their flask-shaped or sac-like appearance and are arranged in clusters or acini. In the pancreas, acinar cells produce digestive enzymes such as amylase, lipase, and trypsin, which are secreted into the small intestine to aid in the digestion of carbohydrates, fats, and proteins. In the salivary glands, acinar cells produce saliva, which contains enzymes that help break down food in the mouth. In the liver, acinar cells produce bile, which is essential for the digestion and absorption of fats. Acinar cells are also involved in the production of hormones, such as insulin in the pancreas, and the regulation of fluid balance in the body. Dysfunction or damage to acinar cells can lead to various medical conditions, including pancreatitis, diabetes, and liver disease.

Neoplasm proteins are proteins that are produced by cancer cells. These proteins are often abnormal and can contribute to the growth and spread of cancer. They can be detected in the blood or other body fluids, and their presence can be used as a diagnostic tool for cancer. Some neoplasm proteins are also being studied as potential targets for cancer treatment.

SMAD4 protein, also known as MAD homolog 4, is a protein that plays a crucial role in the TGF-beta signaling pathway. It is a type of transcription factor that helps regulate gene expression in response to signals from the extracellular environment. In the context of the medical field, SMAD4 protein is often studied in relation to cancer. Mutations in the SMAD4 gene have been linked to several types of cancer, including gastrointestinal stromal tumors (GISTs), pancreatic cancer, and colorectal cancer. These mutations can lead to abnormal activation of the TGF-beta signaling pathway, which can contribute to the development and progression of cancer. SMAD4 protein is also involved in other biological processes, such as cell growth and differentiation, and has been implicated in the development of other diseases, such as inflammatory bowel disease and cardiovascular disease.

Neoplasm metastasis refers to the spread of cancer cells from a primary tumor to other parts of the body. This occurs when cancer cells break away from the primary tumor, enter the bloodstream or lymphatic system, and travel to distant organs or tissues, where they can form new tumors. Metastasis is a major cause of cancer-related deaths, as it makes the disease more difficult to treat and increases the risk of complications. The ability of cancer cells to metastasize is a key factor in determining the prognosis for patients with cancer.

Disease progression refers to the worsening or progression of a disease over time. It is a natural course of events that occurs in many chronic illnesses, such as cancer, heart disease, and diabetes. Disease progression can be measured in various ways, such as changes in symptoms, physical examination findings, laboratory test results, or imaging studies. In some cases, disease progression can be slowed or stopped through medical treatment, such as medications, surgery, or radiation therapy. However, in other cases, disease progression may be inevitable, and the focus of treatment may shift from trying to cure the disease to managing symptoms and improving quality of life. Understanding disease progression is important for healthcare providers to develop effective treatment plans and to communicate with patients about their condition and prognosis. It can also help patients and their families make informed decisions about their care and treatment options.

Carcinoma, Transitional Cell is a type of cancer that originates in the transitional cells lining the urinary tract, including the bladder, ureters, and renal pelvis. These cells are responsible for regulating the flow of urine and lining the inner surface of the urinary tract. Transitional cell carcinoma can develop in any part of the urinary tract, but it is most commonly found in the bladder. It is the most common type of bladder cancer and can be either non-invasive (in situ) or invasive (infiltrating) depending on whether the cancer cells have spread beyond the lining of the bladder. Symptoms of transitional cell carcinoma may include blood in the urine, frequent urination, pain or burning during urination, and abdominal pain or discomfort. Diagnosis typically involves a combination of physical examination, imaging studies, and biopsy. Treatment for transitional cell carcinoma may include surgery, chemotherapy, radiation therapy, or a combination of these approaches, depending on the stage and location of the cancer. Early detection and treatment are important for improving outcomes and reducing the risk of recurrence.

In the medical field, RNA, Messenger (mRNA) refers to a type of RNA molecule that carries genetic information from DNA in the nucleus of a cell to the ribosomes, where proteins are synthesized. During the process of transcription, the DNA sequence of a gene is copied into a complementary RNA sequence called messenger RNA (mRNA). This mRNA molecule then leaves the nucleus and travels to the cytoplasm of the cell, where it binds to ribosomes and serves as a template for the synthesis of a specific protein. The sequence of nucleotides in the mRNA molecule determines the sequence of amino acids in the protein that is synthesized. Therefore, changes in the sequence of nucleotides in the mRNA molecule can result in changes in the amino acid sequence of the protein, which can affect the function of the protein and potentially lead to disease. mRNA molecules are often used in medical research and therapy as a way to introduce new genetic information into cells. For example, mRNA vaccines work by introducing a small piece of mRNA that encodes for a specific protein, which triggers an immune response in the body.

Cell transformation, neoplastic refers to the process by which normal cells in the body undergo genetic changes that cause them to become cancerous or malignant. This process involves the accumulation of mutations in genes that regulate cell growth, division, and death, leading to uncontrolled cell proliferation and the formation of tumors. Neoplastic transformation can occur in any type of cell in the body, and it can be caused by a variety of factors, including exposure to carcinogens, radiation, viruses, and inherited genetic mutations. Once a cell has undergone neoplastic transformation, it can continue to divide and grow uncontrollably, invading nearby tissues and spreading to other parts of the body through the bloodstream or lymphatic system. The diagnosis of neoplastic transformation typically involves a combination of clinical examination, imaging studies, and biopsy. Treatment options for neoplastic transformation depend on the type and stage of cancer, as well as the patient's overall health and preferences. Common treatments include surgery, radiation therapy, chemotherapy, targeted therapy, and immunotherapy.

Carcinoma, bronchogenic is a type of cancer that starts in the cells that line the airways of the lungs. These airways include the bronchi, which are the large tubes that carry air into and out of the lungs, and the bronchioles, which are smaller tubes that branch off from the bronchi. Carcinoma, bronchogenic is also known as lung cancer. There are several different types of lung cancer, including small cell lung cancer and non-small cell lung cancer. Carcinoma, bronchogenic is a type of non-small cell lung cancer. It is the most common type of lung cancer and is usually diagnosed at a later stage, when it has already spread to other parts of the body. Symptoms of carcinoma, bronchogenic may include a persistent cough, chest pain, shortness of breath, hoarseness, and coughing up blood. These symptoms may be caused by the cancer itself or by the body's response to the cancer. Treatment for carcinoma, bronchogenic may include surgery, radiation therapy, chemotherapy, or a combination of these treatments. The best treatment option will depend on the stage and location of the cancer, as well as the overall health of the person.

Multiple primary neoplasms, also known as synchronous or metachronous neoplasms, are two or more neoplasms (cancerous or non-cancerous tumors) that occur in the same individual at the same time or at different times. In the medical field, multiple primary neoplasms can occur in different organs or tissues of the body, and they can be either cancerous (malignant) or non-cancerous (benign). The occurrence of multiple primary neoplasms can be due to various factors, including genetic predisposition, exposure to environmental toxins, lifestyle factors such as smoking and alcohol consumption, and certain medical conditions such as immunosuppression. The diagnosis of multiple primary neoplasms typically involves a thorough medical history, physical examination, imaging studies, and biopsy of the tumors. Treatment options depend on the type, location, and stage of the neoplasms, as well as the overall health of the individual.

Carcinoma, Medullary is a type of cancer that originates in the medullary layer of the thyroid gland. The medullary layer is the innermost layer of the thyroid gland, and it is responsible for producing hormones that regulate metabolism. Medullary thyroid carcinoma (MTC) is a rare type of thyroid cancer, accounting for about 5% of all thyroid cancers. It is more common in women than in men and is often associated with multiple endocrine neoplasia type 2 (MEN 2), a genetic disorder that increases the risk of developing MTC and other types of endocrine tumors. MTC typically presents with symptoms such as a lump in the neck, difficulty swallowing, hoarseness, and a persistent cough. Diagnosis is usually made through a combination of imaging studies, such as ultrasound and CT scans, and a biopsy of the thyroid gland. Treatment for MTC typically involves surgery to remove the affected thyroid gland and any nearby lymph nodes that may be affected. In some cases, additional treatments such as radioactive iodine therapy or targeted therapy may be used to help control the cancer. The prognosis for MTC depends on the stage of the cancer at the time of diagnosis and the effectiveness of treatment.

Carcinoma, Adenoid Cystic is a type of cancer that originates in the salivary glands, particularly the minor salivary glands located in the mouth, nose, and throat. It is a slow-growing cancer that can spread to nearby tissues and organs, as well as to distant parts of the body through the bloodstream or lymphatic system. The adenoid cystic carcinoma cells are characterized by their ability to invade surrounding tissues and form cysts or nodules. These tumors can be difficult to diagnose and treat because they often do not cause symptoms until they have spread to other parts of the body. Treatment options for adenoid cystic carcinoma may include surgery, radiation therapy, chemotherapy, or a combination of these approaches. The prognosis for this type of cancer depends on several factors, including the stage of the cancer at diagnosis, the location of the tumor, and the patient's overall health.

The Ampulla of Vater, also known as the hepatopancreatic ampulla or the hepatopancreatic duct, is a small, funnel-shaped structure located at the confluence of the bile duct and the main pancreatic duct. It is situated in the head of the pancreas, just inferior to the duodenum, and is surrounded by the ampulla of Vater's gland, which is a group of specialized cells that produce mucus to lubricate the passage of bile and pancreatic juice through the ampulla. The ampulla of Vater plays a critical role in the digestive process by allowing bile and pancreatic juice to mix and enter the duodenum, where they help to break down and digest food. Disorders of the ampulla of Vater can lead to a variety of digestive problems, including jaundice, abdominal pain, and malabsorption. Some common conditions that affect the ampulla of Vater include ampullary cancer, pancreatitis, and bile duct stones.

Carcinoma, Small Cell is a type of cancer that begins in the cells of the lungs. It is called "small cell" because the cancer cells are smaller than the normal cells in the lungs. Small cell carcinoma is a fast-growing cancer that spreads quickly to other parts of the body. It is usually treated with chemotherapy and radiation therapy, and in some cases, surgery. Small cell carcinoma is more common in men than in women and is often associated with smoking. It is a very aggressive form of cancer and can be difficult to treat.

Metaplasia is a biological process in which one type of mature cell is replaced by another type of mature cell in a tissue. This process is usually triggered by chronic inflammation, injury, or other forms of tissue damage. For example, in the lining of the stomach, normal cells are replaced by cells that are better able to withstand the acidic environment of the stomach. This is a normal response to chronic inflammation and is not usually considered a disease. However, if the process of metaplasia continues unchecked, it can lead to the development of cancer. Metaplasia can occur in many different tissues throughout the body, including the respiratory tract, the urinary tract, and the digestive tract. It is an important area of study in the field of medicine, as it can provide insights into the development of cancer and other diseases.

Neoplasm recurrence, local refers to the return of cancer cells to the original site of the tumor after treatment. This can occur even if the cancer has been completely removed through surgery or other treatments. Local recurrence is typically treated with additional surgery, radiation therapy, or chemotherapy, depending on the type and stage of the cancer. It is important to note that local recurrence does not necessarily mean that the cancer has spread to other parts of the body.

Carcinoma, Lobular refers to a type of cancer that originates in the lobules of the breast tissue. Lobules are the small glandular structures in the breast that produce milk. Lobular carcinoma is a type of invasive breast cancer, which means that it has the potential to spread to other parts of the body. Lobular carcinoma is typically diagnosed through a combination of mammography, ultrasound, and biopsy. It is often difficult to detect on mammography because it does not typically form a mass, but rather spreads throughout the breast tissue. Ultrasound can help identify areas of abnormal tissue that may be indicative of lobular carcinoma. Treatment for lobular carcinoma may include surgery, radiation therapy, chemotherapy, hormonal therapy, or a combination of these approaches. The specific treatment plan will depend on the stage and grade of the cancer, as well as the overall health of the patient. Early detection and treatment are key to improving outcomes for patients with lobular carcinoma.

Carcinoma, Neuroendocrine is a type of cancer that arises from neuroendocrine cells, which are specialized cells that produce hormones and neurotransmitters. These cells can be found in various parts of the body, including the lungs, pancreas, thymus, and gastrointestinal tract. Neuroendocrine carcinomas can be further classified based on the location of the tumor and the hormones produced by the cells. For example, small cell lung cancer is a type of neuroendocrine carcinoma that arises in the lungs and produces large amounts of hormones. Pancreatic neuroendocrine tumors (PNETs) are another type of neuroendocrine carcinoma that can produce hormones such as insulin and gastrin. The symptoms of neuroendocrine carcinomas can vary depending on the location of the tumor and the hormones produced. Some common symptoms include abdominal pain, weight loss, diarrhea, flushing, and high blood pressure. Treatment options for neuroendocrine carcinomas may include surgery, chemotherapy, radiation therapy, and targeted therapy.

Deoxycytidine is a nucleoside that is a building block of DNA. It is composed of a deoxyribose sugar, a nitrogenous base (cytosine), and a phosphate group. Deoxycytidine is a key component of the nucleic acid chain that makes up DNA, and it plays a crucial role in the process of DNA replication. In the medical field, deoxycytidine is sometimes used as a medication to treat certain types of cancer, such as chronic lymphocytic leukemia (CLL) and acute myeloid leukemia (AML). It works by inhibiting the growth and division of cancer cells.

CA-19-9 Antigen is a protein that is found on the surface of certain cells in the body, including cells in the pancreas, bile ducts, and colon. It is also found in some types of cancer cells, such as those in pancreatic and ovarian cancer. In the medical field, the CA-19-9 antigen is often used as a tumor marker, which means that it can be measured in the blood to help diagnose and monitor certain types of cancer. High levels of CA-19-9 in the blood may indicate the presence of cancer, while low levels may indicate that the cancer is in remission or has not spread. However, it is important to note that the CA-19-9 antigen is not specific to cancer and can also be elevated in other conditions, such as chronic pancreatitis and inflammatory bowel disease.

Tumor suppressor protein p53 is a protein that plays a crucial role in regulating cell growth and preventing the development of cancer. It is encoded by the TP53 gene and is one of the most commonly mutated genes in human cancer. The p53 protein acts as a "guardian of the genome" by detecting DNA damage and initiating a series of cellular responses to repair the damage or trigger programmed cell death (apoptosis) if the damage is too severe. This helps to prevent the accumulation of mutations in the DNA that can lead to the development of cancer. In addition to its role in preventing cancer, p53 also plays a role in regulating cell cycle progression, DNA repair, and the response to cellular stress. Mutations in the TP53 gene can lead to the production of a non-functional or mutated p53 protein, which can result in the loss of these important functions and contribute to the development of cancer. Overall, the p53 protein is a critical regulator of cell growth and survival, and its dysfunction is a common feature of many types of cancer.

Nasopharyngeal neoplasms refer to tumors that develop in the nasopharynx, which is the part of the throat located at the back of the nose and the top of the throat. These tumors can be either benign or malignant, and they can occur in any part of the nasopharynx, including the nasopharyngeal epithelium, the lymphoid tissue, and the salivary glands. Nasopharyngeal neoplasms are relatively uncommon, but they can be aggressive and difficult to treat. Some of the most common types of nasopharyngeal neoplasms include nasopharyngeal carcinoma, which is a type of head and neck cancer that is particularly common in certain parts of the world, such as Southeast Asia and Southern China, and nasopharyngeal angiofibroma, which is a benign tumor that is more common in adolescent boys. The symptoms of nasopharyngeal neoplasms can vary depending on the location and size of the tumor, but they may include nasal congestion, difficulty swallowing, ear pain, hearing loss, and a persistent sore throat. Diagnosis typically involves a combination of physical examination, imaging studies, and biopsy. Treatment for nasopharyngeal neoplasms may include surgery, radiation therapy, chemotherapy, or a combination of these approaches. The choice of treatment depends on the type and stage of the tumor, as well as the overall health of the patient.

DNA, or deoxyribonucleic acid, is a molecule that carries genetic information in living organisms. It is composed of four types of nitrogen-containing molecules called nucleotides, which are arranged in a specific sequence to form the genetic code. Neoplasm refers to an abnormal growth of cells in the body, which can be either benign (non-cancerous) or malignant (cancerous). Neoplasms can occur in any part of the body and can be caused by a variety of factors, including genetic mutations, exposure to carcinogens, and hormonal imbalances. In the medical field, DNA and neoplasms are closely related because many types of cancer are caused by mutations in the DNA of cells. These mutations can lead to uncontrolled cell growth and the formation of tumors. DNA analysis is often used to diagnose and treat cancer, as well as to identify individuals who are at increased risk of developing the disease.

Cyclic S-oxides are a class of organic compounds that contain a sulfur-oxygen bond in a ring structure. They are also known as thioethers or sulfides. In the medical field, cyclic S-oxides have been studied for their potential therapeutic applications, particularly in the treatment of cancer and other diseases. One example of a cyclic S-oxide with potential therapeutic applications is 1,2-dithiolane-3-thione (DTT), which has been shown to have anti-cancer properties. DTT has been found to inhibit the growth of various cancer cell lines and to induce apoptosis (cell death) in these cells. It has also been shown to have anti-inflammatory and anti-angiogenic effects, which may contribute to its anti-cancer activity. Another example of a cyclic S-oxide with potential therapeutic applications is 1,2,4-trithiolane (TTL), which has been studied for its potential to treat Alzheimer's disease. TTL has been found to have neuroprotective effects and to improve cognitive function in animal models of Alzheimer's disease. Overall, cyclic S-oxides are a promising class of compounds for the development of new therapeutic agents, particularly for the treatment of cancer and neurodegenerative diseases.

Antineoplastic agents, also known as cytotoxic agents or chemotherapeutic agents, are drugs that are used to treat cancer by killing or slowing the growth of cancer cells. These agents work by interfering with the normal processes of cell division and growth, which are necessary for the survival and spread of cancer cells. There are many different types of antineoplastic agents, including alkylating agents, antimetabolites, topoisomerase inhibitors, and monoclonal antibodies, among others. These agents are often used in combination with other treatments, such as surgery and radiation therapy, to provide the most effective treatment for cancer.

Thyroid neoplasms refer to abnormal growths or tumors in the thyroid gland, which is a butterfly-shaped gland located in the neck. These neoplasms can be either benign (non-cancerous) or malignant (cancerous). Thyroid neoplasms can occur in any part of the thyroid gland, but some areas are more prone to developing tumors than others. The most common type of thyroid neoplasm is a thyroid adenoma, which is a benign tumor that arises from the follicular cells of the thyroid gland. Other types of thyroid neoplasms include papillary thyroid carcinoma, follicular thyroid carcinoma, medullary thyroid carcinoma, and anaplastic thyroid carcinoma. Thyroid neoplasms can cause a variety of symptoms, depending on the size and location of the tumor, as well as whether it is benign or malignant. Some common symptoms include a lump or swelling in the neck, difficulty swallowing, hoarseness, and a rapid or irregular heartbeat. Diagnosis of thyroid neoplasms typically involves a combination of physical examination, imaging studies such as ultrasound or CT scan, and biopsy of the thyroid tissue. Treatment options for thyroid neoplasms depend on the type, size, and location of the tumor, as well as the patient's overall health and age. Treatment may include surgery, radiation therapy, or medication to manage symptoms or slow the growth of the tumor.

In the medical field, the term "breast" refers to the female reproductive gland that produces milk for nursing infants. It is located on the chest and is composed of glandular tissue, fat, and connective tissue. The breast is also home to the lactiferous ducts, which carry milk from the glands to the nipple. In men, the breast tissue is much less developed and is primarily composed of fat and connective tissue. In some cases, men may develop breast tissue due to hormonal imbalances or other medical conditions.

Ras proteins are a family of small, membrane-bound GTPases that play a critical role in regulating cell growth and division. They are involved in transmitting signals from cell surface receptors to the cell interior, where they activate a cascade of downstream signaling pathways that ultimately control cell behavior. Ras proteins are found in all eukaryotic cells and are encoded by three genes: HRAS, KRAS, and NRAS. These genes are frequently mutated in many types of cancer, leading to the production of constitutively active Ras proteins that are always "on" and promote uncontrolled cell growth and division. In the medical field, Ras proteins are an important target for cancer therapy, as drugs that can inhibit the activity of Ras proteins have the potential to slow or stop the growth of cancer cells. However, developing effective Ras inhibitors has proven to be a challenging task, as Ras proteins are highly conserved and essential for normal cell function. Nonetheless, ongoing research continues to explore new ways to target Ras proteins in cancer treatment.

Apoptosis is a programmed cell death process that occurs naturally in the body. It is a vital mechanism for maintaining tissue homeostasis and eliminating damaged or unwanted cells. During apoptosis, cells undergo a series of changes that ultimately lead to their death and removal from the body. These changes include chromatin condensation, DNA fragmentation, and the formation of apoptotic bodies, which are engulfed by neighboring cells or removed by immune cells. Apoptosis plays a critical role in many physiological processes, including embryonic development, tissue repair, and immune function. However, when apoptosis is disrupted or dysregulated, it can contribute to the development of various diseases, including cancer, autoimmune disorders, and neurodegenerative diseases.

Carcinoma, Adenosquamous is a type of cancer that arises from the cells that line the inside of certain organs, such as the lungs, bladder, and pancreas. These cells are called glandular cells, and they produce mucus or other substances that help to lubricate and protect the organs. Adenosquamous carcinoma is a rare type of cancer that arises when glandular cells and squamous cells, which are flat, scale-like cells that line the surface of organs, mix together and form a tumor. This type of cancer is often aggressive and can spread quickly to other parts of the body. Treatment for adenosquamous carcinoma typically involves surgery, radiation therapy, and chemotherapy.

Mucin-1 (MUC1) is a type of protein that is found in the mucus lining of various organs in the human body, including the digestive tract, respiratory tract, and female reproductive system. It is also expressed on the surface of some types of cancer cells, particularly those in the breast, lung, and colon. In the medical field, MUC1 is often studied as a potential biomarker for cancer, as its expression levels can be used to detect and monitor the progression of certain types of cancer. MUC1 is also being investigated as a potential target for cancer therapy, as drugs that can specifically bind to and inhibit MUC1 may be able to selectively kill cancer cells while sparing healthy cells. In addition to its role in cancer, MUC1 is also involved in a number of other physiological processes, including the regulation of cell growth and differentiation, the maintenance of tissue integrity, and the immune response.

Lung neoplasms refer to abnormal growths or tumors that develop in the lungs. These growths can be either benign (non-cancerous) or malignant (cancerous). Lung neoplasms can occur in any part of the lung, including the bronchi, bronchioles, and alveoli. Lung neoplasms can be further classified based on their type, including: 1. Primary lung neoplasms: These are tumors that develop in the lungs and do not spread to other parts of the body. 2. Secondary lung neoplasms: These are tumors that develop in the lungs as a result of cancer that has spread from another part of the body. 3. Benign lung neoplasms: These are non-cancerous tumors that do not spread to other parts of the body. 4. Malignant lung neoplasms: These are cancerous tumors that can spread to other parts of the body. Some common types of lung neoplasms include lung adenocarcinoma, squamous cell carcinoma, large cell carcinoma, and small cell carcinoma. The diagnosis of lung neoplasms typically involves a combination of imaging tests, such as chest X-rays and CT scans, and a biopsy to examine a sample of tissue from the tumor. Treatment options for lung neoplasms depend on the type, size, and location of the tumor, as well as the overall health of the patient.

Keratins are a family of fibrous proteins that are primarily found in the epidermis and hair of mammals. They are responsible for providing strength and protection to the skin and hair, and are also involved in the formation of nails and claws. In the medical field, keratins are often studied in relation to various skin conditions, such as psoriasis, eczema, and skin cancer. They are also used as markers for the differentiation of various types of skin cells, and as a diagnostic tool for identifying different types of cancer. Keratins are also found in other tissues, such as the gastrointestinal tract, respiratory tract, and the eye. In these tissues, they play important roles in maintaining the integrity and function of the epithelial lining. Overall, keratins are an important component of the skin and other tissues, and their study is important for understanding the function and health of these tissues.

Cadherins are a family of transmembrane proteins that play a crucial role in cell-cell adhesion in the human body. They are responsible for the formation and maintenance of tissues and organs by linking neighboring cells together. There are over 20 different types of cadherins, each with its own unique function and distribution in the body. Cadherins are involved in a wide range of biological processes, including embryonic development, tissue repair, and cancer progression. In the medical field, cadherins are often studied as potential targets for therapeutic interventions. For example, some researchers are exploring the use of cadherin inhibitors to treat cancer by disrupting the adhesion between cancer cells and normal cells, which can help prevent the spread of the disease. Additionally, cadherins are being studied as potential biomarkers for various diseases, including cancer, cardiovascular disease, and neurological disorders.

Carcinoma, Mucoepidermoid is a type of cancer that originates in the mucus-producing cells of the salivary glands. It is a rare type of salivary gland cancer, accounting for about 10% of all salivary gland cancers. Mucoepidermoid carcinoma can occur in any of the salivary glands, but it is most commonly found in the parotid gland, which is located in front of the ear. The cancer cells in mucoepidermoid carcinoma can vary in appearance and function, which can affect the behavior and treatment of the cancer. Symptoms of mucoepidermoid carcinoma may include a lump or mass in the neck or mouth, difficulty swallowing, ear pain, and facial weakness. Diagnosis typically involves a combination of imaging tests, such as CT scans or MRI, and a biopsy of the affected tissue. Treatment for mucoepidermoid carcinoma may include surgery to remove the cancerous tissue, radiation therapy, and/or chemotherapy. The specific treatment plan will depend on the stage and location of the cancer, as well as the overall health of the patient.

RNA, Neoplasm refers to the presence of abnormal RNA molecules in a neoplasm, which is a mass of abnormal cells that grow uncontrollably in the body. RNA is a type of genetic material that plays a crucial role in the regulation of gene expression and protein synthesis. In neoplasms, abnormal RNA molecules can be produced due to mutations in the DNA that codes for RNA. These abnormal RNA molecules can affect the normal functioning of cells and contribute to the development and progression of cancer. The detection and analysis of RNA in neoplasms can provide important information about the genetic changes that are occurring in the cells and can help guide the development of targeted therapies for cancer treatment.

Common bile duct neoplasms refer to tumors or growths that develop in the common bile duct, which is a tube that carries bile from the liver to the small intestine. These neoplasms can be either benign or malignant, and they can cause a variety of symptoms, including abdominal pain, jaundice, and weight loss. Treatment options for common bile duct neoplasms depend on the type and stage of the tumor, as well as the overall health of the patient. Some possible treatments include surgery, chemotherapy, radiation therapy, and targeted therapy.

Nitrosamines are a group of organic compounds that are formed by the reaction of amines with nitric oxide or nitrous acid. They are commonly found in a variety of industrial and environmental settings, as well as in certain foods and tobacco products. In the medical field, nitrosamines are of concern because they are potent carcinogens, meaning that they can cause cancer in animals and humans. Exposure to nitrosamines has been linked to an increased risk of several types of cancer, including stomach cancer, liver cancer, and colorectal cancer. Because of their carcinogenic properties, nitrosamines are regulated by various government agencies around the world, and efforts are being made to reduce exposure to these compounds in food and other products.

In the medical field, "Antigens, Neoplasm" refers to proteins or other molecules that are produced by cancer cells (neoplasms) and are recognized by the immune system as foreign. These antigens can be used as targets for cancer immunotherapy, which aims to stimulate the immune system to attack and destroy cancer cells. Antigens, neoplasm can also be used as diagnostic markers to identify cancer cells in the body or to monitor the effectiveness of cancer treatment.

Cystadenoma, papillary is a type of benign (non-cancerous) tumor that develops in the lining of certain organs, particularly the ovaries, pancreas, and bile ducts. It is characterized by the formation of cysts (fluid-filled sacs) within the tumor, which can vary in size and number. The cystadenoma, papillary is a slow-growing tumor and usually does not cause any symptoms until it becomes large enough to compress surrounding tissues or organs. Treatment for cystadenoma, papillary typically involves surgical removal of the tumor, although in some cases, it may be monitored with regular imaging studies to ensure that it does not grow or cause any problems.

Cystadenocarcinoma, mucinous is a type of cancer that arises from the epithelial cells lining the cysts of the ovary. It is a type of ovarian cancer that is characterized by the production of large amounts of a thick, gelatinous substance called mucus. This type of cancer is typically slow-growing and may not cause symptoms in the early stages. However, as the cancer grows, it can cause abdominal pain, bloating, and other symptoms. Treatment for cystadenocarcinoma, mucinous typically involves surgery to remove the affected ovary and any other affected tissue. In some cases, chemotherapy may also be used to help kill any remaining cancer cells.

HSP47 Heat-Shock Proteins are a type of heat-shock protein that are specifically expressed in connective tissue, such as fibroblasts and chondrocytes. They play a crucial role in the synthesis and assembly of extracellular matrix proteins, particularly collagen. HSP47 is involved in the folding and transport of procollagen molecules to the cell surface, where they are secreted and incorporated into the extracellular matrix. HSP47 is also involved in the regulation of collagen fibrillogenesis and the maintenance of tissue homeostasis. Dysregulation of HSP47 expression has been implicated in various connective tissue disorders, such as fibrosis and osteogenesis imperfecta.

Carcinoma, endometrioid is a type of cancer that originates in the endometrium, which is the lining of the uterus. It is the most common type of uterine cancer and usually affects women in their 50s and 60s. Endometrioid carcinomas are characterized by the presence of glandular structures that resemble the normal endometrial glands. These tumors are usually slow-growing and may not cause symptoms in the early stages. However, as the tumor grows, it can cause abnormal bleeding, pain, and other symptoms. The diagnosis of endometrioid carcinoma is typically made through a combination of imaging tests, such as ultrasound and MRI, and a biopsy of the tumor. Treatment options for endometrioid carcinoma may include surgery, radiation therapy, and hormone therapy, depending on the stage and severity of the cancer. The prognosis for endometrioid carcinoma is generally good, with a high survival rate if the cancer is detected and treated early.

Head and neck neoplasms refer to tumors that develop in the head and neck region of the body. These tumors can be benign (non-cancerous) or malignant (cancerous) and can affect any part of the head and neck, including the mouth, nose, throat, sinuses, salivary glands, thyroid gland, and neck lymph nodes. Head and neck neoplasms can be further classified based on the type of tissue they arise from, such as squamous cell carcinoma (which develops from the squamous cells that line the inside of the mouth and throat), adenoid cystic carcinoma (which develops from the glands that produce mucus), and salivary gland tumors (which develop from the salivary glands). The treatment for head and neck neoplasms depends on the type, size, location, and stage of the tumor, as well as the overall health of the patient. Treatment options may include surgery, radiation therapy, chemotherapy, targeted therapy, and immunotherapy. Early detection and treatment are crucial for improving the prognosis and reducing the risk of complications.

Blotting, Western is a laboratory technique used to detect specific proteins in a sample by transferring proteins from a gel to a membrane and then incubating the membrane with a specific antibody that binds to the protein of interest. The antibody is then detected using an enzyme or fluorescent label, which produces a visible signal that can be quantified. This technique is commonly used in molecular biology and biochemistry to study protein expression, localization, and function. It is also used in medical research to diagnose diseases and monitor treatment responses.

Keratin-19 (KRT19) is a type of keratin protein that is expressed in the epithelial cells of various organs and tissues in the human body, including the skin, hair, nails, and respiratory tract. In the medical field, KRT19 is often used as a biomarker to detect and monitor various types of cancer, including lung cancer, head and neck cancer, and esophageal cancer. KRT19 is a type of intermediate filament protein that provides structural support to epithelial cells and helps to maintain their shape and integrity. In cancer cells, the expression of KRT19 can be altered, leading to changes in cell behavior and the development of tumors. In addition to its use as a cancer biomarker, KRT19 has also been studied for its potential role in other medical conditions, such as skin diseases and hair loss. For example, KRT19 has been shown to be involved in the development of certain types of alopecia, or hair loss, and may be a potential target for new treatments.

Pancreatic diseases refer to a group of medical conditions that affect the pancreas, a gland located in the abdomen behind the stomach. The pancreas plays a vital role in the digestive and endocrine systems, producing enzymes that help break down food and hormones that regulate blood sugar levels. Pancreatic diseases can be classified into two main categories: exocrine pancreatic diseases and endocrine pancreatic diseases. Exocrine pancreatic diseases affect the pancreas' ability to produce digestive enzymes, leading to malabsorption of nutrients and digestive problems. Examples of exocrine pancreatic diseases include chronic pancreatitis, cystic fibrosis, and pancreatic cancer. Endocrine pancreatic diseases affect the pancreas' ability to produce hormones, leading to imbalances in blood sugar levels. Examples of endocrine pancreatic diseases include type 1 diabetes, type 2 diabetes, and pancreatic neuroendocrine tumors. Pancreatic diseases can be challenging to diagnose and treat, as they often present with non-specific symptoms and can affect multiple organ systems. Treatment options depend on the specific disease and may include medications, surgery, or other interventions.

Carcinoma, Embryonal is a type of cancer that arises from the cells that are similar to those found in an embryo or fetus. It is a rare and aggressive form of cancer that can occur in various parts of the body, including the brain, liver, kidney, and testicles. Carcinoma, Embryonal is typically diagnosed in children and young adults, and it is more common in males than females. The exact cause of this type of cancer is not known, but it is believed to be related to genetic mutations and abnormalities. Treatment for Carcinoma, Embryonal usually involves a combination of surgery, chemotherapy, and radiation therapy. The prognosis for this type of cancer depends on several factors, including the location and stage of the cancer, as well as the age and overall health of the patient. In some cases, the cancer may be cured with treatment, while in other cases, it may be more difficult to treat and may recur or spread to other parts of the body.

Esophageal neoplasms refer to abnormal growths or tumors that develop in the esophagus, which is the muscular tube that carries food from the throat to the stomach. These neoplasms can be either benign (non-cancerous) or malignant (cancerous). Benign esophageal neoplasms include polyps, which are small, non-cancerous growths that can develop on the lining of the esophagus. Other examples of benign neoplasms include leiomyomas, which are smooth muscle tumors, and lipomas, which are fatty tumors. Malignant esophageal neoplasms, on the other hand, are more serious and can be further classified into two main types: squamous cell carcinomas and adenocarcinomas. Squamous cell carcinomas develop in the squamous cells that line the esophagus, while adenocarcinomas develop in the glandular cells that line the lower part of the esophagus, near the stomach. Esophageal neoplasms can cause a range of symptoms, including difficulty swallowing, chest pain, weight loss, and difficulty breathing. Treatment options for esophageal neoplasms depend on the type, size, and location of the tumor, as well as the overall health of the patient. Treatment options may include surgery, radiation therapy, chemotherapy, or a combination of these approaches.

Mouth neoplasms refer to abnormal growths or tumors that develop in the mouth, including the lips, tongue, gums, palate, and throat. These growths can be benign (non-cancerous) or malignant (cancerous), and they can occur in any part of the mouth. Mouth neoplasms can be further classified based on their type, including: 1. Squamous cell carcinoma: This is the most common type of mouth cancer and usually develops on the lips, tongue, or floor of the mouth. 2. Adenoid cystic carcinoma: This type of cancer usually develops in the salivary glands and can spread to other parts of the mouth and neck. 3. Mucoepidermoid carcinoma: This is a rare type of cancer that develops in the salivary glands and can spread to other parts of the mouth and neck. 4. Basal cell carcinoma: This type of cancer usually develops on the lips and can spread to other parts of the mouth and neck. 5. Melanoma: This is a type of cancer that develops in the melanocytes (pigment-producing cells) of the mouth. Mouth neoplasms can cause a variety of symptoms, including pain, difficulty swallowing, changes in the appearance of the mouth, and bleeding. Treatment options for mouth neoplasms depend on the type, size, and location of the tumor, as well as the overall health of the patient. Treatment may include surgery, radiation therapy, chemotherapy, or a combination of these approaches.

Cyclin-dependent kinase inhibitor p16, also known as CDKN2A or p16INK4a, is a protein that plays a crucial role in regulating the cell cycle and preventing uncontrolled cell growth. It is encoded by the CDKN2A gene and is a member of the cyclin-dependent kinase inhibitor (CKI) family. In normal cells, p16 is expressed in response to DNA damage and acts as a brake on the cell cycle by inhibiting the activity of cyclin-dependent kinases (CDKs), which are enzymes that control cell cycle progression. When cells are damaged, p16 is activated and binds to CDK4 and CDK6, preventing them from phosphorylating and activating the retinoblastoma protein (Rb), which is a key regulator of the cell cycle. However, in many types of cancer, the CDKN2A gene is mutated or deleted, leading to a loss of p16 expression and allowing cells to bypass the cell cycle checkpoint controlled by p16. This can result in uncontrolled cell growth and the development of tumors. Therefore, p16 is considered a tumor suppressor gene, and its loss of function is associated with an increased risk of developing various types of cancer, including melanoma, lung cancer, and pancreatic cancer. In addition, p16 is also used as a diagnostic and prognostic marker in cancer, as its expression levels can be used to predict the aggressiveness of tumors and the response to treatment.

Carcinoma, Merkel cell is a rare and aggressive type of skin cancer that arises from Merkel cells, which are specialized cells found in the skin's outermost layer. It typically occurs on sun-exposed areas of the body, such as the head, neck, and arms, and is more common in older adults and people with weakened immune systems. The exact cause of Merkel cell carcinoma is not known, but it is believed to be related to exposure to ultraviolet (UV) radiation from the sun or tanning beds. Other risk factors include a history of sunburns, fair skin, and a weakened immune system. Symptoms of Merkel cell carcinoma may include a firm, painless lump or bump on the skin, a red or bluish-red nodule, or a sore that does not heal. The cancer can also spread to nearby lymph nodes and other parts of the body. Treatment for Merkel cell carcinoma typically involves surgery to remove the tumor and any nearby lymph nodes, followed by radiation therapy or chemotherapy to kill any remaining cancer cells. In some cases, targeted therapy or immunotherapy may also be used. Early detection and treatment are important for improving the chances of a good outcome.

Cholangiopancreatography, Endoscopic Retrograde (ERCP) is a medical procedure used to diagnose and treat problems with the bile ducts and pancreas. It involves inserting a thin, flexible tube (endoscope) through the mouth and into the small intestine, where a dye is injected to highlight the bile ducts and pancreas on an X-ray. This allows doctors to see any blockages or abnormalities in the ducts and to take samples of tissue for further testing. ERCP is often used to diagnose and treat conditions such as gallstones, pancreatitis, and bile duct cancer. It is a minimally invasive procedure that is generally considered safe, although there are some risks associated with it.

Cell division is the process by which a single cell divides into two or more daughter cells. This process is essential for the growth, development, and repair of tissues in the body. There are two main types of cell division: mitosis and meiosis. Mitosis is the process by which somatic cells (non-reproductive cells) divide to produce two identical daughter cells with the same number of chromosomes as the parent cell. This process is essential for the growth and repair of tissues in the body. Meiosis, on the other hand, is the process by which germ cells (reproductive cells) divide to produce four genetically diverse daughter cells with half the number of chromosomes as the parent cell. This process is essential for sexual reproduction. Abnormalities in cell division can lead to a variety of medical conditions, including cancer. In cancer, cells divide uncontrollably and form tumors, which can invade nearby tissues and spread to other parts of the body.

In the medical field, "cell growth processes" refer to the various mechanisms that cells use to divide and multiply, resulting in the growth and development of tissues and organs. These processes are tightly regulated and involve a complex interplay of genetic and environmental factors. There are two main types of cell growth processes: mitosis and cell differentiation. Mitosis is the process by which a single cell divides into two identical daughter cells, each with the same genetic material as the parent cell. This process is essential for tissue repair and growth, as well as for the development of embryos. Cell differentiation, on the other hand, is the process by which cells acquire specialized functions and characteristics, allowing them to become different types of cells within a tissue or organ. This process is also tightly regulated and involves changes in gene expression and cellular structure. Abnormalities in cell growth processes can lead to a variety of medical conditions, including cancer, developmental disorders, and degenerative diseases. Understanding the mechanisms that regulate cell growth is therefore critical for developing effective treatments for these conditions.

RNA, Small Interfering (siRNA) is a type of non-coding RNA molecule that plays a role in gene regulation. siRNA is approximately 21-25 nucleotides in length and is derived from double-stranded RNA (dsRNA) molecules. In the medical field, siRNA is used as a tool for gene silencing, which involves inhibiting the expression of specific genes. This is achieved by introducing siRNA molecules that are complementary to the target mRNA sequence, leading to the degradation of the mRNA and subsequent inhibition of protein synthesis. siRNA has potential applications in the treatment of various diseases, including cancer, viral infections, and genetic disorders. It is also used in research to study gene function and regulation. However, the use of siRNA in medicine is still in its early stages, and there are several challenges that need to be addressed before it can be widely used in clinical practice.

Ovarian neoplasms refer to abnormal growths or tumors that develop in the ovaries, which are the female reproductive organs responsible for producing eggs and hormones. These neoplasms can be either benign (non-cancerous) or malignant (cancerous), and they can vary in size, shape, and location within the ovaries. Ovarian neoplasms can be classified based on their histological type, which refers to the type of cells that make up the tumor. Some common types of ovarian neoplasms include epithelial ovarian cancer, germ cell tumors, sex cord-stromal tumors, and stromal tumors. Symptoms of ovarian neoplasms may include abdominal pain, bloating, pelvic pain, and changes in menstrual patterns. However, many ovarian neoplasms are asymptomatic and are discovered incidentally during routine pelvic exams or imaging studies. Diagnosis of ovarian neoplasms typically involves a combination of imaging studies, such as ultrasound or CT scans, and blood tests to measure levels of certain hormones and tumor markers. A biopsy may also be performed to confirm the diagnosis and determine the type and stage of the neoplasm. Treatment for ovarian neoplasms depends on the type, stage, and location of the tumor, as well as the patient's overall health and preferences. Options may include surgery, chemotherapy, radiation therapy, or a combination of these approaches. Early detection and treatment are crucial for improving outcomes and survival rates for patients with ovarian neoplasms.

Hyperplasia is a medical term that refers to an increase in the number of cells in a tissue or organ. It is a normal response to various stimuli, such as injury, inflammation, or hormonal changes, and can be either physiological or pathological. In a physiological sense, hyperplasia is a normal process that occurs in response to growth factors or hormones, such as estrogen or testosterone, which stimulate the growth of cells in certain tissues. For example, during puberty, the ovaries and testes undergo hyperplasia to produce more hormones. However, in a pathological sense, hyperplasia can be a sign of disease or dysfunction. For example, in the prostate gland, benign hyperplasia (also known as BPH) is a common condition that occurs when the gland becomes enlarged due to an overproduction of cells. This can cause symptoms such as difficulty urinating or frequent urination. In the breast, hyperplasia can be a precursor to breast cancer, as it involves an increase in the number of cells in the breast tissue. Similarly, in the uterus, hyperplasia can be a sign of endometrial cancer. Overall, hyperplasia is a complex process that can have both normal and pathological consequences, depending on the tissue or organ involved and the underlying cause of the increase in cell number.

Mucins are a family of high molecular weight glycoproteins that are found in mucus, a slimy substance that covers and protects the lining of various organs in the body, including the respiratory, digestive, and reproductive tracts. Mucins are responsible for maintaining the viscosity and elasticity of mucus, which helps to trap and remove foreign particles, such as bacteria and viruses, from the body. Mucins are composed of a central core protein, which is heavily glycosylated, meaning it is heavily modified with sugar molecules. These sugar molecules give mucins their unique properties, such as their ability to bind to other molecules and form a gel-like matrix. Mucins are also involved in a variety of other functions, such as cell signaling, cell adhesion, and immune response. In the medical field, mucins are often studied in the context of diseases that affect the respiratory and digestive tracts, such as asthma, chronic obstructive pulmonary disease (COPD), and inflammatory bowel disease (IBD). Mucins are also being studied in the context of cancer, as changes in the expression and function of mucins can be associated with the development and progression of certain types of cancer.

Mucin-2 (MUC2) is a type of mucin, a family of glycoproteins that are found in mucus, a slimy substance that covers and protects the lining of various organs in the body, including the digestive tract, respiratory tract, and reproductive tract. MUC2 is a particularly important mucin in the colon, where it plays a crucial role in maintaining the health and function of the gut lining. MUC2 is produced by goblet cells, which are specialized cells in the lining of the colon that secrete mucus. MUC2 is a large, complex protein that is composed of a central core region and two branching carbohydrate-rich regions. The core region contains a series of tandem repeats that are responsible for the protein's ability to form a gel-like matrix that helps to protect the gut lining from damage and infection. In addition to its protective role, MUC2 also plays a role in regulating the immune system and promoting the growth and differentiation of colon cells. Dysregulation of MUC2 production or function has been linked to a number of digestive disorders, including inflammatory bowel disease, colon cancer, and irritable bowel syndrome.

Gamma-Synuclein is a protein that is found in the brain and other parts of the body. It is a member of the synuclein family of proteins, which are involved in the regulation of neurotransmitter release and the maintenance of neuronal structure. Gamma-Synuclein is primarily expressed in the brain, where it is found in high concentrations in the substantia nigra, a region of the brain that is involved in movement control. In recent years, gamma-Synuclein has been implicated in the development of several neurological disorders, including Parkinson's disease and dementia with Lewy bodies. These disorders are characterized by the accumulation of abnormal forms of the protein, which can lead to the death of brain cells and the development of symptoms such as tremors, rigidity, and cognitive decline.

Colonic neoplasms refer to abnormal growths or tumors that develop in the colon, which is the final part of the large intestine. These growths can be either benign (non-cancerous) or malignant (cancerous). Benign colonic neoplasms include polyps, which are small, non-cancerous growths that can develop on the inner lining of the colon. Polyps can be further classified as adenomas, which are made up of glandular tissue, or hyperplastic polyps, which are non-glandular. Malignant colonic neoplasms, on the other hand, are cancerous tumors that can invade nearby tissues and spread to other parts of the body. The most common type of colon cancer is adenocarcinoma, which starts in the glandular tissue of the colon. Colonic neoplasms can be detected through various diagnostic tests, including colonoscopy, sigmoidoscopy, and fecal occult blood testing. Treatment options for colonic neoplasms depend on the type, size, and location of the growth, as well as the overall health of the patient. Early detection and treatment of colonic neoplasms can significantly improve the chances of a successful outcome.

Adrenocortical carcinoma (ACC) is a rare and aggressive form of cancer that originates in the adrenal cortex, which is the outer layer of the adrenal gland. The adrenal gland is located on top of each kidney and produces hormones that regulate various bodily functions, including blood pressure, metabolism, and the stress response. ACC can produce excessive amounts of hormones, leading to a variety of symptoms, including weight gain, high blood pressure, and electrolyte imbalances. The cancer can also spread to other parts of the body, including the liver, lungs, and bones. Treatment for ACC typically involves surgery to remove the tumor, followed by chemotherapy or radiation therapy to kill any remaining cancer cells. In some cases, hormone therapy may also be used to manage symptoms caused by excess hormone production. The prognosis for ACC depends on the stage of the cancer at diagnosis and the patient's overall health.

Proto-oncogenes are normal genes that are involved in regulating cell growth and division. When these genes are mutated or overexpressed, they can become oncogenes, which can lead to the development of cancer. Proto-oncogenes are also known as proto-oncogene proteins.

Carcinoma, verrucous is a type of cancer that arises from the skin cells, specifically from the basal cells that line the epidermis, the outermost layer of the skin. It is also known as basal cell carcinoma in situ or intraepithelial carcinoma. Carcinoma, verrucous is usually slow-growing and tends to spread locally rather than metastasizing to other parts of the body. It is often found on sun-exposed areas of the skin, such as the face, neck, and hands, and is more common in fair-skinned individuals who have a history of sun exposure or who have had previous skin damage. The diagnosis of carcinoma, verrucous is typically made through a biopsy, which involves removing a small sample of tissue from the affected area for examination under a microscope. Treatment options for this type of cancer include surgical removal, cryotherapy, radiation therapy, and topical medications. In some cases, no treatment may be necessary if the cancer is small and not causing any symptoms.

Cell differentiation is the process by which cells acquire specialized functions and characteristics during development. It is a fundamental process that occurs in all multicellular organisms, allowing cells to differentiate into various types of cells with specific functions, such as muscle cells, nerve cells, and blood cells. During cell differentiation, cells undergo changes in their shape, size, and function, as well as changes in the proteins and other molecules they produce. These changes are controlled by a complex network of genes and signaling pathways that regulate the expression of specific genes in different cell types. Cell differentiation is a critical process for the proper development and function of tissues and organs in the body. It is also involved in tissue repair and regeneration, as well as in the progression of diseases such as cancer, where cells lose their normal differentiation and become cancerous.

Carcinoma, Signet Ring Cell is a type of cancer that originates in the cells of the stomach lining. It is characterized by the presence of cells with a distinctive appearance, called signet ring cells, which have a large central nucleus surrounded by a clear, eosinophilic cytoplasm that stains pink. These cells are thought to be derived from glandular cells in the stomach lining and are often associated with the production of excess acid by the stomach. Carcinoma, Signet Ring Cell is a relatively rare type of stomach cancer, accounting for less than 1% of all cases. It is typically diagnosed at an advanced stage and has a poor prognosis, with a high risk of recurrence and metastasis. Treatment options for Carcinoma, Signet Ring Cell may include surgery, chemotherapy, radiation therapy, and targeted therapy.

In the medical field, "trans-activators" refer to proteins or molecules that activate the transcription of a gene, which is the process by which the information in a gene is used to produce a functional product, such as a protein. Trans-activators can bind to specific DNA sequences near a gene and recruit other proteins, such as RNA polymerase, to initiate transcription. They can also modify the chromatin structure around a gene to make it more accessible to transcription machinery. Trans-activators play important roles in regulating gene expression and are involved in many biological processes, including development, differentiation, and disease.

Urinary bladder neoplasms refer to abnormal growths or tumors that develop in the urinary bladder. These neoplasms can be either benign (non-cancerous) or malignant (cancerous). Benign neoplasms include cysts, polyps, and adenomas, while malignant neoplasms are classified as urothelial carcinomas, which are the most common type of bladder cancer. Symptoms of urinary bladder neoplasms may include blood in the urine, frequent urination, pain or burning during urination, and abdominal pain or discomfort. Diagnosis typically involves a combination of physical examination, imaging studies, and biopsy. Treatment options depend on the type, size, and stage of the neoplasm, and may include surgery, chemotherapy, radiation therapy, or a combination of these approaches.

Stomach neoplasms refer to abnormal growths or tumors that develop in the lining of the stomach. These growths can be either benign (non-cancerous) or malignant (cancerous). Stomach neoplasms can occur in different parts of the stomach, including the stomach lining, the muscular wall of the stomach, and the glands that produce stomach acid. Some common types of stomach neoplasms include gastric adenocarcinoma (a type of cancer that starts in the glandular cells of the stomach lining), gastric lymphoma (a type of cancer that starts in the lymphatic cells of the stomach), and gastric stromal tumors (benign tumors that develop in the connective tissue of the stomach). Stomach neoplasms can cause a variety of symptoms, including abdominal pain, nausea, vomiting, weight loss, and loss of appetite. Diagnosis typically involves a combination of medical history, physical examination, imaging tests (such as endoscopy or CT scan), and biopsy. Treatment for stomach neoplasms depends on the type, size, and location of the tumor, as well as the overall health of the patient. Treatment options may include surgery, chemotherapy, radiation therapy, or a combination of these approaches.

In the medical field, "Disease Models, Animal" refers to the use of animals to study and understand human diseases. These models are created by introducing a disease or condition into an animal, either naturally or through experimental manipulation, in order to study its progression, symptoms, and potential treatments. Animal models are used in medical research because they allow scientists to study diseases in a controlled environment and to test potential treatments before they are tested in humans. They can also provide insights into the underlying mechanisms of a disease and help to identify new therapeutic targets. There are many different types of animal models used in medical research, including mice, rats, rabbits, dogs, and monkeys. Each type of animal has its own advantages and disadvantages, and the choice of model depends on the specific disease being studied and the research question being addressed.

MicroRNAs (miRNAs) are small, non-coding RNA molecules that play a crucial role in regulating gene expression at the post-transcriptional level. They are typically 18-24 nucleotides in length and are transcribed from endogenous genes. In the medical field, miRNAs have been found to be involved in a wide range of biological processes, including cell growth, differentiation, apoptosis, and metabolism. Dysregulation of miRNA expression has been implicated in various diseases, including cancer, cardiovascular disease, neurological disorders, and infectious diseases. MiRNAs can act as either oncogenes or tumor suppressors, depending on the target gene they regulate. They can also be used as diagnostic and prognostic markers for various diseases, as well as therapeutic targets for the development of new drugs.

Skin neoplasms refer to abnormal growths or tumors that develop on the skin. These growths can be benign (non-cancerous) or malignant (cancerous). Skin neoplasms can occur anywhere on the body and can vary in size, shape, and color. Some common types of skin neoplasms include basal cell carcinoma, squamous cell carcinoma, melanoma, and keratosis. These growths can be treated with a variety of methods, including surgery, radiation therapy, chemotherapy, and immunotherapy. It is important to have any unusual skin growths evaluated by a healthcare professional to determine the best course of treatment.

In the medical field, cell movement refers to the ability of cells to move from one location to another within a tissue or organism. This movement can occur through various mechanisms, including crawling, rolling, and sliding, and is essential for many physiological processes, such as tissue repair, immune response, and embryonic development. There are several types of cell movement, including: 1. Chemotaxis: This is the movement of cells in response to chemical gradients, such as the concentration of a signaling molecule. 2. Haptotaxis: This is the movement of cells in response to physical gradients, such as the stiffness or topography of a substrate. 3. Random walk: This is the movement of cells in a seemingly random manner, which can be influenced by factors such as cell adhesion and cytoskeletal dynamics. 4. Amoeboid movement: This is the movement of cells that lack a well-defined cytoskeleton and rely on changes in cell shape and adhesion to move. Understanding cell movement is important for many medical applications, including the development of new therapies for diseases such as cancer, the study of tissue regeneration and repair, and the design of new materials for tissue engineering and regenerative medicine.

In the medical field, "calculi" refers to solid masses or stones that form in the urinary tract or other organs. The most common type of calculi are kidney stones, which can form in the kidneys, ureters, or bladder. Kidney stones are typically composed of minerals such as calcium, oxalate, or phosphate, and can vary in size from a grain of sand to a golf ball. They can cause severe pain, blood in the urine, and other symptoms, and may require medical intervention to remove. Other types of calculi can form in the gallbladder (gallstones), bile ducts (cholecystolithiasis), or pancreas (pancreatic calculi). These calculi can also cause serious health problems if left untreated.

A pancreatic pseudocyst is a fluid-filled sac that forms in the pancreas as a result of injury or inflammation. It is not a true cyst, as it does not have a lining of epithelial cells. Instead, it is filled with digestive enzymes and other substances that have leaked from the pancreas. Pseudocysts can develop after acute pancreatitis, a condition in which the pancreas becomes inflamed and can cause severe abdominal pain. They can also occur after trauma to the pancreas, such as a blow to the abdomen, or after surgery on the pancreas or nearby organs. Pseudocysts can be small and asymptomatic, or they can be large and cause symptoms such as abdominal pain, nausea, vomiting, and weight loss. Treatment options for pancreatic pseudocysts include observation, drainage, and surgery, depending on the size and location of the cyst and the severity of symptoms.

The Epidermal Growth Factor Receptor (EGFR) is a type of cell surface receptor protein that is found on the surface of cells in the epidermis, as well as in other tissues throughout the body. The EGFR is a member of a family of receptors called receptor tyrosine kinases, which are involved in regulating cell growth, differentiation, and survival. When the EGFR binds to its ligand, a protein called epidermal growth factor (EGF), it triggers a cascade of intracellular signaling events that ultimately lead to the activation of various genes involved in cell growth and proliferation. This process is important for normal tissue growth and repair, but it can also contribute to the development of cancer when the EGFR is overactive or mutated. EGFR inhibitors are a class of drugs that are used to treat certain types of cancer, such as non-small cell lung cancer and head and neck cancer, by blocking the activity of the EGFR and preventing it from signaling downstream genes. These drugs can be used alone or in combination with other treatments, such as chemotherapy or radiation therapy.

Receptor, erbB-2, also known as HER2 or neu, is a protein that is found on the surface of certain cells in the human body. It is a type of receptor tyrosine kinase, which means that it is a protein that is activated when it binds to a specific molecule, called a ligand. In the case of erbB-2, the ligand is a protein called epidermal growth factor (EGF). ErbB-2 is involved in a number of important cellular processes, including cell growth, differentiation, and survival. It is also a key player in the development of certain types of cancer, particularly breast cancer. In some cases, the erbB-2 gene may be overexpressed or mutated, leading to an overabundance of the erbB-2 protein on the surface of cancer cells. This can contribute to the uncontrolled growth and spread of the cancer. There are several ways that doctors can test for erbB-2 overexpression in breast cancer patients. One common method is to use a test called immunohistochemistry (IHC), which involves staining tissue samples with an antibody that binds specifically to the erbB-2 protein. If the erbB-2 protein is present in high levels, the tissue will appear dark under the microscope. Another method is to use a test called fluorescence in situ hybridization (FISH), which involves using a fluorescent probe to detect the presence of the erbB-2 gene on the cancer cells. If a patient's breast cancer is found to be positive for erbB-2 overexpression, they may be eligible for treatment with drugs called trastuzumab (Herceptin) or pertuzumab (Perjeta), which are designed to target the erbB-2 protein and help to shrink or stop the growth of the cancer. These drugs are often used in combination with other treatments, such as chemotherapy or radiation therapy.

In the medical field, a base sequence refers to the specific order of nucleotides (adenine, thymine, cytosine, and guanine) that make up the genetic material (DNA or RNA) of an organism. The base sequence determines the genetic information encoded within the DNA molecule and ultimately determines the traits and characteristics of an individual. The base sequence can be analyzed using various techniques, such as DNA sequencing, to identify genetic variations or mutations that may be associated with certain diseases or conditions.

Serpins are a family of proteins that play important roles in regulating a variety of physiological processes in the body. They are named after their ability to inhibit serine proteases, a class of enzymes that cleave proteins at specific sites using serine as a nucleophile. Serpins are found in many different tissues and fluids throughout the body, and they have a wide range of functions. Some serpins act as inhibitors of proteases involved in blood clotting, inflammation, and immune responses, while others play roles in the metabolism of hormones and other signaling molecules. In the medical field, serpins are of particular interest because of their potential therapeutic applications. For example, some serpins have been shown to have anti-inflammatory and anti-cancer effects, and they are being studied as potential treatments for a variety of diseases, including cardiovascular disease, cancer, and neurodegenerative disorders. Additionally, some serpins are used as diagnostic markers for certain conditions, such as liver disease and certain types of cancer.

Cystadenoma, Serous is a type of benign (non-cancerous) tumor that develops in the ovaries or fallopian tubes. It is a type of cystadenoma, which is a cyst that forms from the epithelial cells lining the glandular tissue of the ovary or fallopian tube. Serous cystadenomas are typically filled with a clear or cloudy fluid and can vary in size from a few millimeters to several centimeters in diameter. They are usually discovered incidentally during a pelvic exam or imaging study, and are often asymptomatic. However, in some cases, they may cause abdominal pain, bloating, or discomfort. Treatment for serous cystadenomas typically involves surgical removal, although smaller tumors may be monitored with regular imaging studies.

Ki-67 is a protein found in the nuclei of cells that are actively dividing. It is a useful marker for assessing the growth rate of tumors and is often used in conjunction with other markers to help diagnose and predict the behavior of cancer. The Ki-67 antigen is named after the Danish pathologist, Kai Erik Nielsen, who first described it in the 1980s. It is typically measured using immunohistochemistry, a technique that uses antibodies to detect specific proteins in tissue samples.

Carcinoma, Large Cell is a type of cancer that originates in the lungs and is characterized by the presence of large, abnormal cells. These cells grow and divide rapidly, forming a tumor that can invade nearby tissues and spread to other parts of the body through the bloodstream or lymphatic system. Large cell carcinoma is one of the most common types of lung cancer, accounting for about 10-15% of all cases. It is more common in men than in women and is often associated with smoking. The symptoms of large cell carcinoma may include coughing, chest pain, shortness of breath, hoarseness, and weight loss. Diagnosis typically involves a combination of imaging tests, such as chest X-rays and CT scans, and a biopsy to examine the tissue sample. Treatment for large cell carcinoma may include surgery, radiation therapy, chemotherapy, or a combination of these approaches. The choice of treatment depends on the stage of the cancer, the patient's overall health, and other factors.

Monoclonal antibodies (mAbs) are laboratory-made proteins that can mimic the immune system's ability to fight off harmful pathogens, such as viruses and bacteria. They are produced by genetically engineering cells to produce large quantities of a single type of antibody, which is specific to a particular antigen (a molecule that triggers an immune response). In the medical field, monoclonal antibodies are used to treat a variety of conditions, including cancer, autoimmune diseases, and infectious diseases. They can be administered intravenously, intramuscularly, or subcutaneously, depending on the condition being treated. Monoclonal antibodies work by binding to specific antigens on the surface of cells or pathogens, marking them for destruction by the immune system. They can also block the activity of specific molecules involved in disease processes, such as enzymes or receptors. Overall, monoclonal antibodies have revolutionized the treatment of many diseases, offering targeted and effective therapies with fewer side effects than traditional treatments.

Receptors, estrogen are proteins found on the surface of cells in the body that bind to and respond to the hormone estrogen. Estrogen is a sex hormone that is primarily produced by the ovaries in women and by the testes in men. It plays a key role in the development and regulation of the female reproductive system, as well as in the development of secondary sexual characteristics in both men and women. Estrogen receptors are classified into two main types: estrogen receptor alpha (ERα) and estrogen receptor beta (ERβ). These receptors are found in a wide variety of tissues throughout the body, including the breast, uterus, bone, and brain. When estrogen binds to its receptors, it triggers a cascade of chemical reactions within the cell that can have a variety of effects, depending on the type of receptor and the tissue in which it is found. In the breast, for example, estrogen receptors play a role in the development and growth of breast tissue, as well as in the regulation of the menstrual cycle. In the uterus, estrogen receptors are involved in the thickening of the uterine lining in preparation for pregnancy. In the bone, estrogen receptors help to maintain bone density and prevent osteoporosis. In the brain, estrogen receptors are involved in a variety of functions, including mood regulation, memory, and learning. Abnormalities in estrogen receptor function or expression have been linked to a number of health conditions, including breast cancer, uterine cancer, osteoporosis, and mood disorders.

Neovascularization, pathologic, refers to the abnormal growth of new blood vessels in the body. This can occur in response to a variety of factors, including injury, inflammation, and certain diseases. In some cases, neovascularization can be a normal part of the healing process, but in other cases it can be a sign of a more serious underlying condition. Pathologic neovascularization is often associated with conditions such as cancer, diabetes, and age-related macular degeneration. It can also be seen in the development of certain types of tumors, where the new blood vessels help to provide the tumor with the nutrients and oxygen it needs to grow. Treatment for pathologic neovascularization may involve medications, laser therapy, or surgery, depending on the underlying cause and the severity of the condition.

Carcinoembryonic Antigen (CEA) is a protein that is produced by certain types of cancer cells, as well as by normal cells in the embryonic stage of development. It is a glycoprotein that is found in the blood and tissues of the body. In the medical field, CEA is often used as a tumor marker, which means that it can be measured in the blood to help diagnose and monitor certain types of cancer. CEA levels are typically higher in people with cancer than in people without cancer, although they can also be elevated in other conditions, such as inflammatory bowel disease, liver disease, and smoking. CEA is most commonly used as a tumor marker for colorectal cancer, but it can also be used to monitor the response to treatment and to detect recurrence of the cancer. It is also used as a tumor marker for other types of cancer, such as pancreatic cancer, breast cancer, and lung cancer. It is important to note that while elevated CEA levels can be a sign of cancer, they do not necessarily mean that a person has cancer. Other factors, such as age, gender, and family history, can also affect CEA levels. Therefore, CEA should be interpreted in conjunction with other diagnostic tests and clinical information.

Beta-catenin is a protein that plays a crucial role in the regulation of cell adhesion and signaling pathways in the body. In the medical field, beta-catenin is often studied in the context of cancer, as mutations in the beta-catenin gene (CTNNB1) can lead to the development of various types of cancer, including colorectal cancer, endometrial cancer, and ovarian cancer. In normal cells, beta-catenin is a component of the cadherin adhesion complex, which helps cells stick together and maintain tissue integrity. However, in cancer cells, mutations in the beta-catenin gene can lead to the accumulation of beta-catenin in the cytoplasm and nucleus, where it can activate downstream signaling pathways that promote cell proliferation and survival. Beta-catenin is also involved in the regulation of other cellular processes, such as cell migration, differentiation, and apoptosis. As such, it is a potential target for the development of new cancer therapies.

Transcription factors are proteins that regulate gene expression by binding to specific DNA sequences and controlling the transcription of genetic information from DNA to RNA. They play a crucial role in the development and function of cells and tissues in the body. In the medical field, transcription factors are often studied as potential targets for the treatment of diseases such as cancer, where their activity is often dysregulated. For example, some transcription factors are overexpressed in certain types of cancer cells, and inhibiting their activity may help to slow or stop the growth of these cells. Transcription factors are also important in the development of stem cells, which have the ability to differentiate into a wide variety of cell types. By understanding how transcription factors regulate gene expression in stem cells, researchers may be able to develop new therapies for diseases such as diabetes and heart disease. Overall, transcription factors are a critical component of gene regulation and have important implications for the development and treatment of many diseases.

Laryngeal neoplasms refer to abnormal growths or tumors that develop in the larynx, which is the voice box located in the throat. These neoplasms can be benign (non-cancerous) or malignant (cancerous) in nature. Benign laryngeal neoplasms include polyps, papillomas, and cysts, which can cause hoarseness, difficulty swallowing, and other symptoms. Malignant laryngeal neoplasms, such as squamous cell carcinoma, can spread to other parts of the body and are more serious. Diagnosis of laryngeal neoplasms typically involves a combination of physical examination, imaging studies, and biopsy. Treatment options depend on the type, size, and location of the neoplasm, as well as the overall health of the patient. Treatment may include surgery, radiation therapy, chemotherapy, or a combination of these approaches.

Uterine cervical neoplasms refer to abnormal growths or tumors that develop in the cervix, which is the lower part of the uterus that connects to the vagina. These neoplasms can be either benign (non-cancerous) or malignant (cancerous). Cervical neoplasms can be classified into different types based on their characteristics and degree of malignancy. The most common type of cervical neoplasm is cervical intraepithelial neoplasia (CIN), which is a precancerous condition that can progress to invasive cervical cancer if left untreated. Cervical cancer is a serious health concern worldwide, and it is the fourth most common cancer in women globally. However, with regular screening and appropriate treatment, the prognosis for cervical cancer is generally good when it is detected early.

In the medical field, "cell survival" refers to the ability of cells to survive and continue to function despite exposure to harmful stimuli or conditions. This can include exposure to toxins, radiation, or other forms of stress that can damage or kill cells. Cell survival is an important concept in many areas of medicine, including cancer research, where understanding how cells survive and resist treatment is crucial for developing effective therapies. In addition, understanding the mechanisms that regulate cell survival can also have implications for other areas of medicine, such as tissue repair and regeneration.

Secretin is a hormone produced by the cells of the small intestine. It is released in response to the presence of food in the small intestine and plays a role in regulating the digestive process. Secretin stimulates the pancreas to release bicarbonate, which helps to neutralize stomach acid and protect the lining of the small intestine. It also stimulates the gallbladder to release bile, which helps to break down fats in the small intestine. In addition to its role in digestion, secretin has been studied for its potential therapeutic uses in a variety of medical conditions, including irritable bowel syndrome, chronic pancreatitis, and certain types of cancer.

Case-control studies are a type of observational study used in the medical field to investigate the relationship between an exposure and an outcome. In a case-control study, researchers identify individuals who have experienced a particular outcome (cases) and compare their exposure history to a group of individuals who have not experienced the outcome (controls). The main goal of a case-control study is to determine whether the exposure was a risk factor for the outcome. To do this, researchers collect information about the exposure history of both the cases and the controls and compare the two groups to see if there is a statistically significant difference in the prevalence of the exposure between the two groups. Case-control studies are often used when the outcome of interest is rare, and it is difficult or unethical to conduct a prospective cohort study. However, because case-control studies rely on retrospective data collection, they are subject to recall bias, where participants may not accurately remember their exposure history. Additionally, because case-control studies only provide information about the association between an exposure and an outcome, they cannot establish causality.

In the medical field, "Neoplasms, Experimental" refers to the study of neoplasms (abnormal growths of cells) in experimental settings, such as in laboratory animals or in vitro cell cultures. These studies are typically conducted to better understand the underlying mechanisms of neoplasms and to develop new treatments for cancer and other types of neoplastic diseases. Experimental neoplasms may be induced by various factors, including genetic mutations, exposure to carcinogens, or other forms of cellular stress. The results of these studies can provide valuable insights into the biology of neoplasms and help to identify potential targets for therapeutic intervention.

Matrix Metalloproteinase 7 (MMP-7) is a protein that belongs to the matrix metalloproteinase family of enzymes. These enzymes are involved in the degradation of extracellular matrix proteins, which are the structural components of tissues in the body. MMP-7 is also known as matrilysin or membrane-type 1 matrix metalloproteinase (MT1-MMP). In the medical field, MMP-7 has been studied for its role in various diseases and conditions, including cancer, inflammatory disorders, and tissue remodeling. For example, MMP-7 has been shown to be overexpressed in certain types of cancer, such as breast, colon, and lung cancer, and is thought to contribute to tumor invasion and metastasis by promoting the breakdown of basement membranes and extracellular matrix proteins. MMP-7 has also been implicated in the development of inflammatory diseases, such as rheumatoid arthritis and psoriasis, by promoting the degradation of extracellular matrix proteins and the release of pro-inflammatory cytokines. Additionally, MMP-7 has been shown to play a role in tissue remodeling during wound healing and organ development. Overall, MMP-7 is a key enzyme involved in the degradation of extracellular matrix proteins and has been implicated in a variety of diseases and conditions.

Tumor suppressor proteins are a group of proteins that play a crucial role in regulating cell growth and preventing the development of cancer. These proteins act as brakes on the cell cycle, preventing cells from dividing and multiplying uncontrollably. They also help to repair damaged DNA and prevent the formation of tumors. Tumor suppressor proteins are encoded by genes that are located on specific chromosomes. When these genes are functioning properly, they produce proteins that help to regulate cell growth and prevent the development of cancer. However, when these genes are mutated or damaged, the proteins they produce may not function properly, leading to uncontrolled cell growth and the development of cancer. There are many different tumor suppressor proteins, each with its own specific function. Some of the most well-known tumor suppressor proteins include p53, BRCA1, and BRCA2. These proteins are involved in regulating cell cycle checkpoints, repairing damaged DNA, and preventing the formation of tumors. In summary, tumor suppressor proteins are a group of proteins that play a critical role in regulating cell growth and preventing the development of cancer. When these proteins are functioning properly, they help to maintain the normal balance of cell growth and division, but when they are mutated or damaged, they can contribute to the development of cancer.

Adenocarcinoma, follicular is a type of cancer that starts in the cells that line the follicles (small fluid-filled sacs) in the thyroid gland. The thyroid gland is located in the neck, just below the voice box. Adenocarcinoma, follicular is a type of thyroid cancer that is usually slow-growing and may not cause symptoms in the early stages. However, if the cancer grows or spreads to other parts of the body, it can cause symptoms such as difficulty swallowing, hoarseness, and a lump or swelling in the neck. Treatment for adenocarcinoma, follicular typically involves surgery to remove the affected part of the thyroid gland, followed by radioactive iodine therapy or medication to manage any remaining cancer cells.

Antimetabolites, antineoplastic are drugs that mimic the structure of essential cellular building blocks, such as nucleotides or amino acids, and interfere with their metabolism, leading to the death of rapidly dividing cancer cells. These drugs are commonly used in cancer chemotherapy and are classified as either antimetabolites or antimetabolite-like agents. Examples of antimetabolites, antineoplastic include methotrexate, 5-fluorouracil, and mercaptopurine.

Mammary Neoplasms, Experimental refers to the study of neoplasms (tumors) that occur in the mammary glands of animals, typically laboratory animals such as mice, rats, and rabbits. These studies are conducted in a controlled laboratory setting to understand the development, progression, and potential treatment of mammary tumors in humans. The animals are typically genetically modified or treated with various chemicals or hormones to induce the development of mammary tumors. The results of these studies can provide valuable information for the development of new treatments for breast cancer in humans.

In the medical field, a cell line refers to a group of cells that have been derived from a single parent cell and have the ability to divide and grow indefinitely in culture. These cells are typically grown in a laboratory setting and are used for research purposes, such as studying the effects of drugs or investigating the underlying mechanisms of diseases. Cell lines are often derived from cancerous cells, as these cells tend to divide and grow more rapidly than normal cells. However, they can also be derived from normal cells, such as fibroblasts or epithelial cells. Cell lines are characterized by their unique genetic makeup, which can be used to identify them and compare them to other cell lines. Because cell lines can be grown in large quantities and are relatively easy to maintain, they are a valuable tool in medical research. They allow researchers to study the effects of drugs and other treatments on specific cell types, and to investigate the underlying mechanisms of diseases at the cellular level.

Homeodomain proteins are a class of transcription factors that play a crucial role in the development and differentiation of cells and tissues in animals. They are characterized by a highly conserved DNA-binding domain called the homeodomain, which allows them to recognize and bind to specific DNA sequences. Homeodomain proteins are involved in a wide range of biological processes, including embryonic development, tissue differentiation, and organogenesis. They regulate the expression of genes that are essential for these processes by binding to specific DNA sequences and either activating or repressing the transcription of target genes. There are many different types of homeodomain proteins, each with its own unique function and target genes. Some examples of homeodomain proteins include the Hox genes, which are involved in the development of the body plan in animals, and the Pax genes, which are involved in the development of the nervous system. Mutations in homeodomain proteins can lead to a variety of developmental disorders, including congenital malformations and intellectual disabilities. Understanding the function and regulation of homeodomain proteins is therefore important for the development of new treatments for these conditions.

Gallbladder neoplasms refer to abnormal growths or tumors that develop in the gallbladder, a small organ located in the upper right part of the abdomen. These neoplasms can be either benign (non-cancerous) or malignant (cancerous). Benign gallbladder neoplasms include polyps, which are small, non-cancerous growths that can develop on the lining of the gallbladder. These polyps are usually asymptomatic and are often discovered incidentally during imaging studies for other conditions. Malignant gallbladder neoplasms, on the other hand, are less common but more serious. These include gallbladder cancer, which can be either primary (occurring in the gallbladder) or secondary (occurring as a result of cancer that has spread from another part of the body to the gallbladder). Symptoms of gallbladder neoplasms may include abdominal pain, jaundice (yellowing of the skin and eyes), nausea, vomiting, and weight loss. Diagnosis typically involves imaging studies such as ultrasound, CT scan, or MRI, as well as biopsy to confirm the presence of a neoplasm. Treatment for gallbladder neoplasms depends on the type and stage of the tumor, as well as the overall health of the patient. Options may include surgery to remove the affected organ, chemotherapy, radiation therapy, or a combination of these approaches.

Breast diseases refer to any medical conditions that affect the breasts, including both benign (non-cancerous) and malignant (cancerous) conditions. Some common examples of breast diseases include: 1. Breast cancer: This is the most common type of cancer in women worldwide. It occurs when abnormal cells in the breast grow and multiply uncontrollably, forming a tumor. 2. Benign breast conditions: These are non-cancerous conditions that can affect the breasts. Examples include fibrocystic breast disease, breast abscess, and breast cysts. 3. Inflammatory breast cancer: This is a rare and aggressive form of breast cancer that causes the skin of the breast to become red, swollen, and warm. 4. Paget's disease of the breast: This is a rare condition that occurs when cancer cells spread from the milk ducts to the skin of the nipple and areola. 5. Mastitis: This is an infection of the breast tissue that can occur in women who are breastfeeding or who have recently given birth. 6. Fibroadenoma: This is a benign tumor that can develop in the breast tissue. It is usually painless and can be felt as a hard, round mass. 7. Ductal carcinoma in situ (DCIS): This is a non-invasive form of breast cancer that occurs when abnormal cells are found in the lining of the milk ducts. 8. Lobular carcinoma in situ (LCIS): This is a non-invasive form of breast cancer that occurs when abnormal cells are found in the lining of the milk glands. Treatment for breast diseases depends on the specific condition and its severity. It may include medications, surgery, radiation therapy, or a combination of these treatments. Early detection and treatment are key to improving outcomes for patients with breast diseases.

Hedgehog proteins are a family of signaling molecules that play important roles in the development and maintenance of various tissues and organs in the body. They are named after the hedgehog animal because of their shape and the way they move around. In the medical field, hedgehog proteins are of particular interest because they have been implicated in the development of certain types of cancer, including basal cell carcinoma and medulloblastoma. These proteins are involved in regulating cell growth and differentiation, and when they are overactive or mutated, they can lead to uncontrolled cell proliferation and the formation of tumors. Hedgehog proteins are also involved in the development of other diseases, such as liver fibrosis and osteoarthritis. In addition, they have been studied as potential targets for the development of new treatments for these conditions. Overall, hedgehog proteins are an important area of research in the medical field, and understanding their role in health and disease is critical for developing new therapies and improving patient outcomes.

Combined modality therapy (CMT) is a cancer treatment approach that involves using two or more different types of treatments simultaneously or in sequence to achieve a better therapeutic effect than any single treatment alone. The goal of CMT is to increase the effectiveness of cancer treatment while minimizing side effects. The different types of treatments that may be used in CMT include surgery, radiation therapy, chemotherapy, immunotherapy, targeted therapy, and hormonal therapy. The specific combination of treatments used in CMT depends on the type and stage of cancer, as well as the patient's overall health and individual needs. CMT is often used for the treatment of advanced or aggressive cancers, where a single treatment may not be effective. By combining different treatments, CMT can help to destroy cancer cells more completely and prevent the cancer from returning. However, CMT can also have more significant side effects than a single treatment, so it is important for patients to discuss the potential risks and benefits with their healthcare provider before starting treatment.

Nuclear proteins are proteins that are found within the nucleus of a cell. The nucleus is the control center of the cell, where genetic material is stored and regulated. Nuclear proteins play a crucial role in many cellular processes, including DNA replication, transcription, and gene regulation. There are many different types of nuclear proteins, each with its own specific function. Some nuclear proteins are involved in the structure and organization of the nucleus itself, while others are involved in the regulation of gene expression. Nuclear proteins can also interact with other proteins, DNA, and RNA molecules to carry out their functions. In the medical field, nuclear proteins are often studied in the context of diseases such as cancer, where changes in the expression or function of nuclear proteins can contribute to the development and progression of the disease. Additionally, nuclear proteins are important targets for drug development, as they can be targeted to treat a variety of diseases.

DNA-binding proteins are a class of proteins that interact with DNA molecules to regulate gene expression. These proteins recognize specific DNA sequences and bind to them, thereby affecting the transcription of genes into messenger RNA (mRNA) and ultimately the production of proteins. DNA-binding proteins play a crucial role in many biological processes, including cell division, differentiation, and development. They can act as activators or repressors of gene expression, depending on the specific DNA sequence they bind to and the cellular context in which they are expressed. Examples of DNA-binding proteins include transcription factors, histones, and non-histone chromosomal proteins. Transcription factors are proteins that bind to specific DNA sequences and regulate the transcription of genes by recruiting RNA polymerase and other factors to the promoter region of a gene. Histones are proteins that package DNA into chromatin, and non-histone chromosomal proteins help to organize and regulate chromatin structure. DNA-binding proteins are important targets for drug discovery and development, as they play a central role in many diseases, including cancer, genetic disorders, and infectious diseases.

Salivary gland neoplasms refer to tumors that develop in the salivary glands, which are responsible for producing saliva. These glands are located in the mouth, head, and neck, and include the parotid gland, submandibular gland, and sublingual gland. Salivary gland neoplasms can be benign (non-cancerous) or malignant (cancerous), and they can affect any part of the salivary gland. Symptoms of salivary gland neoplasms may include a lump or swelling in the gland, difficulty swallowing or chewing, and pain or discomfort in the gland or surrounding area. Treatment for salivary gland neoplasms may include surgery, radiation therapy, or chemotherapy, depending on the type and stage of the tumor.

DNA primers are short, single-stranded DNA molecules that are used in a variety of molecular biology techniques, including polymerase chain reaction (PCR) and DNA sequencing. They are designed to bind to specific regions of a DNA molecule, and are used to initiate the synthesis of new DNA strands. In PCR, DNA primers are used to amplify specific regions of DNA by providing a starting point for the polymerase enzyme to begin synthesizing new DNA strands. The primers are complementary to the target DNA sequence, and are added to the reaction mixture along with the DNA template, nucleotides, and polymerase enzyme. The polymerase enzyme uses the primers as a template to synthesize new DNA strands, which are then extended by the addition of more nucleotides. This process is repeated multiple times, resulting in the amplification of the target DNA sequence. DNA primers are also used in DNA sequencing to identify the order of nucleotides in a DNA molecule. In this application, the primers are designed to bind to specific regions of the DNA molecule, and are used to initiate the synthesis of short DNA fragments. The fragments are then sequenced using a variety of techniques, such as Sanger sequencing or next-generation sequencing. Overall, DNA primers are an important tool in molecular biology, and are used in a wide range of applications to study and manipulate DNA.

Carcinoma, Papillary, Follicular is a type of cancer that affects the thyroid gland. It is the most common type of thyroid cancer and is usually slow-growing. It is classified into two subtypes: papillary carcinoma and follicular carcinoma. Papillary carcinoma is the most common subtype and is usually treated with surgery, radioactive iodine therapy, and sometimes hormone therapy. Follicular carcinoma is less common and may require surgery, radioactive iodine therapy, and sometimes chemotherapy. It is important to note that not all follicular carcinomas are papillary carcinomas.

A biopsy is a medical procedure in which a small sample of tissue is removed from a person's body for examination under a microscope. The sample is usually taken from a lump, growth, or other abnormal area, and is used to help diagnose a medical condition or disease. There are several types of biopsy procedures, including: 1. Fine-needle aspiration biopsy: A sample of tissue is removed using a thin needle inserted into the abnormal area. 2. Core biopsy: A larger sample of tissue is removed using a hollow needle that takes multiple cores of tissue. 3. Excision biopsy: A larger piece of tissue is removed using a scalpel or other surgical instrument. 4. Endoscopic biopsy: A biopsy is performed using a flexible tube with a camera and light on the end, which is inserted into the body through a natural opening or a small incision. Biopsies are commonly used to diagnose cancer, but they can also be used to diagnose other medical conditions, such as infections, autoimmune diseases, and genetic disorders. The results of a biopsy can help guide treatment decisions and provide important information about a person's prognosis.

Carcinogens are substances or agents that have the potential to cause cancer. They can be found in various forms, including chemicals, radiation, and biological agents. Carcinogens can be classified into two categories: 1. Direct carcinogens: These are substances that can directly damage DNA and cause mutations, leading to the development of cancer. Examples of direct carcinogens include tobacco smoke, asbestos, and ultraviolet radiation. 2. Indirect carcinogens: These are substances that do not directly damage DNA but can cause cancer by promoting the growth and survival of cancer cells. Examples of indirect carcinogens include certain hormones, viruses, and certain chemicals found in food and water. Carcinogens can cause cancer by disrupting the normal functioning of cells, leading to uncontrolled growth and division. Exposure to carcinogens can occur through various means, including inhalation, ingestion, or skin contact. The risk of developing cancer from exposure to carcinogens depends on several factors, including the type and duration of exposure, the individual's age and overall health, and their genetic makeup.

Carcinoma, Non-Small-Cell Lung (NSCLC) is a type of lung cancer that starts in the cells that line the airways or the alveoli (tiny air sacs) in the lungs. NSCLC is the most common type of lung cancer, accounting for about 85% of all lung cancer cases. NSCLC is further classified into three subtypes: adenocarcinoma, squamous cell carcinoma, and large cell carcinoma. Adenocarcinoma is the most common subtype of NSCLC and is often associated with long-term exposure to tobacco smoke or other environmental factors. Squamous cell carcinoma is also associated with smoking, while large cell carcinoma is less common and can occur in both smokers and non-smokers. Treatment options for NSCLC depend on the stage of the cancer, the patient's overall health, and other factors. Treatment may include surgery, radiation therapy, chemotherapy, targeted therapy, or a combination of these approaches. The goal of treatment is to remove or destroy the cancer cells and prevent them from spreading to other parts of the body.

The cell cycle is the series of events that a cell undergoes from the time it is born until it divides into two daughter cells. It is a highly regulated process that is essential for the growth, development, and repair of tissues in the body. The cell cycle consists of four main phases: interphase, prophase, metaphase, and anaphase. During interphase, the cell grows and replicates its DNA in preparation for cell division. In prophase, the chromatin condenses into visible chromosomes, and the nuclear envelope breaks down. In metaphase, the chromosomes align at the center of the cell, and in anaphase, the sister chromatids separate and move to opposite poles of the cell. The cell cycle is tightly regulated by a complex network of proteins that ensure that the cell only divides when it is ready and that the daughter cells receive an equal share of genetic material. Disruptions in the cell cycle can lead to a variety of medical conditions, including cancer.

Mucin 5AC (MUC5AC) is a type of mucin, which is a complex glycoprotein that is produced by cells lining the respiratory, gastrointestinal, and genitourinary tracts. MUC5AC is a major component of the mucus that coats these surfaces and helps to protect them from infection and injury. In the respiratory tract, MUC5AC is produced by cells in the bronchial epithelium and is a major component of the mucus that is secreted in response to infection or injury. This mucus helps to trap and remove inhaled particles and pathogens, and also helps to lubricate the airways. In the gastrointestinal tract, MUC5AC is produced by cells in the lining of the stomach and small intestine. It is thought to play a role in protecting the gut from damage and infection, and also helps to regulate the movement of food through the digestive tract. MUC5AC is also produced by cells in the genitourinary tract, where it is thought to play a role in protecting the urinary and reproductive tracts from infection and injury. Abnormal production or function of MUC5AC has been linked to a number of conditions, including chronic obstructive pulmonary disease (COPD), cystic fibrosis, and inflammatory bowel disease.

A pancreatic fistula is a abnormal connection between the pancreas and another body cavity or surface, such as the stomach, small intestine, colon, or abdominal wall. This can occur due to injury, surgery, or infection, and can lead to the leakage of digestive enzymes and fluids from the pancreas into the surrounding tissue. Symptoms of a pancreatic fistula may include abdominal pain, nausea, vomiting, fever, and diarrhea. Treatment typically involves addressing the underlying cause of the fistula and managing any complications that may arise. In severe cases, surgery may be necessary to repair or remove the fistula.

Endometrial neoplasms refer to abnormal growths or tumors that develop in the lining of the uterus, known as the endometrium. These neoplasms can be benign (non-cancerous) or malignant (cancerous). Endometrial neoplasms are classified based on their degree of malignancy, with the most common types being endometrial hyperplasia and endometrial cancer. Endometrial hyperplasia is a condition in which the cells in the endometrium grow abnormally, but do not invade into nearby tissues. Endometrial cancer, on the other hand, is a more serious condition in which the abnormal cells invade into nearby tissues and can spread to other parts of the body. Endometrial neoplasms can cause a variety of symptoms, including abnormal vaginal bleeding, pelvic pain, and pain during sexual intercourse. Diagnosis typically involves a combination of physical examination, imaging studies, and biopsy of the endometrial tissue. Treatment for endometrial neoplasms depends on the type, stage, and severity of the condition. Benign neoplasms may be treated with medication, surgery, or a combination of both. Malignant neoplasms may require more aggressive treatment, such as surgery, radiation therapy, or chemotherapy. Early detection and treatment are important for improving outcomes and reducing the risk of complications.

Adenocarcinoma, Clear Cell is a type of cancer that begins in the glandular cells of the body. It is characterized by the presence of clear, glassy cells that are easily visible under a microscope. This type of cancer is most commonly found in the lungs, kidneys, and thyroid gland, but it can also occur in other parts of the body, such as the ovaries, uterus, and colon. Adenocarcinoma, Clear Cell is typically diagnosed through a combination of imaging tests, such as CT scans or ultrasounds, and a biopsy, in which a small sample of tissue is removed from the affected area and examined under a microscope. Treatment for this type of cancer depends on the location and stage of the cancer, as well as the overall health of the patient. It may include surgery, radiation therapy, chemotherapy, or a combination of these treatments.

Colorectal neoplasms refer to abnormal growths or tumors that develop in the colon or rectum. These growths can be either benign (non-cancerous) or malignant (cancerous). Colorectal neoplasms can be further classified into polyps, adenomas, and carcinomas. Polyps are non-cancerous growths that typically arise from the inner lining of the colon or rectum. Adenomas are a type of polyp that have the potential to become cancerous if left untreated. Carcinomas, on the other hand, are cancerous tumors that can invade nearby tissues and spread to other parts of the body. Colorectal neoplasms are a common health concern, and regular screening is recommended for individuals at high risk, such as those with a family history of colorectal cancer or those over the age of 50. Early detection and treatment of colorectal neoplasms can significantly improve outcomes and reduce the risk of complications.

Adjuvant chemotherapy is a type of chemotherapy that is given after surgery to help destroy any remaining cancer cells and reduce the risk of the cancer returning. It is often used in combination with other treatments, such as radiation therapy or hormone therapy, to increase the effectiveness of the treatment. Adjuvant chemotherapy is typically given for several months following surgery, and the specific drugs and duration of treatment will depend on the type and stage of cancer being treated.

In the medical field, a cyst is a closed, fluid-filled sac that forms in or on an organ or tissue. Cysts can be benign (non-cancerous) or malignant (cancerous), and they can occur in various parts of the body, including the skin, liver, kidneys, ovaries, and brain. Cysts can be classified based on their location, size, and contents. Some common types of cysts include: 1. Epidermoid cysts: These are the most common type of cyst, and they form in the skin or hair follicles. They are usually benign and can be removed surgically. 2. Cystic acne: This is a type of cyst that occurs on the skin and is caused by the blockage of hair follicles. 3. Pancreatic cysts: These are cysts that form in the pancreas and can be either benign or malignant. 4. Kidney cysts: These are cysts that form in the kidneys and can be either benign or malignant. 5. Ovarian cysts: These are cysts that form in the ovaries and can be either benign or malignant. Treatment for cysts depends on their size, location, and type. Small cysts may not require treatment, while larger cysts or cysts that cause symptoms may need to be removed surgically. In some cases, medication may be used to treat cysts.

Mammary neoplasms, also known as mammary tumors, are abnormal growths that develop in the mammary glands of animals. These tumors can be benign or malignant, and they can occur in both male and female animals. In female animals, mammary neoplasms are most commonly associated with the development of mammary gland tumors, which can lead to the formation of mammary masses or lumps. In male animals, mammary neoplasms are less common and can include tumors of the prostate gland or other tissues in the mammary region. Treatment for mammary neoplasms depends on the type and severity of the tumor, as well as the overall health of the animal.

Fibroadenoma is a benign (non-cancerous) tumor that develops in the breast tissue. It is the most common type of benign breast tumor, accounting for about 80-90% of all breast lumps in women of childbearing age. Fibroadenomas are usually round or oval, smooth, and firm to the touch. They are usually painless and move easily under the skin. They are usually found in women between the ages of 15 and 30, but can occur at any age. Fibroadenomas are usually diagnosed through a physical examination and a mammogram. A biopsy may be performed to confirm the diagnosis. Treatment for fibroadenomas is usually not necessary, as they are not cancerous and do not increase the risk of breast cancer. However, if a fibroadenoma is causing discomfort or if it is large, a doctor may recommend surgical removal.

Alpha-fetoprotein (AFP) is a protein that is produced by the yolk sac and the fetal liver during pregnancy. It is normally present in small amounts in the blood of pregnant women, but levels can increase if there is a problem with the fetus, such as a neural tube defect or a tumor. In adults, high levels of AFP can be a sign of liver disease, cancer, or other conditions. It is often used as a tumor marker in the diagnosis and monitoring of certain types of cancer, such as liver cancer and testicular cancer.

Tongue neoplasms refer to abnormal growths or tumors that develop on the tongue. These growths can be benign (non-cancerous) or malignant (cancerous). Benign tongue neoplasms include conditions such as fibromas, papillomas, and granulomas, while malignant tongue neoplasms are more serious and can include squamous cell carcinoma, adenoid cystic carcinoma, and others. Tongue neoplasms can cause a variety of symptoms, including difficulty swallowing, pain, and changes in the appearance or texture of the tongue. Treatment for tongue neoplasms depends on the type and stage of the tumor, and may include surgery, radiation therapy, chemotherapy, or a combination of these approaches.

Nestin is a type of intermediate filament protein that is expressed in various types of stem cells, including neural stem cells, muscle stem cells, and hematopoietic stem cells. It is a marker of neural progenitor cells and is often used to identify and isolate these cells for research and therapeutic purposes. In the medical field, Nestin is also used as a diagnostic tool to identify certain types of tumors, such as gliomas and neuroblastomas, which often express high levels of Nestin. Additionally, Nestin has been shown to play a role in the development and maintenance of neural stem cells, making it a potential target for therapies aimed at promoting neural regeneration and repair.

GPI-linked proteins, also known as glycosylphosphatidylinositol (GPI)-anchored proteins, are a class of membrane proteins that are attached to the cell membrane through a glycosylphosphatidylinositol (GPI) anchor. The GPI anchor is a complex molecule that consists of a glycerol backbone, two phosphatidylcholine molecules, a mannose residue, and a phosphatidylinositol group. GPI-linked proteins are involved in a variety of cellular processes, including cell signaling, cell adhesion, and immune response. They are found on the surface of many different types of cells, including red blood cells, leukocytes, and neurons. GPI-linked proteins are important for the proper functioning of the immune system, as they play a role in the recognition and clearance of pathogens by immune cells. They are also involved in the regulation of cell growth and differentiation, and have been implicated in the development of certain diseases, including cancer and autoimmune disorders.

Cystadenocarcinoma, serous is a type of ovarian cancer that arises from the epithelial cells lining the cysts of the ovary. It is a malignant tumor that can spread to other parts of the body through the bloodstream or lymphatic system. The tumor is characterized by the production of a large number of fluid-filled cysts on the ovaries, which can cause abdominal pain, bloating, and other symptoms. Treatment for cystadenocarcinoma, serous typically involves surgery to remove the affected ovaries and any other affected organs, followed by chemotherapy or radiation therapy to kill any remaining cancer cells. The prognosis for this type of cancer depends on the stage of the disease at the time of diagnosis and the response to treatment.

Carcinoma, Lewis Lung is a type of cancer that originates in the lung tissue. It is named after the Lewis lung, a strain of mice that was used in early research on lung cancer. This type of cancer is a form of non-small cell lung cancer (NSCLC), which is the most common type of lung cancer in humans. It is usually found in older adults and is more common in men than in women. Carcinoma, Lewis Lung is typically diagnosed through imaging tests such as chest X-rays or CT scans, and confirmed through a biopsy. Treatment options may include surgery, radiation therapy, chemotherapy, or a combination of these approaches. The prognosis for this type of cancer depends on several factors, including the stage of the cancer at diagnosis and the overall health of the patient.

Tissue Inhibitor of Metalloproteinase-3 (TIMP-3) is a protein that belongs to the TIMP family of proteins. TIMPs are endogenous inhibitors of matrix metalloproteinases (MMPs), a group of enzymes that play a crucial role in the degradation and remodeling of the extracellular matrix (ECM) in various tissues and organs. TIMP-3 is synthesized and secreted by a variety of cells, including fibroblasts, epithelial cells, and immune cells. It is known to regulate the activity of MMPs by binding to them and inhibiting their proteolytic activity. TIMP-3 has been implicated in a variety of physiological and pathological processes, including tissue repair, inflammation, cancer, and fibrosis. In the medical field, TIMP-3 has been studied as a potential therapeutic target for various diseases, including cancer, fibrosis, and osteoporosis. For example, TIMP-3 has been shown to inhibit the growth and invasion of cancer cells, and to reduce the severity of fibrosis in various organs. Additionally, TIMP-3 has been proposed as a biomarker for the diagnosis and prognosis of certain diseases, such as breast cancer and liver fibrosis.

Membrane proteins are proteins that are embedded within the lipid bilayer of a cell membrane. They play a crucial role in regulating the movement of substances across the membrane, as well as in cell signaling and communication. There are several types of membrane proteins, including integral membrane proteins, which span the entire membrane, and peripheral membrane proteins, which are only in contact with one or both sides of the membrane. Membrane proteins can be classified based on their function, such as transporters, receptors, channels, and enzymes. They are important for many physiological processes, including nutrient uptake, waste elimination, and cell growth and division.

Bronchial neoplasms refer to abnormal growths or tumors that develop in the bronchial tubes, which are the airways that carry air from the trachea (windpipe) to the lungs. These neoplasms can be either benign (non-cancerous) or malignant (cancerous). Benign bronchial neoplasms, also known as bronchial adenomas, are relatively rare and usually do not cause any symptoms. However, they can sometimes cause blockages in the bronchial tubes, leading to difficulty breathing or recurrent infections. Malignant bronchial neoplasms, also known as bronchogenic carcinomas, are more common and can be further classified into several subtypes, including small cell lung cancer and non-small cell lung cancer. These tumors can grow rapidly and spread to other parts of the body, leading to serious health problems and potentially death if left untreated. Diagnosis of bronchial neoplasms typically involves a combination of imaging tests, such as chest X-rays or CT scans, and bronchoscopy, a procedure in which a thin, flexible tube is inserted into the bronchial tubes to visualize the tumors and take biopsies for further analysis. Treatment options for bronchial neoplasms depend on the type, size, and location of the tumor, as well as the overall health of the patient.

Fibrocystic breast disease (FBD) is a common condition that affects the breasts. It is characterized by the presence of benign (non-cancerous) lumps or cysts in the breast tissue. These lumps or cysts can cause discomfort or pain, particularly during menstruation or pregnancy. FBD is also known as fibrocystic changes or fibrocystic mastopathy. It is not a single disease, but rather a group of conditions that share similar symptoms and characteristics. Some of the most common types of FBD include: * Benign breast disease (BBD) * Fibroadenoma * Cystic breast disease * Mastalgia (breast pain) FBD is not a cancerous condition, but it can sometimes be confused with breast cancer. However, the symptoms of FBD are usually benign and do not require treatment. In some cases, FBD may be treated with medications or surgery to relieve symptoms or to remove any abnormal growths.

In the medical field, the chi-square distribution is a statistical tool used to analyze the relationship between two categorical variables. It is often used in medical research to determine whether there is a significant association between two variables, such as the presence of a disease and a particular risk factor. The chi-square distribution is a probability distribution that describes the sum of the squared differences between the observed and expected frequencies of a categorical variable. It is commonly used in hypothesis testing to determine whether the observed frequencies of a categorical variable differ significantly from the expected frequencies. In medical research, the chi-square test is often used to analyze the relationship between two categorical variables, such as the presence of a disease and a particular risk factor. For example, a researcher may want to determine whether there is a significant association between smoking and lung cancer. To do this, the researcher would collect data on the smoking habits of a group of people and their incidence of lung cancer. The chi-square test would then be used to determine whether the observed frequencies of lung cancer among smokers differ significantly from the expected frequencies based on the overall incidence of lung cancer in the population. Overall, the chi-square distribution is a valuable tool in medical research for analyzing the relationship between categorical variables and determining whether observed frequencies differ significantly from expected frequencies.

Keratin-7 (KRT7) is a type of keratin protein that is expressed in the epithelial cells of various organs in the human body, including the skin, hair, nails, and respiratory tract. It is a type I cytokeratin, which means it is a filament-forming protein that helps to provide structural support to the epithelial cells. In the medical field, KRT7 is often used as a diagnostic marker for various types of cancer, particularly in the skin and respiratory tract. For example, the expression of KRT7 in squamous cell carcinoma (SCC) of the skin and lung is often higher than in normal epithelial cells, making it a useful marker for detecting and monitoring the disease. KRT7 is also used in research to study the development and function of epithelial cells, as well as the mechanisms underlying various diseases that affect these cells, such as cancer, inflammation, and fibrosis.

I'm sorry, but I couldn't find any information on a medical term called "Ceruletide." It's possible that you may have misspelled the term or that it is not a commonly used term in the medical field. If you have any additional information or context about the term, please let me know and I'll do my best to assist you further.

Matrix Metalloproteinase 9 (MMP-9) is a type of protein that belongs to the matrix metalloproteinase family. It is also known as gelatinase B or 92 kDa gelatinase. MMP-9 is a protease that breaks down and remodels the extracellular matrix, which is a network of proteins and carbohydrates that provides structural support to cells and tissues. In the medical field, MMP-9 plays a role in various physiological and pathological processes, including tissue remodeling, wound healing, angiogenesis, and cancer invasion and metastasis. MMP-9 is also involved in the development of inflammatory diseases such as rheumatoid arthritis, psoriasis, and atherosclerosis. MMP-9 is a potential therapeutic target for the treatment of various diseases, including cancer, cardiovascular disease, and inflammatory disorders. However, the overexpression of MMP-9 can also contribute to tissue damage and disease progression, making it a double-edged sword. Therefore, the regulation of MMP-9 activity is crucial for maintaining tissue homeostasis and preventing disease.

Apocrine glands are a type of sweat gland found in the skin, particularly in areas such as the armpits, groin, and areola of the breast. These glands are larger than eccrine glands and are responsible for producing a thicker, more viscous fluid that contains lipids, proteins, and other substances. The secretions of apocrine glands are typically odorless, but they can become malodorous when they are broken down by bacteria on the skin. This breakdown can occur due to factors such as heat, friction, or hormonal changes, and it is often associated with conditions such as body odor or. In addition to their role in sweat production, apocrine glands also play a role in the production of pheromones, which are chemical signals that can influence the behavior of other individuals of the same species.

Proto-oncogene proteins c-akt, also known as protein kinase B (PKB), is a serine/threonine kinase that plays a critical role in various cellular processes, including cell survival, proliferation, and metabolism. It is a member of the Akt family of kinases, which are activated by various growth factors and cytokines. In the context of cancer, c-akt has been shown to be frequently activated in many types of tumors and is often associated with poor prognosis. Activation of c-akt can lead to increased cell survival and resistance to apoptosis, which can contribute to tumor growth and progression. Additionally, c-akt has been implicated in the regulation of angiogenesis, invasion, and metastasis, further contributing to the development and progression of cancer. Therefore, the study of c-akt and its role in cancer has become an important area of research in the medical field, with the goal of developing targeted therapies to inhibit its activity and potentially treat cancer.

Cisplatin is a chemotherapy drug that is commonly used to treat various types of cancer, including ovarian, testicular, bladder, and lung cancer. It works by binding to the DNA of cancer cells, which prevents them from dividing and growing. Cisplatin is usually administered intravenously and can cause a range of side effects, including nausea, vomiting, hair loss, and damage to the kidneys and hearing. It is important to note that cisplatin is not effective for all types of cancer and may not be suitable for everyone. The use of cisplatin should be determined by a healthcare professional based on the individual's specific medical needs and circumstances.

In the medical field, "Cells, Cultured" refers to cells that have been grown and maintained in a controlled environment outside of their natural biological context, typically in a laboratory setting. This process is known as cell culture and involves the isolation of cells from a tissue or organism, followed by their growth and proliferation in a nutrient-rich medium. Cultured cells can be derived from a variety of sources, including human or animal tissues, and can be used for a wide range of applications in medicine and research. For example, cultured cells can be used to study the behavior and function of specific cell types, to develop new drugs and therapies, and to test the safety and efficacy of medical products. Cultured cells can be grown in various types of containers, such as flasks or Petri dishes, and can be maintained at different temperatures and humidity levels to optimize their growth and survival. The medium used to culture cells typically contains a combination of nutrients, growth factors, and other substances that support cell growth and proliferation. Overall, the use of cultured cells has revolutionized medical research and has led to many important discoveries and advancements in the field of medicine.

Bile duct neoplasms refer to tumors that develop in the bile ducts, which are the tubes that carry bile from the liver to the small intestine. These tumors can be either benign or malignant, and they can occur in any part of the bile duct system, including the intrahepatic bile ducts (which are located within the liver), the extrahepatic bile ducts (which are located outside the liver), and the ampulla of Vater (which is the point where the common bile duct and the main pancreatic duct join). Bile duct neoplasms can present with a variety of symptoms, depending on the location and size of the tumor. Some common symptoms include jaundice (yellowing of the skin and eyes), abdominal pain, weight loss, and fever. Diagnosis typically involves imaging studies such as ultrasound, CT scan, or MRI, as well as biopsy to confirm the presence of cancer cells. Treatment for bile duct neoplasms depends on the type and stage of the tumor, as well as the overall health of the patient. Options may include surgery, chemotherapy, radiation therapy, or a combination of these approaches. The prognosis for bile duct neoplasms varies widely, depending on the specific type and stage of the tumor, as well as the patient's age, overall health, and response to treatment.

14-3-3 proteins are a family of proteins that are found in all eukaryotic cells. They are named for their ability to form dimers or trimers, with each subunit consisting of 143 amino acids. These proteins play a variety of roles in cellular processes, including regulation of protein activity, cell cycle progression, and stress response. They are also involved in the development and progression of certain diseases, such as cancer and neurodegenerative disorders. In the medical field, 14-3-3 proteins are often studied as potential diagnostic or therapeutic targets for these and other diseases.

Keratin-5 (KRT5) is a type of keratin protein that is expressed in the basal layer of the epidermis, the outermost layer of the skin. It is a structural protein that provides strength and protection to the skin and hair. In the medical field, KRT5 is often studied in the context of skin diseases and cancer. For example, mutations in the KRT5 gene have been associated with several types of skin cancer, including squamous cell carcinoma and basal cell carcinoma. Additionally, changes in KRT5 expression have been observed in various skin conditions, such as psoriasis and atopic dermatitis. Overall, KRT5 plays an important role in maintaining the integrity and function of the skin, and its study can provide insights into the pathogenesis of skin diseases and inform the development of new treatments.

Intrahepatic bile ducts are the small tubes that carry bile from the liver to the small intestine. They are located within the liver and are responsible for transporting bile from the liver cells (hepatocytes) to the bile ducts that lead to the small intestine. Bile is a greenish-yellow fluid that is produced by the liver and helps to digest fats in the small intestine. Intrahepatic bile ducts are an important part of the digestive system and any problems with them can lead to a condition called cholangitis, which is an inflammation of the bile ducts.

Receptors, Notch are a family of cell surface receptors that play a critical role in cell fate determination, differentiation, proliferation, and apoptosis in various tissues and organs during embryonic development and in adult organisms. The Notch signaling pathway is activated by binding of a ligand, such as Delta or Jagged, to the extracellular domain of the Notch receptor, leading to a series of intracellular events that ultimately regulate gene expression and cellular behavior. Dysregulation of Notch signaling has been implicated in a variety of human diseases, including cancer, cardiovascular disease, and neurodegenerative disorders.

Intraductal papilloma is a type of benign (non-cancerous) growth that occurs in the milk ducts of the breast. It is also known as a ductal papilloma or a papillomatosis. Intraductal papillomas are usually small and can occur in one or multiple ducts in the breast. They are usually detected through a breast biopsy or during a routine mammogram. Intraductal papillomas are not typically cancerous, but they can sometimes be associated with an increased risk of developing breast cancer. Women with intraductal papillomas may be advised to have regular mammograms and breast exams to monitor for any changes in the growths. Treatment for intraductal papillomas typically involves surgical removal of the affected ducts. This is usually done using a procedure called a duct excision, in which the affected ducts are removed through a small incision in the breast. In some cases, a lumpectomy (removal of a small portion of breast tissue) may be performed to remove the papilloma and a small amount of surrounding tissue. It is important to note that intraductal papillomas are not the same as ductal carcinoma in situ (DCIS), which is a type of non-invasive breast cancer that can occur in the milk ducts. DCIS is typically treated with surgery, radiation therapy, or a combination of both.

Keratin-6 (KRT6) is a type of keratin protein that is expressed in the skin and hair. It is a member of the type I keratin family, which is responsible for providing strength and protection to the skin and hair. In the medical field, KRT6 is often studied in relation to skin diseases such as psoriasis and eczema, as well as in the development of skin cancer. It has also been implicated in the formation of skin barrier defects, which can lead to dryness, itching, and other skin conditions. In addition, KRT6 has been found to be involved in the development of certain types of cancer, including breast cancer and lung cancer. Researchers are currently exploring the potential use of KRT6 as a biomarker for cancer diagnosis and prognosis, as well as as a target for cancer therapy.

Pancreatic ductal carcinoma is a common form of pancreatic cancer. The pancreatic duct is also called the duct of Wirsung. This ... The pancreatic duct, or duct of Wirsung (also, the major pancreatic duct due to the existence of an accessory pancreatic duct ... Pancreatic duct Deep dissection.Anterior view. Ultrasonography of a dilated pancreatic duct (in this case 9mm) due to ... Pancreatic duct or parts of pancreatic duct can be demonstrated on ultrasound in 75 to 85% of people. ...
Breast: Nearly all breast cancers are ductal carcinoma. Prostate: The most common form of carcinoma of the prostate is ... Pancreas: Pancreatic carcinoma is almost always of the adenocarcinoma type and is highly lethal. Ovaries: One of the most ... In some types of carcinomas, Stage 0 carcinoma has been used to describe carcinoma in situ, and occult carcinomas detectable ... Some carcinomas are named for their or the putative cell of origin, (e.g.hepatocellular carcinoma, renal cell carcinoma). ...
December 2008). "Secretion of N-ERC/mesothelin and expression of C-ERC/mesothelin in human pancreatic ductal carcinoma". ... Hellstrom I, Hellstrom KE (2008). "SMRP and HE4 as Biomarkers for Ovarian Carcinoma when Used Alone and in Combination with ... Bharadwaj U, Li M, Chen C, Yao Q (November 2008). "Mesothelin-induced pancreatic cancer cell proliferation involves alteration ... February 2008). "Mesothelin is a malignant factor and therapeutic vaccine target for pancreatic cancer". Molecular Cancer ...
... is a human pancreatic cancer cell line isolated from a pancreatic carcinoma of ductal cell origin. PANC-1 was derived ... 15 May 1975). "Establishment of a continuous tumor‐cell line (PANC‐1) from a human carcinoma of the exocrine pancreas". ... May 2010). "Phenotype and Genotype of Pancreatic Cancer Cell Lines". Pancreas. 39 (4): 425-435. doi:10.1097/MPA. ...
Types include: Mammary Ductal carcinoma in situ Invasive ductal carcinoma Pancreatic ductal carcinoma "NCI Dictionary of Cancer ... Media related to Ductal carcinomas at Wikimedia Commons v t e (Articles with short description, Short description is different ... Ductal carcinoma is a type of tumor that primarily presents in the ducts of a gland. ... from Wikidata, All set index articles, Set index articles, Commons category link from Wikidata, Carcinoma, All stub articles, ...
In breast cancer, CIB1 expression has been shown to be higher in invasive ductal carcinoma compared to normal breast tissue. ... CIB1 expression has been observed in several types of cancer, including breast, lung, prostate, ovarian, and pancreatic cancer ...
... miR-224 has also been linked with pancreatic ductal carcinoma, where it is thought to repress CD40 expression in cancer cells. ... "Involvement of CD40 targeting miR-224 and miR-486 on the progression of pancreatic ductal adenocarcinomas". Annals of Surgical ... miR-224 has been noted as the most upregulated microRNA in hepatocellular carcinoma. The same study identified a target of mir- ... "Profiling microRNA expression in hepatocellular carcinoma reveals microRNA-224 up-regulation and apoptosis inhibitor-5 as a ...
... expression analysis in human pancreatic ductal carcinomas". Genomics. 46 (2): 284-6. doi:10.1006/geno.1997.5018. PMID 9417916. ... Cattaneo M, Fontanella E, Canton C, Delia D, Biunno I (2006). "SEL1L affects human pancreatic cancer cell cycle and ...
... mix their production with acinar cells to make up the pancreatic juice. Ductal cells comprise about 10% of the ... Ductal carcinoma in situ (DCIS) is the proliferation of malignant ductal cells without penetrating the stromal tissue around ... Pancreatic ductal cells are very similar to ductal cells of other exocrine glands (liver, bile duct, salivary glands). Because ... Pancreatic adenocarcinoma cells resemble pancreatic ductal cells. Both cell groups show tubule formation, cuboidal shape, and ...
Overexpression contributes to the malignant phenotype of a subset of human ductal pancreatic cancers. Mice lacking Akt2 have a ... The gene was shown to be amplified and overexpressed in 2 of 8 ovarian carcinoma cell lines and 2 of 15 primary ovarian tumors ... Cheng JQ, Ruggeri B, Klein WM, Sonoda G, Altomare DA, Watson DK, Testa JR (1996). "Amplification of AKT2 in human pancreatic ... is amplified in human ovarian carcinomas". Proc Natl Acad Sci U S A. 89 (19): 9267-71. Bibcode:1992PNAS...89.9267C. doi:10.1073 ...
... anal carcinoma, lung adenocarcinoma, pancreatic ductal carcinoma, and some breast ductal carcinoma. In breast cancer, entosis ... Entosis correlates with cancer worse prognosis in head and neck squamous cell carcinoma, ... and endometrial stromal carcinomas. A cell trapped by entosis is initially alive and can divide inside the cell that has ...
... ductal carcinoma of the pancreas and colorectal cancer. Several germline KRAS mutations have been found to be associated with ... The most common KRAS mutation is G12D which is estimated to be present in up to 37% pancreatic cancers and over 12% of ... Almoguera C, Shibata D, Forrester K, Martin J, Arnheim N, Perucho M (May 1988). "Most human carcinomas of the exocrine pancreas ... In June 2022, a case report was published about a 71-year-old woman with metastatic pancreatic cancer after extensive treatment ...
... such as non-triple negative ductal carcinoma in situ, breast cancer, pancreatic adenocarcinoma, and colorectal carcinoma. It is ... Brown J (2016). Immunohistochemical and genomic analysis of ductal carcinoma in situ of the human breast (PDF) (Ph.D.). King's ... "FAM71E1- Pancreatic islet-like cell clusters derived from T3 embryonic stem cells". www.ncbi.nlm.nih.gov. Retrieved 2018-05-07 ... Its expression is elevated prior to the differentiation of embryonic stem cells into pancreatic islet-like cells. The FAM71E1 ...
... ductal MeSH C04.557.470.615.132.500 - carcinoma, ductal, breast MeSH C04.557.470.615.132.750 - carcinoma, pancreatic ductal ... ductal MeSH C04.557.470.200.025.232.500 - carcinoma, ductal, breast MeSH C04.557.470.200.025.232.750 - carcinoma, pancreatic ... carcinoma, pancreatic ductal MeSH C04.588.322.455 - ovarian neoplasms MeSH C04.588.322.455.398 - granulosa cell tumor MeSH ... carcinoma, pancreatic ductal MeSH C04.588.274.780 - peritoneal neoplasms MeSH C04.588.322.078 - adrenal gland neoplasms MeSH ...
... has been shown to attenuate the growth of patient-derived xenografts of pancreatic ductal adenocarcinoma. A contrary argument ... For example, the GPER antagonist, G36, delays the estrogen-dependent outgrowth of transplanted endometrial carcinoma in mice, ... "Pharmacologic Activation of the G Protein-Coupled Estrogen Receptor Inhibits Pancreatic Ductal Adenocarcinoma". Cellular and ...
... carcinoma, pancreatic ductal MeSH C19.344.609.145 - acth-secreting pituitary adenoma MeSH C19.344.609.145.500 - nelson syndrome ... carcinoma, islet cell MeSH C19.344.421.500.124 - gastrinoma MeSH C19.344.421.500.249 - glucagonoma MeSH C19.344.421.500.500 - ... carcinoma, endometrioid MeSH C19.391.630.705.398 - granulosa cell tumor MeSH C19.391.630.705.464 - luteoma MeSH C19.391.630.705 ... adrenocortical carcinoma MeSH C19.344.400.500 - multiple endocrine neoplasia type 1 MeSH C19.344.400.505 - multiple endocrine ...
... carcinoma, pancreatic ductal MeSH C06.405.117.102 - barrett esophagus MeSH C06.405.117.119 - deglutition disorders MeSH C06.405 ... carcinoma, pancreatic ductal MeSH C06.689.750.650 - pancreatitis, acute necrotizing MeSH C06.689.750.660 - pancreatitis, ... carcinoma, islet cell MeSH C06.301.761.500.124 - gastrinoma MeSH C06.301.761.500.249 - glucagonoma MeSH C06.301.761.500.500 - ... pancreatic pseudocyst MeSH C06.689.667.249 - adenoma, islet cell MeSH C06.689.667.249.500 - insulinoma MeSH C06.689.667.500 - ...
... thyroid carcinoma, bladder urothelial carcinoma - nonpapillary, uterine corpus (endometrial carcinoma), pancreatic ductal ... lung squamous cell carcinoma, kidney papillary carcinoma, clear cell kidney carcinoma, breast ductal carcinoma, renal cell ... Pancreatic cancer - Ductal adenocarcinoma and ovarian cancer - Serous cystadenocarcinoma Canada: Pancreatic cancer - Ductal ... esophageal carcinoma, ovarian serous cystadenocarcinoma, lung squamous cell carcinoma, adrenocortical carcinoma, Diffuse Large ...
... for metastatic small cell lung cancer Treatment of advanced or metastatic pancreatic ductal adenocarcinoma Comparison of ... aldoxorubicin and doxorubicin for patients with metastatic or locally advanced carcinoma A phase III trial for patients with ... "Pilot Phase 2 Study to Investigate the Preliminary Efficacy and Safety of INNO-206 in Advanced Pancreatic Cancer" at ... therapy schedules of doxorubicin and an acid-sensitive albumin-binding prodrug of doxorubicin in the MIA PaCa-2 pancreatic ...
... certain types of skin diseases Cancer Prostate cancer Pancreatic ductal carcinoma Cosmetic applications Facial rejuvenation ...
Poor prognosis and clinical progression of hepatocellular carcinoma, pancreatic adenocarcinoma, and colorectal cancer are all ... "Expression of MAP4K4 is associated with worse prognosis in patients with stage II pancreatic ductal adenocarcinoma". Clinical ... Additionally, miRNA silencing of MAP4K4 in pancreatic beta-cells conferred protection against TNF-α repression of insulin ... pancreatic and ovarian cancer where such up-regulation is associated with increased cell migration, adhesion and invasiveness. ...
... thyroid carcinoma, bladder urothelial carcinoma - nonpapillary, uterine corpus (endometrial carcinoma), pancreatic ductal ... kidney papillary carcinoma, clear cell kidney carcinoma, breast ductal carcinoma, renal cell carcinoma, cervical cancer ( ... esophageal carcinoma, ovarian serous cystadenocarcinoma, lung squamous cell carcinoma, adrenocortical carcinoma, Diffuse Large ... "Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma". Cancer Cell. 32 (2): 185-203.e13. doi:10.1016/j.ccell ...
November 1995). "Characterization of extensive genetic alterations in ductal carcinoma in situ by fluorescence in situ ... esophageal adenocarcinoma and esophageal squamous-cell carcinoma, gastric cancer, bile duct cancer, pancreatic cancer, small ... Habuchi T (August 2005). "Origin of multifocal carcinomas of the bladder and upper urinary tract: molecular analysis and ... January 1983). "Unstable methotrexate resistance in human small-cell carcinoma associated with double minute chromosomes". The ...
Breast Acute myeloid leukemia Pancreatic ductal adenocarcinoma Ovarian B-cell lymphoma Renal cell carcinomas Lung Glioblastoma ...
... with the most common being pancreatic ductal adenocarcinoma (PDAC). Following PDACs, acinar cell carcinomas account for 5% of ... Pancreatic tumors are rare in children. Classification is based on cellular differentiation (ductal, acinar, neuroendocrine, ... A pancreatic tumor is an abnormal growth in the pancreas. In adults, almost 90% are pancreatic cancer and a few are benign. ... The most common type of pancreatic tumor is pancreatic adenocarcinoma, which accounts near 90% of all pancreas cancers. ...
A recent study investigated the use of miRNA as a biomarker in pancreatic ductal adenocarcinoma, a form of pancreatic cancer. ... Included in the findings was an association between hepatocellular carcinoma and the upregulation of miR-92a, a member of ... The study analyzed RNA from biopsied pancreatic cysts to identify deviations in expression of miRNAs. The study found that 228 ... "Towards a clinical use of miRNAs in pancreatic cancer biopsies". Expert Rev Mol Diagn. 13 (1): 31-4. doi:10.1586/erm.12.136. ...
"Inactivating mutations of RNF43 confer Wnt dependency in pancreatic ductal adenocarcinoma". Proc. Natl. Acad. Sci. U.S.A. 110 ( ... "RNF43 mutations are recurrent in Chinese patients with mucinous ovarian carcinoma but absent in other subtypes of ovarian ... "Reversing effect of ring finger protein 43 inhibition on malignant phenotypes of human hepatocellular carcinoma". Mol. Cancer ...
"GPR120 promotes metastasis but inhibits tumor growth in pancreatic ductal adenocarcinoma". Pancreatology. 22 (6): 749-759. doi: ... "Oncogenic signaling of the free-fatty acid receptors FFA1 and FFA4 in human breast carcinoma cells". Biochemical Pharmacology. ... The FFAR4 agonist GSK137647 and docosahexaenoic acid stimulated the release of insulin from cultured mouse and rat pancreatic ... Insight from gastrointestinal-pancreatic-adipose interactions". Frontiers in Endocrinology. 13: 956277. doi:10.3389/fendo. ...
Invasive ductal carcinoma: 55% of breast cancers Ductal carcinoma in situ: 13% Invasive lobular carcinoma: 5% The vast majority ... pancreas; over 80% of pancreatic cancers are ductal adenocarcinomas. prostate cancer is nearly always adenocarcinoma cervical ... Thus invasive ductal carcinoma, the most common form of breast cancer, is adenocarcinoma but does not use the term in its name- ... "The changing incidence of in situ and invasive ductal and lobular breast carcinomas: United States, 1999-2004". Cancer ...
"Prognostic significance of growth factors and the urokinase-type plasminogen activator system in pancreatic ductal ... April 2005). "Altered expression of members of the IGF-axis in clear cell renal cell carcinoma". International Journal of ... pancreatic cancer, and clear cell renal cell cancer in which high tissue IGFBP-3 expression has been linked to poor prognostic ... expression of insulin-like growth factor binding protein-3 and its promoter hypermethylation in human hepatocellular carcinoma ...
Ductal pancreatic carcinoma (DPC) is definitely a deadly disease with an. Ductal pancreatic carcinoma (DPC) is definitely a ... Ductal pancreatic carcinoma (DPC) can be the most common pancreatic tumor type accounting TSU-68 for approximately 90% of most ... Overexpression of KLF4 inside a human being pancreatic carcinoma cell range induced a substantial reduction in the ... Pancreatic tumor is the 5th leading reason behind cancer-related loss of life in men and women under western culture being in ...
See also Ampullary Carcinoma, Pancreatic Cancer, Pancreatic Trauma, and Carcinoma of the Ampulla of Vater. ... Pancreatic ductal adenocarcinoma. Feig BW, Ching CD, eds. The MD Anderson Surgical Oncology Handbook. 6th ed. Philadelphia: ... for surgical treatment of periampullary and pancreatic carcinoma. Cochrane Database Syst Rev. 2014 Nov 11. 11:CD006053. [QxMD ... for surgical treatment of periampullary and pancreatic carcinoma. Cochrane Database Syst Rev. 2016 Feb 16. 2:CD006053. [QxMD ...
pancreatic ductal carcinoma DOID:3587. DOID:10023. ICD10CM:C25.3. ICD9CM:157.3. MESH:D021441. UMLS_CUI:C0153461. UMLS_CUI: ... pancreatic cancer DOID:1793. DOID:14356. DOID:1797. DOID:3588. DOID:9859. ICD10CM:C25.0. ICD10CM:C25.1. ICD10CM:C25.2. ICD9CM: ...
Pancreatic ductal carcinoma is a common form of pancreatic cancer. The pancreatic duct is also called the duct of Wirsung. This ... The pancreatic duct, or duct of Wirsung (also, the major pancreatic duct due to the existence of an accessory pancreatic duct ... Pancreatic duct Deep dissection.Anterior view. Ultrasonography of a dilated pancreatic duct (in this case 9mm) due to ... Pancreatic duct or parts of pancreatic duct can be demonstrated on ultrasound in 75 to 85% of people. ...
Advanced hepatocellular carcinoma, pancreatic ductal adenocarcinoma (PDAC) and biliary tract cancer. Patients with these ... Advanced pheochromocytoma/paraganglioma (PPGL) or pancreatic neuroendocrine tumor (pNET). Patients with these cancers can join ... Locally advanced or metastatic hepatocellular carcinoma (HCC). Adult patients with biopsy-proven advanced hepatocellular cancer ...
Approximately 80% of all pancreatic cancers are adenocarcinomas, with only 2% of exocrine pancreatic tumors diagnosed as benign ... Pancreatic cancer is a leading cause of cancer deaths in both men and women. ... ductal adenocarcinomas are far more common than all other histologic subtypes of pancreatic cancer. Most ductal adenocarcinomas ... DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer. J Clin Oncol ...
Presented by Masayuki Tori, MD Keyword(s): HALSP-DP, invasive ductal carcinoma, pancreatic tumors ... SAGES Poster Rounds: P003 STANDARDIZATION OF HALS-DP FOR PANCREATIC MALIGNANT TUMORS. ...
Thus the final diagnoses of pancreatic tumours included 49 patients with pancreatic ductal carcinomas, seven patients with ... of all pancreatic ductal carcinomas. This pathophysiological phenomenon of pancreatic tumours was first visualised by means of ... of pancreatic ductal carcinomas, although most were relatively hypovascular compared with the surrounding pancreatic tissue. ... On contrast enhanced US, tumour vessels were visualised in 33 (67%) of all pancreatic ductal carcinomas (29 type II; one type ...
However, adenocarcinomas of the lung, and occasional breast, transitional cell and pancreatic carcinomas had moderate or high ... In a series of 175 human adult tumors, gene expression was highest in ovarian serous carcinomas. ... In addition to consistent positivity in ovarian carcinoma, some pulmonary, endometrial, and breast adenocarcinomas, ... mesotheliomas, and less often, gastrointestinal, renal and transitional cell carcinomas were also positive. Knowledge of the ...
... which promotes the growth of pancreatic ductal adenocarcinoma (26). More recently, TFE3 was shown to exert protumorigenic roles ... Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A ... Mutations in BHD and TP53 genes, but not in HNF1β gene, in a large series of sporadic chromophobe renal cell carcinoma. B J ... Using the invasive breast carcinoma TCGA data set, we show that FLCN, FNIP1, and FNIP2 levels are all significantly ...
Three participants were on-study at the prior data cutoff date: a fourth-line (4L) metastatic pancreatic ductal adenocarcinoma ... Participant with 3L non-clear cell renal cell carcinoma. *Week 23 scan showed progressive disease demonstrating a meaningful ... "In the metastatic pancreatic cancer patient who had previously achieved a confirmed partial response, tumor reduction of both ... Continued tumor reduction and complete regression of one of three metastatic lesions in fourth-line pancreatic cancer patient ...
... and CPS with 22C3/SP263 assays in head and neck and urothelial carcinomas. On the other hand, for other malignancies, such as ... In the rare variant of pancreatic ductal adenocarcinoma called undifferentiated carcinoma with osteoclast-like giant cells, PD- ... PD-1, PD-L1, and CD163 in pancreatic undifferentiated carcinoma with osteoclast-like giant cells: Expression patterns and ... Comprehensive characterisation of pancreatic ductal adenocarcinoma with microsatellite instability: Histology, molecular ...
The most common cause of malignant biliary obstruction is pancreatic adenocarcinoma. Gallbladder carcinoma is 9 times more ... Biliary ductal calculi occur in 20-50% of patients with cholangiocarcinoma; however, the association of gallstones with ... An Algorithmic Approach to Immunotherapy-Based Treatment in Hepatobiliary Carcinomas 1.25 CME / ABIM MOC Credits ... 22] Hepatocellular carcinoma shows an early peak increase in attenuation with a progressive decrease. The overlying liver ...
However, the efficacy of using pyroptosis-related genes (PRGs) in predicting the prognosis of pancreatic adenocarcinoma (PAAD) ... The most frequent type of pancreatic cancer is pancreatic ductal adenocarcinoma (PDAC), which accounts for up to 90% of ... colorectal carcinoma [65], and small-cell lung cancer [66]. PLCG1 has not been reported in pancreatic cancer, and we only found ... J. Kleeff, M. Korc, M. Apte et al., "Pancreatic cancer," Pancreatic cancer. Nat Rev Dis Primers, vol. 2, no. 1, p. 16022, 2016. ...
... receptor subtype-1 and SR 48692 counteracts neurotensin induced cell proliferation in human pancreatic ductal carcinoma cell ... Wang JG, Li NN, Li HN, Cui L, Wang P (2011) Pancreatic cancer bears overexpression of neurotensin and neurotensin ... The neurotensin receptor-1 pathway contributes to human ductal breast cancer progression. PloS One 4(1):e4223. https://doi.org/ ...
Ductal carcinoma in situ, Parathyroid cancer, Goiter, Tertiary hyperparathyroidism, Hyperthyroidism, Thyroid cancer, Atypical ... Radiopharmaceutical therapy, Positron emission tomography scan, Thyroid cancer, Pancreatic neuroendocrine tumor, Neuroe... ... Anyone here with Hurthle Cell (Oncocytic) Carcinoma? 46 Replies Mon, Aug 14, 2023 ... Mastectomy, Breast reduction, Minimally invasive parathyroidectomy, Laparoscopic surgery, Adrenalectomy, Pancreatic enu... ...
This is a "connection" page, showing publications Kathryn Colborn has written about Carcinoma, Pancreatic Ductal. ... Comparing neoadjuvant chemotherapy with or without radiation therapy for pancreatic ductal adenocarcinoma: National Cancer ... Pulmonary metastasectomy is associated with survival after lung-only recurrence in pancreatic cancer. Surgery. 2023 09; 174(3): ... Association of Adjuvant Chemotherapy in Patients With Resected Pancreatic Adenocarcinoma After Multiagent Neoadjuvant ...
... pancreatic ductal adenocarcinoma. Patients with clinical suspicion of pancreatic adenocarcinoma can be enrolled for pre- ... Patients with squamous carcinoma, adenosquamous carcinoma or neuroendocrine tumor will be excluded. Tumor Biopsy can be omitted ... BMS-813160 With Nivolumab and Gemcitabine and Nab-paclitaxel in Borderline Resectable and Locally Advanced Pancreatic Ductal ... BMS-813160 With Nivolumab and Gemcitabine and Nab-paclitaxel in Borderline Resectable and Locally Advanced Pancreatic Ductal ...
... of ductal pancreatic carcinomas, NT receptor expression of endocrine pancreatic tumors, pancreatitis, and normal pancreatic ... It has been determined that in the majority of medullary thyroid carcinomas (MTCs), in a high rate of small-cell lung cancer ... but the most appropriate ratios for imaging pancreatic tumors were obtained with the 111In-labeled analogues [86]. ...
Real-Time Genomic Profiling of Pancreatic Ductal Adenocarcinoma: Potential Actionability and Correlation with Clinical ... Biliary carcinomas: pathology and the role of DNA mismatch repair deficiency., Chinese clinical oncology, 2016 Journal Article ... Real-Time Genomic Profiling of Pancreatic Ductal Adenocarcinoma: Potential Actionability and Correlation with Clinical ... in pancreatic ductal adenocarcinoma (PDAC)., Journal of Clinical Oncology, 35, (4{\_), 2017, p260--260 Journal Article, 2017 ...
A mass spectrometry-based analyses of institutional fluid from a pancreatic ductal carcinoma mouse model showed depletion of ... 2018) Hypoxic Tumor-Derived exosomal miR-301a mediates M2 macrophage polarization via PTEN/PI3Kγ to promote pancreatic Cancer ... pancreatic cancer cells secrete microRNAs into EVs that activate the PI3K signaling pathway to induce M2 macrophage ... we investigated gene gain-of-function as well as loss-of-function across genes with annotated function in a colon carcinoma ...
However, cancers including pancreatic ductal adenocarcinoma (PDA) and microsatellite stable colorectal carcinoma (MSS CRC) have ... T cell receptor repertoire features associated with survival in immunotherapy-treated pancreatic ductal adenocarcinoma. JCI ... Abstract IA01: Turning the heat up on pancreatic cancer: Lessons on overcoming a "cold" immunologic microenvironment Elizabeth ... Elizabeth M. Jaffee; Abstract IA01: Turning the heat up on pancreatic cancer: Lessons on overcoming a "cold" immunologic ...
Carcinoma Ductal Pancreático; Neoplasias Pancreáticas; Carcinoma Ductal Pancreático/diagnóstico por imagem; Carcinoma Ductal ... Preoperative predictors for early and very early disease recurrence in patients undergoing resection of pancreatic ductal ... Carcinoma Ductal Pancreático Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humanos ... Carcinoma Ductal Pancreático Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humanos ...
Approximately 75% of all pancreatic carcinomas occur within the head or neck of the pancreas, 15-20% occur in the body of the ... Pancreatic cancer is the fourth leading cause of cancer deaths, being responsible for 7% of all cancer-related deaths in both ... Molecular analysis to detect pancreatic ductal adenocarcinoma in high-risk groups. Gastroenterology. June 2005. 128:2124-30. [ ... Pancreatic cancer. T staging for pancreatic carcinoma. T1 and T2 stages are confined to the pancreatic parenchyma. T3 lesions ...
KLF4 is a Novel Candidate Tumor Suppressor Gene in Pancreatic Ductal Carcinoma Humans / Tumor Suppressor Gene / Cell ... KLF4 is a Novel Candidate Tumor Suppressor Gene in Pancreatic Ductal Carcinoma Humans / Tumor Suppressor Gene / Cell ... KLF4 is a Novel Candidate Tumor Suppressor Gene in Pancreatic Ductal Carcinoma Humans / Tumor Suppressor Gene / Cell ...
To explore survival-related ATIRE events in lung squamous cell carcinoma (LUSC), ATIRE profile, gene expression data, and ... CircNEIL3 regulatory loop promotes pancreatic ductal adenocarcinoma progression via miRNA sponging and A-to-I RNA-editing. Mol ... A nomogram based on A-to-I RNA editing predicting overall survival of patients with lung squamous carcinoma. *Li Liu1 na1, ... Yan Y, Zhang M, Xu S, Xu S. Identification of an Immune Gene Expression Signature for Predicting Lung Squamous Cell Carcinoma ...
A Phase II Study of Neoadjuvant FOLFIRINOX in Patients with Resectable Pancreatic Ductal Adenocarcinoma with Tissue Collection ... treated basal cell or squamous carcinoma of the skin, superficial bladder tumors (Ta, Tis \& T1), ductal carcinoma in situ ( ... A Phase II Study of Neoadjuvant FOLFIRINOX in Patients with Resectable Pancreatic Ductal Adenocarcinoma with Tissue Collection ... A core pancreatic or liver biopsy does not preclude the patient from the study.. 11. Unable or unwilling to discontinue use of ...
CARCINOMA, PANCREATIC DUCTAL. CARCINOMA PANCREATICO DUCTAL. CARCINOMA DUCTAL PANCREÁTICO. CAVEOLAE. CAVEOLAS. CAVÉOLAS. ...
CARCINOMA DUCTAL PANCREÁTICO. CARCINOMA, PANCREATIC DUCTAL. CARCINOMA PANCREATICO DUCTAL. CAVÉOLAS. CAVEOLAE. CAVEOLAS. ...
  • Advanced hepatocellular carcinoma, pancreatic ductal adenocarcinoma (PDAC) and biliary tract cancer. (medscape.com)
  • Answer: A. Ductal adenocarcinoma. (medscape.com)
  • Mutations in which of the following genes are commonly found in pancreatic adenocarcinoma? (medscape.com)
  • Mutations in all of the genes listed in slide 4 are found in pancreatic adenocarcinoma. (medscape.com)
  • The most common cause of malignant biliary obstruction is pancreatic adenocarcinoma . (medscape.com)
  • However, the efficacy of using pyroptosis-related genes (PRGs) in predicting the prognosis of pancreatic adenocarcinoma (PAAD) patients is unknown. (hindawi.com)
  • The most frequent type of pancreatic cancer is pancreatic ductal adenocarcinoma (PDAC), which accounts for up to 90% of pancreatic adenocarcinoma cases [ 3 ]. (hindawi.com)
  • This resistance makes surgery the best option for pancreatic adenocarcinoma (PAAD) treatment, and for 10-20% of patients who undergo surgery, the 5-year survival rate is still only 15-25% [ 8 ]. (hindawi.com)
  • Patients with clinical suspicion of pancreatic adenocarcinoma can be enrolled for pre- treatment biopsy, and must be histologically confirmed to have adenocarcinoma before being treated on study. (mycancergenome.org)
  • Preoperative predictors for early and very early disease recurrence in patients undergoing resection of pancreatic ductal adenocarcinoma. (bvsalud.org)
  • This study aimed to identify predictors for early and very early disease recurrence in patients undergoing resection of pancreatic ductal adenocarcinoma (PDAC) resection with and without neoadjuvant therapy . (bvsalud.org)
  • However, cancers including pancreatic ductal adenocarcinoma (PDA) and microsatellite stable colorectal carcinoma (MSS CRC) have on average only 50-70 expressed mutations per exome and do not respond to single-agent ICIs. (aacrjournals.org)
  • T cell receptor repertoire features associated with survival in immunotherapy-treated pancreatic ductal adenocarcinoma. (aacrjournals.org)
  • Olaparib, a poly (ADP-ribose) polymerase (PARP) inhibitor, is used for maintenance therapy in pancreatic adenocarcinoma. (medscape.com)
  • Olaparib has US Food and Drug Administration (FDA) approval for adults with germline BRCA -mutated metastatic pancreatic adenocarcinoma whose disease has not progressed on at least 16 weeks of a first-line platinum-based chemotherapy regimen. (medscape.com)
  • It is indicated for maintenance treatment of adults with deleterious or suspected deleterious gBRCAm metastatic pancreatic adenocarcinoma whose disease has not progressed on at least 16 weeks of a first-line platinum-based chemotherapy regimen. (medscape.com)
  • It has a better prognosis than traditional ductal adenocarcinoma. (msdmanuals.com)
  • See Pancreatic Adenocarcinoma Imaging: What You Need to Know , a Critical Images slideshow, to help identify which imaging studies to use to identify and evaluate this disease. (medscape.com)
  • Approximately 80% of all pancreatic cancers are adenocarcinomas, with only 2% of exocrine pancreatic tumors diagnosed as benign. (medscape.com)
  • In a series of 175 human adult tumors, gene expression was highest in ovarian serous carcinomas. (nature.com)
  • 2. Other malignancies within the past 3 years except for the following: adequately treated cervical or vulvar carcinoma in situ, treated basal cell or squamous carcinoma of the skin, superficial bladder tumors (Ta, Tis \& T1), ductal carcinoma in situ (DCIS) of the breast and low grade prostate cancer. (iu.edu)
  • Digestive system tumors including esophageal cancer, colorectal cancer, gastric cancer, pancreatic cancer, hepatic cancer, cholangiocarcinoma, and gallbladder carcinoma are associated with significantly high mortality and morbidity rates [ 1 ]. (ijbs.com)
  • Most pancreatic cancers are exocrine tumors that develop from ductal and acinar cells. (msdmanuals.com)
  • Extrahepatic tumors are divided into proximal, middle, and distal ductal tumors. (medscape.com)
  • Solitary well-demarcated tumors are difficult to differentiate from primary hepatocellular carcinomas (HCCs). (medscape.com)
  • Compared with other tumors, they are less cellular and have relatively few well-differentiated carcinoma cells in a dense connective tissue stroma. (medscape.com)
  • Pancreatic tumor is the 5th leading reason behind cancer-related loss of life in men and women under western culture being in charge of 5% of most cancer-related fatalities.1 Having less reliable early diagnostic strategies and effective therapeutic regimens makes the mortality prices in TSU-68 individuals with pancreatic carcinoma virtually exactly like the incidence prices. (scienceexhibitions.org)
  • See also Ampullary Carcinoma , Pancreatic Cancer , Pancreatic Trauma , and Carcinoma of the Ampulla of Vater . (medscape.com)
  • Pancreatic ductal carcinoma is a common form of pancreatic cancer. (wikipedia.org)
  • Ultrasonography of a dilated pancreatic duct (in this case 9mm) due to pancreatic cancer. (wikipedia.org)
  • Pancreatic cancer is a leading cause of cancer deaths in both men and women. (medscape.com)
  • The American Cancer Society estimated that in 2022, there would be 62,210 new cases of pancreatic cancer and 49,830 deaths from pancreatic cancer (25,970 in men and 23,860 in women). (medscape.com)
  • [1] The overall average 5-year survival rate for patients with pancreatic cancer is 11%, though survival is highly dependent on staging. (medscape.com)
  • Which of the following histologic subtypes of pancreatic cancer is the most common? (medscape.com)
  • With a prevalence of 80-85%, ductal adenocarcinomas are far more common than all other histologic subtypes of pancreatic cancer. (medscape.com)
  • The image portrays a progressive model of pancreatic cancer, from normal epithelium to invasively growing tumor. (medscape.com)
  • [3] A general rule for the genetic onset of pancreatic cancer is that multiple combinations of genetic mutations are present in adenocarcinomas. (medscape.com)
  • Among newly diagnosed patients with pancreatic cancer, which of the following clinical examination findings is most commonly noted? (medscape.com)
  • Jaundice and weight loss are the most common symptoms plaguing patients with pancreatic cancer. (medscape.com)
  • In the metastatic pancreatic cancer patient who had previously achieved a confirmed partial response, tumor reduction of both target lesions continued. (tmcnet.com)
  • Pancreatic cancer is the fourth leading cause of cancer-related death in the USA and Europe [ 1 ], and it is expected to overtake lung carcinoma as the second leading cause by 2030 [ 2 ]. (hindawi.com)
  • The insidious and nonspecific symptoms of the disease make it difficult to diagnose, and cases of pancreatic cancer that can be definitively diagnosed are usually already in advanced stages. (hindawi.com)
  • In addition, a growing number of clinical cases have found that pancreatic cancer exhibits significant resistance to traditional treatment options, including chemotherapy, radiation, and immunotherapy [ 6 , 7 ]. (hindawi.com)
  • Pulmonary metastasectomy is associated with survival after lung-only recurrence in pancreatic cancer. (ucdenver.edu)
  • The purpose of this research study is to learn more about a new combination of drugs being given to treat pancreatic cancer. (mycancergenome.org)
  • Her work is supported by the Pancreatic Cancer Research Fund (https://www.pcrf.org.uk), Science Foundation Ireland, through the Precision Oncology Ireland Consortium and the EU Horizon 2020 Marie Sklodowska-Curie Programme. (tcd.ie)
  • Turning the heat up on pancreatic cancer: Lessons on overcoming a "cold" immunologic microenvironment [abstract]. (aacrjournals.org)
  • The most active agents for pancreatic cancer have been 5-fluorouracil (5-FU) and gemcitabine. (medscape.com)
  • Response rates are typically less than 20% in pancreatic cancer. (medscape.com)
  • Erlotinib has been approved by the FDA for use, in combination with gemcitabine, as a first-line treatment for locally advanced, unresectable, or metastatic pancreatic cancer. (medscape.com)
  • Acinar cell carcinoma is a rare cause of pancreatic cancer. (msdmanuals.com)
  • Genetic testing is now offered routinely to all patients diagnosed with pancreatic cancer. (msdmanuals.com)
  • Symptoms of pancreatic cancer such as pain and weight loss are nonspecific, leading to a later diagnosis by which time the disease has spread. (msdmanuals.com)
  • Pancreatic cancer causes diabetes in up to half of patients, leading to symptoms of glucose intolerance (eg, polyuria and polydipsia). (msdmanuals.com)
  • Biomarkers of the transsulfuration pathway and risk of renal cell carcinoma in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. (who.int)
  • Ductal carcinoma in situ (DCIS) is a breast disease that may lead to invasive breast cancer. (cdc.gov)
  • In men, mutations in the BRCA1 and BRCA2 genes can increase the risk of breast cancer, high-grade prostate cancer, and pancreatic cancer. (cdc.gov)
  • Advanced pheochromocytoma/paraganglioma (PPGL) or pancreatic neuroendocrine tumor (pNET). (medscape.com)
  • Patients with squamous carcinoma , adenosquamous carcinoma or neuroendocrine tumor will be excluded. (mycancergenome.org)
  • Locally advanced or metastatic hepatocellular carcinoma (HCC). (medscape.com)
  • Mutations in K- ras are found in more than 90% of diagnosed pancreatic cancers. (medscape.com)
  • Mutations in P16 are seen in 80-95% of diagnosed pancreatic cancers. (medscape.com)
  • Alterations in P53 are found in 50-75% of diagnosed pancreatic cancers. (medscape.com)
  • Alterations in SMAD4 are seen in approximately 55% of diagnosed pancreatic cancers. (medscape.com)
  • The diagnosis of pancreatic cancers, particularly their differential diagnosis from chronic pancreatitis, has often been difficult, even when a combination of various imaging modalities such as ultrasonography (US), magnetic resonance cholangiopancreatography (MRCP), endoscopic retrograde cholangiopancreatography (ERCP), endosonography (EUS), contrast enhanced computed tomography (CT), and catheterised angiography are employed. (bmj.com)
  • 10% of pancreatic cancers are associated with an underlying genetic component. (msdmanuals.com)
  • Lack of KLF4 manifestation is closely linked to the genomic reduction and its repair inhibits tumor cell proliferation recommending an integral suppressor part in pancreatic tumorigenesis. (scienceexhibitions.org)
  • Ductal pancreatic carcinoma (DPC) can be the most common pancreatic tumor type accounting TSU-68 for approximately 90% of most pancreatic malignancies. (scienceexhibitions.org)
  • The images in the slide are of cytologic samples from fine-needle aspiration (FNA) of pancreatic adenocarcinomas: (A) well-differentiated tumor, (B) moderately differentiated tumor, (C) moderately to poorly differentiated tumor, and (D) poorly differentiated tumor. (medscape.com)
  • Biliary ductal dilatation is easily demonstrated with US, but the tumor mass is seldom localized with it. (medscape.com)
  • In 1946, Waugh and Clagett described a formal en-bloc resection of the gallbladder with the common bile duct (CBD), gastric antrum, duodenum, and pancreatic head performed as a one-stage procedure, which we recognize today as the classic pancreaticoduodenectomy. (medscape.com)
  • however, the association of gallstones with cholangiocarcinoma is less marked than with carcinoma of the gallbladder. (medscape.com)
  • Gallbladder carcinoma is 9 times more common than bile duct malignancy. (medscape.com)
  • Pancreatic-protocol computed tomography (CT) with thin collimation will detect anatomic contraindications for surgical resection. (medscape.com)
  • Sixty five patients with suspicious pancreatic tumours received contrast enhanced coded phase inversion harmonic ultrasonography, contrast enhanced computed tomography, and endosonography. (bmj.com)
  • Values for sensitivity in depicting pancreatic tumours of 2 cm or less in size were 68% for contrast enhanced computed tomography, 95% for endosonography, and 95% for contrast enhanced ultrasonography. (bmj.com)
  • ERCP image showing the pancreatic duct and biliary tree. (wikipedia.org)
  • This supplies it with pancreatic juice from the exocrine pancreas, which aids in digestion. (wikipedia.org)
  • To explore survival-related ATIRE events in lung squamous cell carcinoma (LUSC), ATIRE profile, gene expression data, and corresponding clinical information of LUSC patients were downloaded from the TCGA database. (biomedcentral.com)
  • Here, we aimed to develop a prediction model using ATIRE to predict overall survival (OS) of individuals affected by lung squamous cell carcinoma (LUSC). (biomedcentral.com)
  • Final diagnoses based on histological findings were pancreatic ductal carcinomas in 49 patients, inflammatory pseudotumours with chronic pancreatitis in seven, and endocrine tumours in nine. (bmj.com)
  • In 1937, Brunschwig extended the indications for pancreaticoduodenectomy by performing the operation for pancreatic head lesions. (medscape.com)
  • Invasive ductal carcinoma. (cdc.gov)
  • However, adenocarcinomas of the lung, and occasional breast, transitional cell and pancreatic carcinomas had moderate or high levels of HE4 expression. (nature.com)
  • 18 With the exception of the ovarian neoplasms, the same carcinomas analyzed for gene expression were also examined for HE4 by immunohistochemistry on tissue microarrays (see below). (nature.com)
  • Although innumerable details of pancreaticoduodenectomy yield to continued innovation, a comprehensive discussion of intraoperative variants (ie, duct to mucosa vs invagination of the pancreaticojejunal anastomosis, diverse approaches to vein resection and reconstructions, nuances of each enteric anastomosis, and modifications of Roux-en-Y reconstructions, to name a few) is beyond the scope of this article. (medscape.com)
  • Most ductal adenocarcinomas are tough and gritty gray-white clumps that mainly metastasize in the head of the pancreas. (medscape.com)
  • [2] Histologically, most pancreatic adenocarcinomas are moderately to poorly differentiated. (medscape.com)
  • and a 3L non-clear cell renal cell carcinoma patient with SD. (tmcnet.com)
  • The relationship between blood pressure and risk of renal cell carcinoma. (who.int)
  • Epidemiology of Renal Cell Carcinoma: 2022 Update. (who.int)
  • Mycotoxin Exposure and Renal Cell Carcinoma Risk: An Association Study in the EPIC European Cohort. (who.int)
  • Contrast enhanced Doppler sonography has been proposed as a valuable technique for the diagnosis of hepatic and pancreatic tumours. (bmj.com)
  • The pancreatic duct, or duct of Wirsung (also, the major pancreatic duct due to the existence of an accessory pancreatic duct), is a duct joining the pancreas to the common bile duct. (wikipedia.org)
  • The image in the slide shows a gross section of a cancerous pancreas measuring 5 × 6 cm that has been resected from the pancreatic body. (medscape.com)
  • Formation of an accessory pancreatic duct Compression, obstruction or inflammation of the pancreatic duct may lead to acute pancreatitis. (wikipedia.org)
  • Contrast enhanced coded phase inversion harmonic ultrasonography successfully visualised fine vessels in pancreatic tumours and may play a pivotal role in the depiction and differential diagnosis of pancreatic tumours. (bmj.com)
  • The pancreatic duct joins the common bile duct just prior to the ampulla of Vater, after which both ducts perforate the medial side of the second portion of the duodenum at the major duodenal papilla. (wikipedia.org)
  • In the other 30% of people, it drains into the main pancreatic duct, which drains into the duodenum via the major duodenal papilla. (wikipedia.org)
  • The main pancreatic duct and the accessory duct both eventually-either directly or indirectly-connect to the second part ('D2', the vertical segment) of the duodenum. (wikipedia.org)
  • A gallstone may get lodged in the constricted distal end of the ampulla of Vater, where it blocks the flow of both bile and pancreatic juice into the duodenum. (wikipedia.org)
  • Termination pattern of main and accessory pancreatic ducts among Tanzanians. (wikipedia.org)
  • Overexpression of KLF4 inside a human being pancreatic carcinoma cell range induced a substantial reduction in the proliferation connected with up-regulation of p21 as well as the down-regulation of cyclin D1. (scienceexhibitions.org)
  • Contrast enhanced ultrasonography demonstrated tumour vessels in 67% of pancreatic ductal carcinomas, although most were relatively hypovascular compared with the surrounding pancreatic tissue. (bmj.com)
  • HE4 is one of more than 8900 different human genes represented on U95a GeneChips (Affymetrix, Santa Clara, CA, USA), which we used previously to develop a molecular classification of 175 human carcinomas based on patterns of gene expression. (nature.com)
  • A radical medical approach can be done in mere 10% of instances and adjuvant therapies are practically ineffective.2 An improved knowledge of the molecular systems resulting in pancreatic tumorigenesis might provide new markers for early analysis and potential focuses on for therapeutic treatment. (scienceexhibitions.org)
  • The pancreatic duct is generally regarded as abnormally enlarged if being over 3 mm in the head and 2 mm in the body or tail on CT scan. (wikipedia.org)